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ABSTRACT 
The hypothalamus has been sho~m to.be intimately involved in the con-
trol of ovulation and the estrous cycle by many experimental approaches • 
. 
Evidence for regulative influences by extrahypothal2mic brain structures has 
also been accumulat.ing.. In ss much as the anyg-dala seems to ha\·e some influence 
on gonadotrophin secretion in various types of non-cyclic animals, the impor-
tance of the &mygdala on gon.adotrophin secretion in cyclic animals was investi-
gated. 
Rats of proven cyclicity {vaginal smears) had bilatei:al electrolytic 
lesions placed in the cortical nucleus of the c.mygdala during l'lletestrus. Ani-
mals were autopsied l) during the third cycle between 2:30 PM and 3:30 PH on 
proestrus, 10:00 JJ1 and 11:00 .A¥,. or 2:30-3:30 PM on estrus, and between 2:30 PM 
and 3:.30 PM on metestrus of the fourth cycle, 2) around the 60th day postope'ra .. 
tive between 2:30-3:30 PM on proestrus, and between 10:00 ~nd 11:00 .ti.Mor be-
tween 2:30-3:30 PM on est.rus, 3) r-round the 120th day postoperative between 
2:30-3:30 PM on prcestrus and between 2:30-3:30 PM on estrus. Neither body rior 
organ weights {pituitary, thyroid, adrenal, ovarian, and uterine) developed any 
trend following lesions to deviate from vclues in either control or sham lesioned 
(electrode lowered but no current) animals. Ovulation, as indicated by the 
number of ova ~ the ovid~ct, was not altered by lesioning. Ovarian histology 
of ovaries from animals in the three cycle study reveals several corpora lutea 
per lesioned animal on metestrus have a· prominent lumen; control &nimals have 
solid corpora lut.ea by metestrus. Lesioned animals from the 2-month and 4-
month studies had l~teal lumens during estrns, but so did their respective 
iii. 
• 
control animals. No consistent effect was noted by the lesion on plasma LH in 
the 3-cycle study; however, there was some indication the afternoon levels of 
LH may have been slightly elevated on estrus, but not during any of the other 
autopsy time peri.ods. Plasma IB showed no apparent alterations in the 2-month 
study. Plasma LH measurements in the 4-month study indicate the proestrus 
critical period may be advanced. Pituitary LH measurements in the 3-cycle 
study reveal an increased reaccumulation of pituitary LlI storage following 
ovulation in lesioned animals. Pituitary LH measurement from· the 2- and 4-
month studies show no difference between lesioned and control animals bece.use 
these older control. animals had higher LR stores than their younger experimental 
counterparts. It appears from these data the ACO may have an effective inhi-
bitory influence in cyclic animals but· much attenuated from the role indicated 
from non-cyclic animals. Because the ACO lesioned animals appear in some 
respects similar to older animals, the loss of certain amygdaloid influences 
as animals age may be involved in some of the endocrine alterations in aged 
animals. Evaluation of ~SH regulation in ACO lesioned animals was tested by 
the ovarian compensatory hypertrophy (OCH) response. Animals were lesioned 
and unilaterally ovariectomized the same day, then autopsied ten days later. 
Lesions of the ACO or of the stria terminalis prevented the OCH response, sham 
lesions or cerebral cortex lesions did not prevent the OCH response. Since the 
age of the animals in the OCH study and the 3-cycle study were comparable, it 
appears the ACO lesions may affect the LH and FSH refUlatory neuroendocrine 
networks in the opposite fashions, i.e., augmenting LH secretion while depres-
sing FSH secretion. 
iv. 
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Chapter I 
LITERATURE .REVIEW 
The central nervous system (CNS) plays a primary role in maintaining 
the rhythmicity of the estrous cycle. This regulatory role of the CNS can be 
modulated by both the ovarian and the pituitary hormones. The prominent CNS 
regulation appears to reside within the hypothalamus in that an independent 
functional hierarchy has been· revealed in this region. The basal hypothalamus 
will maintain ovarian histology but not ovulation. Deafferentation of the 
. . 
anterior hypothalamus-preoptic area (POA.) as a unit with the basal hypothala-
mus will support both ovarian histology and ovulation, but the ovulations are 
at longer intervals than normal. The hypothalamus thus has the ability to 
support ovulation but requires extra hypothalamic influences to maintain 
uniform cyclicity of four- or five-day cycles characteristic of the rat. It 
is the purpose of the literature review to explore functional roles of the 
ovary, pituitary, and hypothalamus in the mechanics of the estrous cycle as 
the background against which the role that the amygdala may play can be dis-
cussed, with particular emphasi.s placed on the cortical nucleus of the 
amygdala. 
A. Gross Anatomical Changes Associated with the Stages of the Rat 
F.strous Cycle 
As discussed below, changes in organ cytology and in weight or size 
are associated with the estrous cycle. These changes reveal fluctuation of 
hormones responsible for maintaining the estrous cycle. 
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1• Vaginal Cytology 
Efforts to elucidate the female reproductive cycle were of limited 
value until 1917 when Stockard and Papanicolaou (263) reported their success 
in identifying the stages of the guinea-pig estrous cycle by making daily 
examinations of the cell types within the vagina. Applying this newly dis-
covered technique, Long and Evans (189) published results of an intensive 
2 
• inVestigation on the rat, correlating the periodic anatomical changes of the 
reproductive tract with the different cell types obtained from the vagina. 
Their· investigations revealed a predominB.'lce of four- to five-day cyclic 
patterns recognizable from the periodical occurrence of leukocytic and cor-
nif'ied epithelial cells in the vagina (189). Placing the rats in an environ-
ment of controlled daily lighting, l!Nerett: (861 89) described the cytological 
changes as a daily sequence during the cycle which was recognized as being 
exactly four or five days long (see also section I.D.2.). In describing the 
daily cyclic changes, the names suggested by Long and Evans (189) for the 
cyclic stages will be retained throughout the dissertation. 
The Four-day Cycle: 
METESTRUS - the first day of the cycle is usually characterized by 
large numbers of leukocytic cells. It is not unusual, though, for variable 
numbers of cornified cells to be interspersed between the leukocytes. 
DIFSTRUS - the second day of the cycle is characterized by a much less 
de~se accumulation of cell types. Although leukocytes often predominate, cor-
nified and nucleated epithelial cells are frequently as numerous as the leuko-
cytes. 
PROESTRUS - the third day of the cycle is characterized by very few or 
no leukocytes. Either nucle~ted or cornified epithelial cells or a combination 
of these two predominate. 
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ESTRUS - the fourth day of the cycle is characterized by very large 
numbers of cornified epithelial cells, occasionally a few nucleated epithelial 
cells, a~d virtually no leukocytes. 
The Five-day Cycle: 
The five-day cycle has an extra day of diestrus. Like the first, the 
second day is characterized by roughly equal numbers of leukocytes, nucleated 
epithelial, and cornified epithelial cells. Thus, proestrus and estrus are 
·the fourth and fi~h days of the five-day cycle, respectively, with the same 
cytological characteristics seen for the four-day cycle. 
Internal physiological phenomena, as discussed below, were found co-
incident with specific days oft he va~nal cycle. The correlation of these 
phenomena has been a driving force toward unravelling the complex interactions 
comprising the rat estrous cycle •. 
2. Ovarian Cyclicity 
Examination of ovaries from animals during the various days of the 
cycle reveals that maturation of the primordial follicles begins during metes-
trus; they ripen on through diestrus reaching maturity during proestrus with 
ovulation occurring durinf estrus (172). After ovulation, the follicular gran-
ulosal cells proliferate forming the corpora lutes (30 1 189). Although the 
corpora lutea persist for several cycles in the rat (189), they are apparently 
functional for less than one cycle (86, 189). 
3.. Ovulation 
The presence of eggs in the oviduct affords direct evidence that ovula-
tion has occurred. In rats with four-day cycles, ovulation begins as early as 
1:10 AM and is completed by 2:30 AM on the day of estrus with rats under a 
lighting regime of lights on· from· 5: 00 AM unt.il 7 :00 PM ( 86). In a ··recent·. s~u9.y 
on four-day rats under the same lighting regimen (ll8) ovulation occurred 
•: 
].ater, i.e., earliest eggs found at 2:30 AM with ovulation completed by 
4:00 AM on estrus. These differences may reflect strain differences of rat 
colonies use?• 
4. Uterine Cyclicity 
Long and Evans (189) first reported the accumulation of fluid within 
.,., ....... 
the lumen of the uterine horns of the rat at the stages of the estrous.cycle 
characterized by cornified and/or nucle~ted epithelial cells in the vaginal 
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· smear. Subsequent investigators confined the qistention of the uterus to 
proestrus (13, 248, 274). Duri'ng the estrous cycle uterine weight fluctuates 
significantly such that the maximum weight is found at proestrus (13, 148, 248). 
Much of this weight gain is due to an increase of tissue fluid, although a 
·significant increase in tissue mass also occurs (13, 248). By estrus 1 uterine 
Weight has declined to a significantly lower weight than that of proestrus; by 
: ·metestrus an additional drop has occurred, although not necessarily signifi-
oantly lower than that of estrus (236, 248). 
B. The Ovary as an Endocrine Organ 
Removal of" both ovaries results in atrophy of the female genital tract 
While autotransplantation of the ovaries prevents it .(189). Ll.kewise, ovariec-
tOllly soon after coitus and before implantation of the embryo results in loss of 
the embryo and atrophy of the genital tract; however, if removal of the ovaries 
' is delayed until after tmplantation, degeneration does not occur and the preg-
nancy results in a normal birth (49). 
l. Endocrine Function of the Follicle 
Allen and Doisy (3) made the first successful demonstration of an ovari-
an extract capable of sustaining the physiological phenomena associated with the 
estrous state of the female. Noting that':.follicles~'.werec'always associated with 
the stage of the cycle when uterine growth and vaginal cell proliferation were 
evident (2), it was assumed that the. follicles were elaborating an estrus-
inducing honnone. With injections of follicular fluid, aspirated from the l 
].areest foll.:f,.cles of cow and pig ovaries, into ovariectomized rats or mice, 
vaginal cornification, maintenance of uterine structure, accumulation of 
uterine lumenal fluid, and mating behavior were demonstrated ('),. 4)o Subse-
quently, chemicals were isolated (193) and identified (68) from the follicular 
liquor which could induce estrus in ovariectomized animals. 
2. Endocrine Function oft he Corpus Luteum 
Although corpora lutea were suspected of having an endocrine function 
related to implantation and the initial stages of pregnancy (188), researchers 
were requiring of luteal extracts an end result which would mimic the charac-
teristics of estrus (.13). After the demonstration by Allen and Doisy (3) that 
the honnone(s) responsible for estrus originated from the follicles, re-evalu• 
ation of the endocrine function of the corpora lutea led to the discovezy of a 
luteal extract, distinct from the follicular extract, necessary for nidation 
and the early stage of pregnancy (5, 49, 51). Soon afterwards, compoilnds which 
had •.iprogestational" properties were. isolated (275) from extracts and identi;;. 
fied (6). 
c. Pituitary - Ovarian Axis 
Although early research on ovarian cyclicity tended to implicate an 
ovarian 11autoregulatozy11 mechanism maintaining the estrous cycle (188), there 
were suggestive data indicating extra-ovarian influences involved in the estrous 
cycle (183). Removal of one ovary was found to result in hypertrophy of the 
remaining ovary (43); this phenomenon is so regular that it has been termed 
"the law or follicular constancy" (183). Ovarian transplant studies also 
yielded evidence for extra-ovarian regulation (1831 1891 263)0 Transplanta-
tion of ovaries into castrated males results only in the development of 
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follicles (183, 263), whereas corpora lutea develop if the ovary is trans-
planted into an ovariectomized female (183, 189)0 Thus, under the influence or 
the male ~ilieu interne the ovary does not cycle. Furthermore, Long and Evans 
· (80) demonstrated that ovaries from inunature rats transplanted into ovariec-
. tomized adult females supported reproductive cyclicity, whereas ovaries from 
adult rats transplanted into immature ovariectomized rats did not support 
.cyclicity, Therefore, the milieu interne of the recipient animal had directed 
the functional development of the donor ovary. · These studies strongly argued 
against the estrous cycle being of independent ovarian origin and provided an 
impetus for subsequent research on the locus of higher levels of overian regu-
lation. 
The first direct indication that ovarian function could be influenced 
by the pituitary came with the demonstration that daily injections of pituitary 
extracts could delay.the onset of puberty and disturb the estrous cycle (79, 80)o 
Although reproductive cyclicity was .suppressed, large ovaries containing both 
corpora lutea and follicles, and nonnal appearing uteri, were found (80) 0 An 
hypophyseal influence over ovarian function was confinned by P. E. Smith (257); 
a consistent and reprod¥cible acceleration of sexual maturity was found fol-
lowing injection of pituitary extracts into immature rats. P.emoval of the 
ovaries prior to treatment prevented the precocious development. Using the 
same techniques, mating was noted in young female mice in which precocious de-
velopment had been induced, indicating a true est~ had been achieved (260). 
The introduction of s technique by which one could hypophysectomize an animal 
Without producing damage to the close lying brain tissue was a marked methodo-
logical advancement (258), since there was some argument at that time over the 
~ 
illlportance of neural tissue (see section I.D.). Ablation of the pituitary with-
out damage to the centrAl nervous system (CNS) resulted in atrophy of the 
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reproductive system and subsequent cessation of estrous cycles; daily injections 
o! extracts of fresh pituitaries resulted in repair of the reproductive system 
(258). ilypophysectomy of immature rats prevente.d vaginal opening; however, 
following injections of pituitary extracts, vaginal opening did occur (259). 
Degeneration of accessory sex tissues in ovariectomized animals could not be 
prevented b~ injections of fresh pituitaries (259). An important ovarian 
dependence on pituitary secretion(s) th'fB seemed evident (259). 
1. Isolation o~ Follicle Stimulating Hormone (FSH) and Luteinizing 
Hormone (LR) 
Evidence for two factors in crude extracts of the pituitary was pre-
sented in 1928 (81); one bad profound effects on somatic growth, although .: 
· apparently was also capable of inducing moderate luteinization of follicles, 
~e other could induce precocious puberty. The authors felt the luteinizing 
ability of the former extract was secondary to its primary growth-promoting 
effect and was therefore not of major importance. That the pituitary did con-
tain_two substances, rather than one, having a profound influence over ovarian 
physiology was demonstrated be Fevold, Hisaw, and Lenard in 1931 (99). These 
substances were termed follicle stimulating hormone (FSH).and luteinizing hor-
mone (LR). Although purification was not achieved at that time, the compounds 
were shown to be chemically separable and distinct. They were also physiolo-
gically uniqueJ the follicle stimulator only induced follicular growth, whereas 
the luteinizer failed in this respect. It would induce formation of corpora 
lutea from the previously developed follicles. These substances were subse-
Quently isolated in crystalline form, the luteinizer (LR) in 1940 (178) and the 
follicle stimulator (FSH) in 19h9 (179). 
2. Some Physiologic Effects of FSH and ·LH 
When first reported (99), LR and FSH were distinguished as separate 
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entities because of specific actions on ovarian development which paralleled 
the changes occurring in the ovary during the estrous cycle, i.e., follicular 
development and luteinization of developed follicles. However, more subtle 
differences were soon ctiscovered. 
a. Estroeen secretion 
Fevold (98) ~eported estrogen secretion by the ovary to be stimulated 
by. a combined action of FSH and LH. While relatively high doses of FSH alone 
had a marginal ability to stimulate estrogen secretion (measured indirectly 
using an increase in uterine weight as_ an end point), estrogen secretion was 
markedly elevated by adding minute amounts of LH; LH alone, even at very high 
doses, did not induce estrogen seq~tion (as measur~d by uterine weights). 
Injection of smaller quantities of FSH failed to induce estrogen secretion un,..: ... ,. 
less· .. ?ccompanied:._by~minute::quantiti'es.'.Qf LH.:: :;ThU.S1; <iivergent··roles .. for:: the two 
pituitary compounds become apparent. Since the FSH preparation was known not 
to be pure, LH contamination may have been responsible for the slight secretion 
of e~trogen following the high doses of FSH alone. It was suggested that pure 
FSH may not stimulate estrogen secretion at all, but rather only stimulate 
follicular growth. LH; on the other hand, although unable to induce estrogen 
secretion by itself, appeared to synergize with subthreshold doses of FSH to 
induce estrogen .secretion. Using a highly purified FSH and LH, Lostroh and 
Johnson (190) confirmed and extended these results. Fevold•s suspicion that 
pure FSH alone might be ineffective in inducing estrogen secretion was veri-
fied. A critical minimal level of FSH (about .1 pg/day) was shown to be needed 1. 
. . 
for both follicular development and promotion of estrogen secretion; however, 
With FSH below this minimal dosage, LH could induce a dose-response curve tor 
estrogen secretion, thus confirming the highly sensitive synergistic relation-
ship between LH and FSH. 
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b. Ovulation 
Immature rat ovarian follicles ripened by exogenous hormone treatments 
can be induced to ovulate by LH and/or FSH (119, 190). Even though FSH alone 
can induce ovulation, other events following ovulation are abnormal; the uterus 
remains ballooned the next day and the corpora lutea are not well developed. 
Ovulation induced by a mixture of FSH and LH, or with just LH, is not accompa-
nied by these abnonnalities (119). Since both FSH (202) and LH (250) are ele-
vated before ovulation both hormones may play a physiologic roleo Thus, LH 
may_ be the primary honnone inducing the physiological events associated with 
ovulation, while FSH plays a secondary role synergizing WitJl LH·7 to;·produce ·a~~ 
ma:icimal ovulatory stimulrns. 
3. General Ovarian Hormone Influence over Pituitary Function in Female Rats 
Evidence for ovarian hormone involvement in the regulation of pituitary 
gonadotrophin levels was first provided by the discovery that pituitaries from 
gonadectomized rats had greater growth-promoting effects on the ovaries of im-
mature rats than pituitaries from intact rats (78, 82). Significantly, the 
·longer the animals were without ovaries, the more.potent were their pituitaries 
in promoting the growth of the immature recipient animals• ovaries (82). The 
increased pituitary gonadotropjin potency of gonadectomized rats was soon 
shown to be inhibited by estrogenic substances (206). Moore and Price presen-
ted a formal hypothesis of inhibition of pituitary secretion of gonadotrophin 
by the gonadal hormones in an elegant series of experiments (213). It was 
demonstrated that gonadal ~xtracts could induce degenerative changes in the 
gonads but these changes could be prevented if extract~ of either pituitaries 
or human pregnancy urine (known to have gonadotrophin~like effects) were admin-
istered simultaneously with the gonadal extract. This hypothesis was tenned 
"push-pull~' in that the pituitary secretions would push the ovary into se~reting 
..--pr 
' 
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its hormones but 1 in return, the ovarian hormones would pull back on, or reduc·e, 
the pituitary secretions (50)o Although this concept gained wide accepta~ce, 
. . 
there was some controversy over its completeness as an explanation of the pheno-
mena associated with the ovarian-pituitary axis. Objection was raised by 
Heller, Heller, and Severinghaus (142), who could induce the well known ovarian 
c~mpensatory hypertrophy (43) and prevent the hypertrophy by injections of 
estrogenic · substan~es, but found that estrogen di.d not prevent the accumulation 
of pituitary gonadotrophin after unilateral ovariectomy. Since the pituitary 
contains several gonadotrophins, a more important question than what happens to 
the total gonadotrophin content 0£ the pituitary is the question of what the 
ovarian hormones do to th~ individual gonadotrophins. An answer to this ques-
tion was attempted by Byrnes and Meyer (37,). The index of pituitary gonado-
trophin secretion (ovarian weight) was found to oscillate around the normal 
average weight, such that at a dose of 002 pg and .l pg of estradiol, ovarian 
· weight was low but at .OB pg ovarian weight was elevated. '.Ihey' concluded that 
whereas FSH secretion appeared to be inhibited by both low and higher circula-
ting estrogen levels, LH secretion appeared to be stimulated by low estrogen 
levels but inhibited by high levels of estrogen. 
With the advent of specific assays for gonadotrophin1 detailed studies 
of FSH and LH could be made (2111 224, 261). 
a. Pituitar-J ar.d plasma LH and FSH in the absence of ovariai steroids 
Bilateral overiectomy of immature and m&ture r~ts results in the eleva-
tion. of both pituitary and .Plasma IJI (227 1 234, 267). This elevation has been 
reported to persist as long as one year after ovariectomy (227). Pituitary 
(54, 114, 227) and plasma (53) FSH also are elevated following ovariectomyo 
Species differences appe~r to exist, however, since in the mouse pituitary 
and plasma FSH rise a~er ovariectomy but pituitary and plasma LH do not (227). 
,. 
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b. Plasma and pituitary LH and FSH in the presence of ovarian steroids 
l) Estrogen 
Estrogen injections will prevent the post-castration rise in both plasma 
and pituitary LH (115,, 226,, 23h,, 267). Although Parlow (226) found that FSH 
also was not detectable in plasma from estrogen-treated ovariectomized rats, a 
differential responsiveness of FSH and LH to the inhibitory action of estrogen 
i~ ovariectomized rats was noted. Injections of physiological doses of estro-
. gen (O.!~ pg/day),, which prevented the post-ovariectomy rise in pituitary LH, 
failed to prevent the rise of FSH. Even with a dose of 2.0 pg/day,, which is 
beyond the physiological range (113,, 226), only a marginally significant 
(p • .05) drop in pituitary FSH was noted. Therefore1 it appears that the FSH 
regulatory system is not as sensitive to the inhibitory effects of estrogen as 
is the LH system. 
Ovarian compensatory hypertrophy (OCH) following unilateral ovariectomy 
was felt to be due to increased circulating gonadotrophin levels (142). How-
ever,, no elevation of LH or FSH was detectable in rat plasma (71). Using a more 
sensitive modification of the Steelman-Pohley FSH assay (261),, Benson et al. 
(24) were able to detect a transient, but significant, rise in plasma FSH on 
the fourth day a~er unilateral ovariectomy, with a return to lower levels 
after abont two weeks. Estrogen inhibits both the OCH response (24, 142) and 
the transient rise in plasma FSH (24). 
In addition to these inhibitory effects of estrogen, estrogen also bas 
a facilitative influence on gonadotrophin secretion. Thus, an injection on the 
second day of a five-day cycle advances ovulation by one day making the cycle 
four days long (86). Estrogen can also induce ovulation in.the rabbit (242) 
and pregnant rat (85). The direct effect of estrogen on LH has revealed that 
plasma LH can be elevated following.daily injection of estradiol for seven 
,. 
---- --- 2'i'Sih 
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days (39) or on the third day following a single injection of estrogen (19)o 
2) Progesterone 
It has been long known that progesterone is less effective than estro-
gen in altering pituitary gonadotrophin content (126). Confirming this, and 
detailing the specific effect of progesterone on LH, McCann (196) found pro-
· gesterone to have only very mini.Jllal effects on the inhibition of LH release in 
ovariectomized rats when physiological levels (83, 192) of 5 mg/day for three 
days were given; only when the dose was increased to 25 mg/day for two days 
was LH release suppressed. However, pretreatment of the ovariectomized rats 
with estrodiol (l pg/day) for two days sensitize~ the animals so that physio-
logical levels of progesterone (4 mg/day for three days) were now effective in 
depressing the elevated LH levels (196). The~e results were partially con- . 
firmed by Nall.ar ~ al. (215) who reported that 1.5 mg progesterone for four 
days failed to reduce plasma LH in ovariectomized rats. 
Daily injections of progesterone (.05 IU/day for twenty days) in 
guinea-pigs prevents ovulation but does not interfere with follicular develop-
ment; therefore progesterone, while inhibiting the ovulatory levels of gonado-
trophins, does not inhibit the follicular growth-promoting levels of FSR (and 
IH) (61). The same results seem applicable during pregnancy (61). However, 
progesterone (1 mg/day) is apparently capable of inhibiting the transient 
increase of FSH starting four days after unilateral ovariectomy (24). 
In addition to its inhibitory effects, progesterone also has facilita-
tive influences over gonadotrophin secretion. Like estrogen, progesterone can 
advance the day of estrus but treatment must be given on the third, rather than 
the second, day of a five-day cycle (84). Furthermore, progesterone has been 
reported to elevate plasma LH levels (38, 215). Thus, progesterone and estro-
gen both have biphasic influences over gonadotrophin secretion. 
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4. Pituitary and Plasma lJI and FSH during the Estrous Cycle 
Early studies on ~onadotrophin secretion revealed that during the after-
noon of proestrus an ovulatory discharge of hormones occurred between 2:00-4:00 
PM; removal of the pituitary from a population of rats before 2:00 PM resulted 
in total suppression of ovulation, whereas removal after 4:00PM did not inter-
rupt ovulation ·(87) (further discussion of this phenomena is in section I.D.2.). 
Since the development of assays specific for the gon~dotrophins (224, 261), as 
outlined below, various investigators have obtained more direct evidence for 
gonadotrophin secretion during the afternoon of"proestrus and throughout the 
remainder of the cycle.· 
a. lJI 
The first characterization of .the dynamic changes occurring in both pi-
tuitary and plasma lJI was presented by Schwartz.and her colleaf;ues (2G>7, 249); 
it was shown that pituitary lJI content is relatively low at netest.rus, somewhat 
. . . 
·pigher at diestrus, and reaches maximal levels by the morning of proestrus. LH 
content begins to drop during the afternoon of proestrus and is significantly 
lower by the morning of estrus. These findinfs have been confirmed by other lab-
oratories. (8, 166). The proest:rus-to-estrus drop in pituitary lJI content appa-
rently reflects· a surge of LH release during the afternoon of proestrus. Plasma 
I.JI levels rise abruptly from marginally- or non~detectablelevels of LH at 10:00 
AM to readily detectt.ble levels by 3 :OOPM (81 1661 176, 236, 250). Plasma I.JI levels 
remain high until 8:QoHf (176), al though it appears only essential that they re-
main high until 4.-00 FM· since hyp:>physectomy after 4.-00 PM does not interrupt ovu-
, . 
lation (87). This prolonged LH release beyond 4:00 PM may be a physiologic over 
sti.lllulation •guaranteeing" ovulation, or it may be essential for stimulating the 
secretion of sufficient progestins for induction of estrous mating behavior (176). 
The development of a radioi~munoassay for rat LH (211) with markedly 
t' 
pr-
~ 
~ 
t, 
~~ 
increased sensitivity has enabled serial measurements from individual rats 
(212). Using this method (212) bioassay findings for both pituitary and plasma 
UI have been confimed. Measurements of serial plasma LH in individual rats 
during the afternoon of proestrus reveals, as one would expect, considerable 
variability in 1) onset of the plasma LH rise, 2) maximum amplitude of the 
rise, and 3) duration of release of the LH surge. This emphasizes the fact that 
the data from the bioassay speaks only of a population average or trend (212). 
be FSH 
Using the FSH bioassay technique of Steelman and Pohley reported in 
1~53 (261), changes in pituitary and plasma FSH levels have also been delineated. 
Pituitary FSH content has been found to drop from high levels on the morning of 
proestrus to low levels on the afternoon of proestrus (119, 202); the drop seems 
to correspond in time with the drop in pituitary LHo Coincident with the sig-
nificant drop in pituitary FSH is a significant rise of plasma FSH during the 
afternoon of proestrus (202). A difference between four- and five-day cyclic 
rats seems to exist; the drop in pituitary FSH is not as marked in the rats 
with four-day cycles as in those with five-day cycles (119, 202). 
D. Hypothalamic Regulation of the Pituitary-OVarim Axis 
' 
l. Functional Dependence of Pituitary on Hypothalamus 
a. Nature of the hypothalamic-pituitary link 
While the pituitary's importance to ovarian function was gaining recog-
nition, evidence for an important role of the· hypothalamus was also accumulaO:..' .· 
ting. Among the first indications of brain involvement in the secretion of •. 
the pituitary gonadotrophins were the experiments of Camus and Roussy (42) and 
. ' 
of Baily and Bremer (lL). Although their primary concetn was studying the 
etiology of diabetes insipidus, they reported, as incidental, atrophy of the 
reproductive organs after destruction of hypothalamic tissue. Environmental 
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influences over pituitary-gonadal function w~re soon demo~trated (3h, 99, 102), 
~dicating that the pituitary-gonadal system was dependent on sensory inputs. 
Thus, ovulation in the rabbit was recognized as being induced by coitus with 
the pituital"'J playing a primary,role in the process; hypophysectomy stopped 
ovulation from occurring only if performed within one hour of coitus (96)~ The 
environmental light-dark cycle was recognized as an important factor regulating 
pituitary-ovarian function (34, 102, 143). Constant light induced sporadic 
cyclicity and, commonly, a state of persistent estrus, i.e., continuous vaginal 
cornification (34, 102). Changing the lighting schedule by 12 hours put the 
. animals in.a cycle 90° out-of-phase with their control state (34). Constant 
light _also induced precocious puberty, while constant dark was found to retard 
puberty (102). Changing the light-dark cycle was also found to shift the time 
of onset of vaginal cornification and behavior during the cycle (143). 
The possibility that the hypothalamus might be involved in the trans-
mission of information from the external environment prompted investigations of 
the hypothalamic involvement with the pituitary-gonadal system. Electrical 
stimulation of dis~rete regions of the hypothalamus was found to induce ovula-
tion in rabbits (133, 135, 140, 194), whereas lesions of the hypothalamus in-
duced anestrus with ~trophy of ovaries and uterus (65, and section I.D.J.), or 
persistent vaginal estrus with the concomitant markedly follicular ovaries (65) 
in spontaneous ovulators. Recognizing neural involvement in the control of 
pituitary secretion, investigators so~ght the nature of the regulation. Two 
possibilities presented themselves: 1) a prominent neural link to the pitui~,.· 
tary, the hypothalamic-hypophyseal tract, was known to exist (101), and 2) a 
vascular portal system linking the pituitary to the hypothalamus had been des-
cribed (231, 276)0 Either or both ~natomical links could serve as communication 
Channels to the pituitary. The first possibility, a direct nerve pathway to the 
f• 
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Figure 1. 
Anatomical relationship of hypothalamic nuclei and the preoptic area. 
ac - anterior commisaure 
aha ~ anterior hypothalamic area 
ap - anterior pituitary 
arh - arcuate nucleus 
cc - corpus callosum 
co - optic chiasma 
cp - posterior commisSUl'e 
Modified from De Groot (60). 
dmh - dorsomedial hypothalamic nucleus 
m - mammmary nuclei 
p - pons 
poa - preoptic area 
pp - posterior pituitary 
pvh - periventricular nucleus of 
. the hypothalamus 
· sc - suprachiasmatic nucleus 
vmh - ventromedial hypothalamic nucleus 
- . 
pituitary, was soon ruled out be various anatomical and physiological studies. 
-Anatomical studies revealed only a very sparse distribution of nerves in the 
pars distalis and these seemed associated with vascular smooth muscle (l22j 
239). This contrasted with the abundant nerve supply observed to be passing 
into the posterior lobe of the pituitary via the hypothalamic-hypophyseal tract 
(101). Examination of avian and cetacean pituitaries (in which there is a dis-
tinct separation of the pars distalis from the neural lobe) failed to reveal 
any nerve fibers in the pars distalis (70, 134)~ In addition, following tran-
section of the hypophyseal stalk, etrophy of the neural lobe resulted; the pars 
distalis was generally little if ·at all affected (136), although a few labs 
noted a structural and functional impairment of this lobe (33, 177, 240) • 
Furthermore, stimulation oft he hypothalamus was found to induce ovulation while 
- stimulation of the pituitary was unsuccessful (i35, 194), thus emphasizing the 
fact that while the hypothalamus was functionally linked to the anterior lobe 
of the pituitary, neural connections to or within the adenohypophysis were 
apparently not involved. 
However, despite the lack of evidence for any neural link between the 
CNS and the adenohypophysis, acceptance of the vascular portal system as the 
informational link was hampered because the direction of portal blood flow was 
disputed. Blood was first believed to pass from the pituitary to the hypothal-
anus (231), but in a later study the possibility of the opposite direction of 
blood flow was proposed (276). Both of these opinions were based on anatomical} 
evidence; the second, however, was later supported by the direct observation of 
flow passing into the pars distalis from the hypothalamus in amphibia (121). 
Evidence:for the hypophyseal-petal flow in ma.1M1alia was accidentally gnined by 
Green and Harris (122). Some of their preparations intended for examination 
of the portal system after systemic infusion of India ink had only been partially 
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infiltrated by the ink. In such "inadequate" preparations,, the hypothalamic 
side of the portal system had been infiltrated while the hypophyseal side had 
no ink. Direct observation of the portal system in the rat finally revealed :" 
the flow was indeed toward the pars distalis (123). 
Another impediment to the acceptance of the portal system was the non-
uniform results o~ stalk sectioning alluded to above. Some reports claimed 
~{· degeneration of the pituitary with resultant. ovarian and uterine atrophy (33,, 
·177, 240), while other reports claimed good maintenance of reproductive func-
tion (62, 63). Building on a previous demonstration (137) that the portal 
vessels, unlike the nerves in the hypophyseal-hypothalamic tract, have great 
regenerative ability, Harris (138) demonstrated the importance of revasculari-
zati·on to the functional state of the pitUitary following stalk sectioning. . 
. . . 
A small piece of waxed peper was placed between the hypothalamus and pituitary 
in some animals after stalk transaction. Only when portal vessels managed to 
regenerate aroun~ the edges of the waxed paper was there any progress toward a 
regaining of pituitary function. 
A second approach which demonstrated that the functional integrity of 
the pars distalis indeed depended on its vascular connections with the hypo-
thalamus was that of hypophyseal ~ransplants (125, 139, 219, 229). It had 
initially been demonstrated that homotrar.splants of pituitaries in the sella 
turcica function normally (125), whereas the cessation of estrous cyclicity 
after hypophysectomy was not overcome by intramuscular implants of pituitaries 
(229). Harris and Jacobsohn (139) extended these observations by hypophysec-
tomizing postpartum rats and, immediately thereafter, transplanting pituitaries 
from their young under either the median eminence or the temporal lobe. Those 
animals receiving transplants under the median eminence resumed full reproduc-
tive capacity, i.e., vaginal cyclicity, .nonnal ovaries and uteri, pregnancy, 
. ,. 
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which could be explained by the lack of regeneration of the neural lobe since 
injections of oxytocin corrected the disturbance. In contrast, rats receiving 
transplants under the temporal lobe did not resume normal reproductive function, 
despite the fact that revascularization of the pituitaries in both sites was 
rich. The concept of a neurohumoral link by the transplant method was elegantly 
finalized when Nikitovitch-Winer and Everett (219) demonstrated that pituitaries 
completely removed from the sella turcica and transplanted onto the kidney for 
one month would not suppo~ reproductive functions; however, they would~­
~ reprod~ctive phenomena if retransplanted under the media~ eminence but 
not if retransplanted under the temporal l_obe. These experiments provided 
strong evidence for the presence of some critical substance(s) in the portal 
blood, but not (at least in as great a quantity) in either the general systemic 
' vascular system or in blood from ttnonspecific" nerve tissue. 
b. Endocrine nature of the hypothalamus 
If the informational link between the hypothalamus and the pars distalis 
was indeed vascular, both the hypothalamus and plasma should contain substances 
which stimulate pituitary secretion. The first demonstration of a hypothalamic 
extract which could elevate gonadotrophin secretion was presented by Mccann and J 
co-workers (201). Other laboratories (40, 411 218) also reported an extract of 
the hypothalamus which, like Mc Cann' s ( 200, 201), induced IJl secretion. The 
active component(s) of the extract did not appear to be neurohypophyseal hor-
mones (40, 41, 201), serotonin (40, lil, 218), histamine (401 41, 218), or 
epinephrine (40, 411 218). Using highly purified preparations of IB-releasing 
factor(s) (LH-RF), Schally and Bowers (243) subsequently demonstrated the 
ability of L.ll-RF to stimulate LH release in' vitro as well as in vivo. 
- --
Early characterization of the LH-releasinf substance(s) was presented 
20 
~ by McCann (195). Ten minutes of boiling destroyed -the activity of LH in pitui-
~ 
I. 
tary extracts:.; but not of the LH-releasing activity in stalk median eminence 
(SME) extracts. However, LR-releasing activity of the SME extracts was found 
totally inactivated by 1n~ubation with pepsin, thus leading to the belief that 
the LH-RF was a polypeptide. These initial observations were supplemented later 
when highly purified LH-RF was prepared and analyzed by several laboratories 
(95, 244).· Although Fawcett ~ !!• (94) prepared highly purified extracts 
capable of inducing ovulation, they were unable to characterize the structure 
because of insufficient material; however, they were able to distinguish two 
separate bioiogically active fractions. Schally and Bowers characterized the 
amino acid content of the LH-RF they separated (244), although no details on 
structure were presented. 
Carotid artery injections of this latter highly pure LH-RF (244) were 
shown t~ have a dose-response effect on inducing ovulation (11); LH contamina-
tion was ruled out by the fact that ovulation was not induced in hypophysecto-
mized rats by the LH-RF. A marked increase in plasma I.JI has been noted within 
ten minutes of an injection of SME extract (117). 
Knowing that plasma and pituitary LH fluctuates during the estrous 
c~le, one may expect the LH-RF to also fluctuate. With this in mind, hypo-
thalami were collected from rats during the estrous cycle (44,· 237) and their 
IJI-releasing activity estimated. Although two laboratories noted a cyclic 
change in potency, their results differed. One (237) demonstrated high potency 
during metestrus, diestrus, and proestrus AM with a sudden drop during pro-
estrus PM. Levels remained low through the morning of estrus, but high levels 
were again obse~ed by the afternoon of estrus. The other laboratory (44) 
found constant low levels throughout the cycle with a single peak during late 
dies~rus and a quick return by the morning of proestrus to control levels. 
. 
difference may be related to the difference in.strains used and/or to the 
: · differences in the environmental lighting schedule of the animals 1 rooms. 
Evaluation of ovarian steroid feedback effects reveals no elevation of 
LH-RF in hypothalami of,ovariectomized rats (44); in fact, a drop of LH-RF has 
been reported (230); which may.indicate that, unlike in the pituitary, storage 
and secretion within the hypothalamus are closely linked. 
If 'the hypothala~us is secreting factors affecting the pars distalis, 
these factors should be detectable in the blood as well as in hypothalamic ex-
tracts. Nsllar and Mccann (216) reported LH-RF-like activity in the systemic 
blood of rats ovariectomized for two to three months; much less ectivity was 
found with lesions destroying the median eminence. Activity was not detectable 
in cyclic rats nor in .rats ovariectomized for one week, indicating a prolonged 
absence of negative feedback effects was needed to obtain detectable plasma 
levels of LH-RF. These results explain the loss of pituitary function when 
~: transplanted to the kidney or temporal cortex (section I.D.l.a. ). With the 
•' •: 
development of a technique for collecting the hypothalamic portal effluent 
(232), the important comparison of LH-RF activity in portal blood versus sys-
temic blood could be made. Detection of LH-RF in'.pott~1· bl~od · p1asina 1 was1; :.:r••o 
achieved by in vitro incubation of pituitaries with collected plasma. Assay 
. -
of the incubation medium revealed that significant LH had been released after 
addition of portal blood plasma, but not after addition of femoral vein blood 
plasma (153). 
Since high activity has been found in extracts of SME, ventral hypo- -
thalamus immediately over the SME,, and the "chiasmatic" region (including the 
optic chiasrna, supraoptic nucleus, suprachiasmatic nucleus, and some of the 
preoptic area) (195), it appears that the neurosecretory neurons may originate 
as far anterior as the preoptic area. Recent reports are beginning to link 
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~ LH-RF activity with what may be the neurosecretory granules isolated from the 
SME region (15l)o 
FSH-releasing factor(s) (FSH-RF) activity was first reported in extracts 
oft he SME in 1964 (149'). While SME extracts elevated plasma FSH in estrogen-
progesterone treated ovariectomized rats, cerebral cortex extracts did noto 
This property was lost when the pituitary was removed, ruling out FSH contamina-
tion. The. SME extracts were still active after median eminence lesions (see 
section I.D.3.) had dropped the plasma FSH levels in ovariectomized rats. 
Initial attempts to separate the FSH-RF activity from LH-RF activity were 
·unsuccessful (150); this study did, however, demonstrate a separation of IH-RF 
and vasopressin activity. Further work separated FSH-RF and LH-RF activity 
(67)o FSH-RF activity from ovine and bovine sources has been reported in both 
in vitro and in vivo experiments (152, 170). Although there is current dis-
- ~-
.cussion over whether the releasing factors are really polypeptides or not (2li5), 
the recent.discovery of the structure of thyroid stimulating hormone-releasing 
factor and its synthesis (311 36) may serve as a model'.for the other hypo-
thalamic factors, i.e., small molecules with peptide linkages (198) 0 
c,: The hypophyseotrophic area of the hypothalamus 
The strong indications of a functional dependence of the pituitary 
hypothalamic humors (section I.D.l.a. and b.) encouraged studies on the histo-
logical and functional maintenance of intrahypothalamic pituitary implants 
(103, 131, 132, 165). The 1962 studies revealed a specific hypothalamic 
region in both males (165) and females (131) which is capable of supporting 
pituitary histology. This hypophyseotrophic area (HTA) (131, 265) was found 
to extend from the preoptic area and anterior hypothalamus to its posterior 
most border ventral and anterior of the premammillary bOdy nuclei. The para-
ventricular nucleus forms the anterior dorsal boundary, and the area extends 
,. 
2.3 
~ ventrally encompassing the ventromedial and arcuate nuclei (Figure 1). The 
lateral extent is not not much more than one millimeter. The HTA contains 
active hypophyseotrophic substances, as indicated by the fact that in pituitary 
i.. grafts straddling the lITA only that portion of tissue adjacent to or within the 
~' ~ .. 
lli 
~~ 
~· 
~~ 
~· 
HTA is maintained (265); juxtaposition of the pituitary graft with the capil-
].ary loops of the median eminence is not essential for histologic maintenance 
(131). Physiologically active releasing factors have been isolated from within 
the rough boundaries of the HTA (265). 
Extension of these findings to functional maintenance of implanted 
pituitaries was presented in 1965 (103, 132). Ovarian weights above hypophy-
sectomized levels, and resumption of vaginal cyclicity, were only found when 
pituitary implants were in the lITA (103, 132). Although mating was reported, 
pregnancy did not result (103); furthermore, Flament-Durand's examination of 
the ovaries revealed many follicles of various sizes but no corpora lutea, 
indicating insufficient release of LH far either ovulation or luteinization. 
Halasz~ al. (132), however, did find corpora lutea along with developed 
follicles but mat:i:ng and ovulation were not directly evaluated by Halasz. 
Since both laboratories described the same lITA and both found resump-
tion of vaginal cyclicity, no obvious explanation presents itself for these 
c.onflicting reports of corpora luteal development. Neither gave details on 
the specific location of the implants supporting vaginal cyclicity and ovarian 
weights; thus, it may be ·that the two laboratories placed the active implants 
in regions of differing sensitivities to the feedback effects (see section· 
I.D.5.) of pituitary hormones. Thus, the local I1I levels may have affected 
LH-RF secretion differently with different implant locations. A second possi-
bility is that placement of the implants in. the former study (103) may have 
cut or destroyed vital afferent nerve tracts to the hypothalamus responsible 
tor initiating the release of an ovulatory surge of LH (see section I.D.J.). 
Nevertheless, the results of the above studies demonstrate that pituitaries im-
planted within specific regions of the hypothalamus can support ovarian function. 
2. Circadian Stimulation for Spontaneous Ovulation 
The physiological stimulus for spontaneous ovulation in the rat was 
first sho~m to have a circadian quality by Everett et !!.• {92, 93). Ovulation 
was blocked completely when drugs such ~s atropine, dibenamine, and barbi-
. · turates were administered at proestrus before 2.~00 PM, but only partially when 
treatment was given between 2:00 PM and 4:00 PM; no blockade occurred if treat~ 
ment was given after 4:00 PM (921 931 94). When allowed to recover from the 
drug, the blocked rat ovulated one whole day later - not after the drug wore 
off; this ovulation can also be blocked by a second injection given before the 
critical period (2:00 - 4:00.PM), with ovulation being retarded an additional 
full day. This process of properly timed injections can be followed until the 
ripe follicles atrophy. Further evidence for a circadian ovulatory stimulus 
is that properly timed estrogen and/or progesterone injections advance or 
delay the time of LH release and ovulation, again by 24 hours (86, 92). Post-
partum ovulation also reflects the circadian nature of the ovulatory stimulus. 
If parturition occurs before the critical period, ovulation occurs that night; 
however, if parturition occurs after the critical petiod 1 ovulation takes place 
the follo~~ng night (146). 
Associated with the critical period during proestrus is··a··rapid,·eleva-
tion of plasma I.JI and a drop in pituitary LH; such_changes are absent if the 
c:r:i.tical period is blocked (248, 249, 250). A significant rapid elevation of 
plasma I.JI also occurs in chronically ovariectomized female rats during what 
would be the critical period of the intact proestrous rat (176) 1 indicating 
that this circadian periodicity in CNS-pituitary activity is independent of 
.. 
. 
hormones of ovarian origino The demonstration of t he critical period in immature 
!emale rats induced to ovulate with exogenous hormones (203, 205), implies that 
the neural mechanism essential for ovulation is developed at an early age; how-
ever, McCormack and Meyer have noted that the minimal age at which ovulation 
can be induced is 18 days of age (204)o 
This circadian stimulus seems unique to the female since ovaries trans-
planted into males do not cycle, but d~velop cystic polyfollicular ovaries 
(189)• In addition, we have failed to detect ~ 24 hour periodicity in pitui-
tary or plasma LH in adult intact or castrated males (176)o Since male pitui-
taries transplanted into females will support ovulation (228), the lack of an 
ovulatory impetus must be centered in the CNS rather than the pituitary. Tes-
ticular transplants (228) or androgen injections (JS, 253) in female rats duripg 
their first week of life, however, induce a persistent-estrous state charac-
terized by continuous vaginal cornification, failure to ovulate, and polycystic 
ovaries similar to those transplanted into males (183, 189). Thus, neonatal 
exposure to androgen appears to abolish the cyclic quality inherent in the 
female central nervous system (120) • 
.30 Hypothalamic Ovulatory Stimu:J_us 
Dey and co-workers (64, 65, 66), using guinea-pigs, first described 
two reproductive dysfunctions following hiPothalamic lesioning and their asso• 
ciation with separate regions of the hypothalamus. An anestrous state was 
found to be associated with lesions in the basal hypothalamus reflecting total 
or near total shutdown of pituitary gonadotrophin secretion. In contrast, 
lesions in the anterior hypothalamic-preoptic region induced a persistent-
estrous state. In this second dysfunction the follicular ovaries indicated 
that FSH was being secreted; secretion of LH was felt to be abnormally low 
since luteinization did not occ~, but apparently was not absent, since the 
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and estrogen levels appeared well maintained (64, 65). The 
iJDplications of these data were only realized through other evidence from 
varied sources as discussed belowo Reference to Figure 1 may be helpful while 
reading this section. 
a. The. basal hypothalamus 
Localization of lesions in the arcuate nucleus and median eminence re-
sulted in gonadal atrophy in both males.(27, 28) and females (56, 108, 110, 197). 
As measured by a total gonadotrophin bioassay, ·loss of pituitary gonadotrophin 
potency follows lesioning in the region of the arcuate nucleus (27, iB). Speci-
fic assays for LH, following lesioning of the median eminence region, confinned 
the previous results; a marked drop in pituitary LH potency was noted, which 
I 
could not be elevated by bilateral ovariectomy as it could in the non-lesioned 
animal (267). Realizing that the arcuate nucleus-median eminence region is the 
posterior extent of the HTA (131) 1 it is not.surprising that destruction of the 
delivery point of the releasing factors from the hypothalamus to the portal 
system leads to loss of pituitary function. The arcuate nucleus apparently is 
more important for reproductive cyclicity than the median eminence, since 
vaginal cyclicity continues after surgical removal of the median eminence, but 
ceases if the arcuate nucleus or parts of it are removed along with the median 
eminence (164). 
As discussed earlier (section I.D.l.a.) 1 stimulation of the basal hypo-
thalamus, but not of the pituitary, induces ovulation in rabbits (135, 194). 
Similarlyl rats in which.spontaneous ovulation has been blocked by pentobarbi-
tal can be induced to ovulate by stimulation of the basal hypothalamus from the 
arcuate nucleus to the optic chiasma (55) - the approximate ventr&l boundaries 
of the HTA (131). Isolation of the basal hYJ>othalamus by an ingenious knife-
cut technique (130) has revealed that this region is capable of maintaining 
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some pituitary functions, but is not able to support ovul&tion without neural 
connections from the anterior hypothalamus (129). Thus, cutting just ·the , ~-'~ '/: 
anterior connections leads to an anovulatory persistent-estrous state; cutting 
all posterior and lateral connections, however, is compatible with ovulation 
(129). Thus, the HTA must have specific cnterior connections for the cyclic 
· release of gonadotrophins. 
b. The anterior hypothalamus 
The persistent-estrous state first observed by Dey after anterior hypo-
thalamic lesions in guinea-pigs (64, 65) also occurs in rats (201 1271 1451 
273). Small localized lesions destroying only the suprachiasmatic nucleus 
(SchN) will cause persistent estrus (20); ovulation can be induced in these 
animals by progesterone (20), which presumably acts via other anterior hypo-
thalamic sites since animals with more extensive lesions involving the POA do 
not ovulate after progesterone treatment (20, 127, 273). Stimulation of the 
basal hypothalamus in the latter animals activates the pituitary to induce 
ovulation (20), further indicating the lITA and pituitary require some afferent 
inputs for LH secretion to exceed tonic levels. 
As mentioned earlier (I.D.2.), transplanted testes (228) or androgen 
injections (15, 253) can also induce persistent estrus; the action of the andro-
gen is not on the pituitary, though, since male pituitaries support female 
cyclicity ~9). As in animals with POA lesions (201 127 1 273), progesterone 
injections in the andrcgenized females fail to induce ovulation whereas stim-
ulation of the basal hypothalamus induces ovulation (18). Stimulation of the 
POA in these anim~ls, however, did not lead to ovulation (18) despite its 
success in inducing ovulation in the barbiturate-blocked proestrous rat (91). 
It was hypothesized from these data that androgens, like lesioning, .removes the 
capacity for the activation of the POA by environmental lighting and honnonal 
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feedbacks stimulating the basal hypothalamus .and resulting in ovulation (18). 
Out of these studies grew a formal theory of the dual nature of hypo-
thalamic control over gonadotrophin secretion (18, 120). The basal hypothala-
mus (HTA) was termed the first level, regulating the secretion of the tonic or 
basal gonadotrophins necessary for follicular development and steady-state ' 
estrogen secretion; this area is incapable, however, of initiating the ovula~ 
tory discharge of pituitary gonadotrop~ns. The second level, the POA-SchN 
area, was seen as periodically stimulating the.first level, thereby inducing 
ovulation. While the first level depends on activation by the second level 
for its release of an ovulatory surge of gonadotrophins, the second level re-
quires a combination of favorable events, exogenous (environmental) as well as 
endogenous (honnone feedback), for its activation. 
This theory is well supported by recent experiments outlined below. 
Structural (69, 210) and metabolic (69}· differences have been described for 
the anterior hypothalsmus of males and females. In support of the concept 
of sequential activation, localized intrahypothalamic injections of pento-
barbital revealed two "critical periods". Injections into the POA must be 
made before 4:00 PM to block ovulation, while injections into the basal hypo-
thalamus can be done as late as 8:00 PM. This implies a sequential activation 
beginning within the POA, then passing to the basal hypothalamus and requiring 
eever~l hours for full .activation (128). Direct evidence for the transfer of 
activation was provided by the demonstration that barbital-blocked proestrous 
rats stimulated in the POA show elevations of multi-unit activity within the 
median eminence-arcuate nucleus region only if ovulation occurs (269) 0 
Further convincing evidence is provided by Halasz' hypothalamic knife-
cut technique (130), as noted previously. Either total or anterior isolation 
Of the JITA is not compatible with ovulation, while posterior md lateral .· ''·":: ;_ -
. , 
·' 
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isolations are compatible with ovulation (1291 130).. Most recently (168) 1 iso ... 
iation of the POA-HTA as a unit 1 difficult because of the high mortality rate, 
has been achieved and sho~m to be compatible with vaginal cyclicity, ovulation, 
and corpora lutea formation. The POA is therefore capable of supporting spon-
taneous ovulation; however, since vaginal cyclicity was not regular, extra-
hypothalamic influences are probably essential for maintaining the coordination 
of physiologic phenomena necessary for normal reproductive cyclicity. 
4. Ovarian Hormone Feedback 
Ovarian steroids are capable of exerting either facilitatory or inhibi-
tory actions on gonadotrophin hormone secretion depending upon the preinjection 
hormonal state of the animal.·· (section I. C. 3.). As discussed below 1 these bi-
phasic steroidal acti.ons are apparently the result of an interaction of proges-
terone and estrogen with both the CNS and adenohypophysis. 
The possibility o~ a direct effect of ovarian steroids on hypothalamic 
structures was first studied by implanting bits of ovarian tissue (109) and 
. I 
crystalline steroid (59 1 155, 184, 256) into the brain. Gonadal atrophy 
(591 1551 184) 1 inhibition of the postcastration rise in pituitary end plasma 
LH (156, 233) 1 and the inhibition of castration cells (1541 185) following 
median eminence implants of estrogen have been reported, sugeesting that this 
region mediates a negative feedback effect of estrogen. This was disputed, 
however, by Bogdanove (29) who found no effect on pituitarJ castration cells 
if implants were in the median eminence, but localized inhibition of castra-
tion cells in the immediate vicinity of intra-pituitary implants. Bogdanove 
(29) felt the reason others found negative feedback only from the median 
eminence implants and not from the pitu:itary implants was that the estrogen 
was well distributed from the hypothalamus by the portal system to the pitui-
tary, thus directly affecting the pituitary; with intra-pituitar.y implants, on 
,. 
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'' the other hand, the distribution of estrogen throughout the gland was poor. 
This possibility was supported by the findings of Ramirez et al. (233), who 
" reported lower plasma LH but not pituitary IB with adenohypophyseal implants 
of estrogen. In addition, studies with tritiated estrogen implants in the 
median eminence resulted in significant levels of radioactivity t~oughout the 
pituitary gland, while with similar implants in the pituitary the spread of 
radioactivity tended to be loc~lized near the implant (222). This same study, 
· however, showed that while pituitary implants led to hypophyseal hypertrophy 
(i.e., a direct effect), pituitary IB levels were not affected. Median erni~·.::. 
nence implants, while causing little hypophyseal hypertrophy, did lower pitui-
tary LH, thus indicating that estrogen. had no direct effects on storage of LH, 
but had powerful indirect effects via the hypothalamus. Estrogen implants in· 
the POA also appear to inhibit ovarian compensatory hypertrophy (97, 186), 
thus complementing the lesion studies indicating that the POA is essential to 
feedback phenomena (details below). The POA seems capable of mediating a 
1.~i~· 
r facilitative influence also, in that estrogen implants will accelerate the 
\ 
:. . onset of puberty ( 255). Hypothalamic implants of progesterone also reveal a 
negative feedback effect at the median eminence; but not at the POA (256). 
The interpretation of this study must be made carefully, however, in the light 
of Bogdanove•s criticism of estrogen implants (29) and since progesterone is 
suspected of interfering with the pituitary responsiveness to the hypothalamic 
releasing factors (262). 
Direct feedback influences of the ovarian steroids on the CNS are 
strongly supported by autoradiography studies indicating radioactivity within 
nerve cells in localized regions of the CNS (7, 264). Uptake of tritiated 
"· est:radiol has been reported in the arcuate and POA nuclear regions of the hypo-
~: l t~~~· (7, 264) as well as the posterior third of the amygdala (7) but·not 
,. 
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elsewhere in the CNS (7, 264). High quantities of radioactivity are also found 
in pituitary tissue following systemic injections of tritiated estradiol, thus 
·• indicating that the pituitary may also be a di.rect feedback site (124, 158). 
t1' 
t 
-:r 
Although estrogen binding to hypothalamic structures has recently been shown to 
vary with the stages oft he estrous cycle, this may be a reflection of the 
changing endogenous estrogen levels during the cycle (157). Estrogen has also 
been shown.capable of elevating peptidase activity in the hypothalamus (100) :: 
and of inhibiting c14-lysine incorporation into both the amino acid pool of 
the hypothalamus and the proteins of nuclear reeions of the basal hypothalamus 
B7). Thus, the gonadal steroids can cross the blood-brain barrier (277) for 
· intimate functional contact with CNS structures. 
~· t · That ovarian steroids can mOdify CNS functioning has been demonstrated 
f f more emphatically by reports of electrophysioloe;ical changes in the CNS follow-
!·· 
K: ~ ing progesterone and estrogen injections (90, 266).. In estrogen-primed rabbits, 
~--
k electroencephalographic (EEG) arousal thresholds have been reported to be ini-
tially elevated by progesterone (0.5 mg) but markedly lowered by the next day 
(161). Cortical EEG patterns in female rats have also been reported depressed 
following subanesthetic doses of progesterone (O.J mg) (10). Studies utili-
zing animals with chronically implanted electrodes reveal a characteristic 
elevation of regional multi-unit activity of the basal hypothalamus and POA 
during the critical period (163). Significantly, progesterone-induced ovula-
tion advancement was accompanied by an advancement of the multi-unit activity 
to the new critical period. Elicitation of single unit activity by peripheral 
stimuli has been found to vary with the stages of the estrous cycle (17). 
Changes in single-unit activity after progesterone.(17) and estrogen (180, 182) 
have been reported. Interpretation of these electrophysiological results must 
be done carefully in that some carrier vehicles (e.g., propylene glycol and 
32 
have been shown to alter EEG and single-unit activity (18l)o 
The sensitivity of neural structures to stimulation-induced ovulation 
seems to shift during the estrous cycle; the earlier in the cycle one stimu-
].ates the POA, the more difficult it is to induce ovulation. However, the 
variability could as likely stern from any point(s) distal to the POA stimulation 
site (147). 
Electrolytic lesioning of the CNS has provided an iDvaluable technique 
for defining CNS functions in maintaining the estrous cycle. As discussed 
earlier {section I.D.l. and I.D.3.), POA lesions result in follicular ovaries 
which do not ru.pt ure, and continuous estrogen secretion ( 61.i, 65, 127, 145) • 
The maintained estrogen levels, however, are inconsistent with data indicating 
, that estrogens hould decrease plasma FSH and ultimately, estrogen· levels (3~,. 
113, 11.iJ..i, 266). Thus, it seems that the POA contains elements directly and/or 
indirectly involved in estrogen feedback regulation of FSH (266), as well as 
tbe secretion of !JI and the ovulatory discharge of gonadotrophins (64, 65, 127, 
~:. ll.15, 273). This is supported by the fact that in intact immature rats para-
p. 
\, 
biotically united with ovariectomized immature rats, large follicular ovaries 
develop and uterine weight increases (104); treatment of the ovariectomized 
partner with estrodiol prevents such changes, unless the rat also has a POA 
lesion. In addition, POA-lesioned rats treated with low physiological doses 
of estrogen maintain histologically normal ovaries but non-lesioned rats when 
treated with the low estrogen doses develop histologically atrophic ovaries, 
thus indicating a deficiency in estrogen feedback suppression of FSH (105). 
Some less sensitive feedback route exists, however, since very high doses of 
estrogen (25-50 pe) will inhibit FSH secretion in :lptact and POA-lesioned rats 
as evidenced by ovarian histology (266)o Furthermore, POA lesions remove the 
normal reciprocal estrogen-FSH relationship as evaluated by ovarian compensatory 
,. 
,, 
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hYPertrophy, i.e., ovarian compensatory hypertrophy does not occur in POA-
1esioned rats (57, 106). The evidence is thus strong that the POA and/or 
some structure(s) conducting information into the POA, is indispensable for ";1 
the feedback regulation of FSH. The evidence also implies that the basal hypo-
thalamic-pituitary unit does not sense estrogen changes for FSH regulationo 
The effects of POA lesions on pituitary LH content appear to depend 
upon the size of the lesion (32 1 267). Large lesions are f olind to reduce LH 
content (267) but smaller lesions do not reduce LH content (32). Even though 
pituitary LH content is reduced by the more extensive Po.A lesions, it increases 
follOwing bilateral ovariectomy as does the plasma LH <267). Therefore, while 
the POA may plvy a significant role in the ovulatory discharge of LH (64, 65, 
127, 145) and the maintenance of proestrous levels of pituitary LH (267), the 
units distal to the POA seem capable of sensing the loss of ovarian steroids. 
Evidence of augmented LH secretion in POA-lesioned rats is also shown by the 
fact that removal of one and a half ovaries results in luteinization of the 
remaining half ovary (107). Thus, while the basal hypothalamus-pituitary unit 
appears capable of .mediating a negative feedback regulation of LH secretion, 
the POA is apparently necessary for full regulation. As discussed earlier, 
although the POA may be essential for maintaining the ovulatory surge of LH, 
apparently extrahypothalamic influences are needed to maintain the steady 
four- or five-day cyclic patteni of the estrous cycle (168) 0 
Further evaluations of estrogen feedback by measuring pituitary and 
plasma LH after injecting various physiological doses of estroeen into ovari-
ectomized normal and neonatally androgenized females imply negative feedback 
effects on the hypothalamus, but a positive feedback effect on the pituitary 
(19). Since there is evidence that estrogen.does not interfere with the action 
of releasing factors (235) 1 it may have a direct effect on pituitary secretion; 
' . \ 
'• 
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this is supported by a recent elegant ,!!! vitro study (247)o 
The facilitation of ovulation by progesterone (section I.C.4.) seems to 
involve specific anterior hyPothalamic structures. A single injection of pro-
gesterone can induce ovtllation following placement of verjf localized lesions 
of the suprachiasmatic nucleus, which resulted in persistent estrus, but is 
ineffective if the lesion~is more extensive, involving part of the medial POA 
(.MPOA) (16~ 20) or more extensive lesions of the POA (127)o Moreover, lesions 
of only the MPOA, while not resulting in persistent estrus, do prevent ovula-
tion advancement in these cyclic rats (16, 20). 
50 Gonadotrophin Feedback 
Gonadotrophins also appear to have feedback effects on both brain elec-
trical activity (159, 161, 270) and pituitary secretions (9, 46, 58, 221)0 The 
rabbit EEG arousal threshold is elevated following FSH injections while the 
threshold is lowered by LH (161). The activity of units monitored in the cat 
hypothalamus seems to be affected by LH; ±,e., some units show increased or 
decreased activity following LH injections (159). Rat hypothalamic multi-unit 
activity (MUA) has also been reported altered by L~ (270); estrogen-treated 
overiectomized rats showed elevated MUA in the arcuate nuclear region while 
simultaneously showing a depression of activity in the POA following LH injec-
tions. Since the rise in arcuate nucleus activity was not seen after isolation 
of the basal hypothalamus, but POA activity still dropped, LH detection may 
.occur outside of the basal hypothalamus. The overall effect of an LH feedback, 
therefore, seems to be positive if one assumes the elevated activity of the 
basal hypothalamus indicates LH-RF secretion. Evidence derived.from LH or 
UI-RF measurements, however, strongly indicates that the feedbuck is negative; 
hypophysectomy elevates plasma LH-RF from nondetect.able levels in ovariectomized 
rats to detectable levels (216), and.LR implants in the median eminence lower 
•pituitary (46,, 58) arrl pl~sma LH (58) o 
Using the ovarian compensatory hypertrophy response (OCH) as an estimate 
of FSH secretion in neonatally androgenized female rats, Arai and Gorski (9) 
found that hypothalanic implants of FSH inhibited the OCH and thus presumably 
FSH secretion, while implants in other parts of the brain or pituitary had no 
effect. These effects, however, may be related to the androgenization, and 
thus unique to the male rather than the female (221). The FSH feedback in the 
nor~l female has been interpreted as b~th positive (220, 221) and negative 
(47, 48, 111). This discrepancy may be related to the age of the experimental 
animals, i.e., prepubertal (220, 221) or postpubertal (47, 48). 
It thus appears that LH and FSH exert negative feedback effects through 
the CNS in the adult rato These feedback effects may be exerted via .the general 
systemic circulation and/or a short vascular loop conveying blood from the ade-
nohypophysis back up into t~e hypothalamus (266). 
The further possibility of regulative feedback effects of the releasing 
factors must also be recognized as possible. 
E. Neuroanat~mical Connections Between the Hypothalamus and Amygdala 
Although anatomical connections between the hypothalamus and the rest 
of the CNS are rich (239, 266), this section will only consider the hypothala-
mus• informational link with the amygdala. 
Using axon degeneration techniques, which were later called into ques-
tion (52), the stria terrninalis (ST) was shown to convey fibers from the 
amygdala to the dorsomedial and ventromedial hypothala~ic nuclei of the monkey 
(1). Usine better techniques, the connection between the amygdala.and the 
hypothalamus was confirmed, but a different distribution of ST.fibers was 
established (217). Fibers from only the posterior amygdala (the corticome-
dial nuclear group) were found to project through the ST to.the medial preoptic 
,. 
and medial anterior hypothalamus. No projections to the ventro-
:inedial nuclear region were found. Some ventral degeneratio~ of fibers to the 
; J_e.teral hypothalamus was described, however. These results in the monkey were 
:.also noted in the cat (266) and rat (52). In that the POA has been demon-
strated to require extrahypothalamic connections to maintain the periodicity 
of the estrous cycle (168), fibers from the amygdala tenninating in the POA 
involved in maintaining reproductive ~yclicity. 
A large diffuse tract of fibers has also been reported to pass hori-
zontally from the amygdala into the hypothalamus (169, 266); however, since & 
large diffuse tract of fibers persists after destruction of the pyrif orm cortex 
surrounding the amygdala (52); interpretation of the horizontal tract following 
aznygdalar lesions is difficult. Lesioning the hypothalamus will also result 
in degeneration of fibers along both the ST and the horizontal pathway (52); 
thus, there appear to be afferent and efferent fibers between the hypothalamus 
and amygdalR. 
Evoked-potential studies reveal that stimulation of tho amygdala can 
increase or decrease hypothalamic unit activity, depending on the site stimu-
t lated (72, 2l1);·the corticomedial portion of the arnyedala tends to j_nhibit 
hypothalamic activity, whereas the lateral region tends to stimulate hypo-
thalamic activity. This regional functional dissociation is discussed further 
in section I.F. 
F. Regulatory Influence of the Amyg:dala over Gonadotrophin Secretion 
.Ovulation followine stimulation of the amygdala was reported as early 
as 1954 (167). Differential responsiveness of the various amygdaloid regions 
was demonstrated, with the best results obtained by stimulation of the medial 
region; ovulation was obtained less frequently when the cortkal a.'l'lygdaloid 
" nucleus was stimulated, and stimulation of the lateral and central nuclear t. 
l 
was totally ineffective.· These findings are supp~rted by work of other 
J.aboratories (141, 160). Ovulation and elevated progesterone levels have been 
~oted following stimulation of the mediel amygdala (141, 162), while stimula-
tion of the basal or lateral regions of the amygdala failed to induce ovulation 
\ 
and was accompanied by a drop in progesterone levels (141). Ovulation has also 
been reported in the cat after amygdaloid stimulation (254) and in the constant 
, light-induced persistent-estrous rat (35). Additional evidence for the involve-
;. ment of the amygdala in the ovulatory.process is that an EEG after-reaction 
.r• 
;. 
· similar to that following coitus in the female rabbit can be evoked by amygda-
loid stimulation (160). 
The amygdala in the constant light-induced persistent-estrous rat (272) 
seems to differ somewhat from the rabbit (141, 162, 167). Although the medial 
amygdaloid nucleus is still the most effective stimulation site for inducing 
ovulation, moderate success can be attained from stimulation of the basal and 
f .. :· lateral nuclear regions, and stimulation of the cortical nucleus is apparently 
t ineffective. This should serve as a caution for careful extrapolation of data 
~ 
between species and especially between species with different ovulatory mecha-
nisms, i.; e., reflex versus spontaneous ovulation. 
Total destruction of the amygdala in the male results in atrophy of 
. the testes (278), implying that the nuclear group as a whole exerts a net stimu-
latory effect on the release or gonadotrophins. If, however, exposure of males 
and females to a different hormonal environment neonatally accounts for th~ 
functional sex: difference .or the POA (120), such exposure may also influence 
the functional capacity of other brain regions, directly or indirectly. Thus, 
one must be very cautious in extrapolating data from one sex to the~other. 
This caution is justified by a recent report showing different effects of amyg-
dala stimulation in male and femal~ rats (272). 
That a specific region of the amygdala can have an inhibitory effect 
,. 
over gonadotrophin secretions in the rat was demonstrated by a series of experi-
, ments by Critchlow and Elwers (22, 76, 77); lesions of the cortical and medial 
nuclear regions of the amygdala, or of the stria terminalis, advanced the onset 
o£ puberty, while stimulation of these sites retarded the onset of puberty. 
;". 
Additional evidence in support of an inhibitory effect from the amygdala has 
been attained from studies on the deermouse (73, 74); pituitary and plasma LH 
became elevated following lesions of th~ basolateral region as do FSH-RF levels 
t in the hypothalamus. 
Electrophysiological studies lend support to the notion that the amyg-
dala has two regions functioning in opposition to one another (268). In intact 
~: female rats, the seizure threshold of the medial amygdala is lower during pro-
~-
t;'· estrus _.than during the rest of the eye le, while the lateral arnygdala has a 
r: ~ !c [ higher threshold during proestrus than the rest of the cycle. 
Reports that ~he posterior third of the smygdala accumulates radioacti-
vity following systemic adminstration of H3-estradiol (7), and that estrogen 
implants in the amygdala induce lactation in the r£bbit (271), makes the amyg-
dala a likely estrogen feedback site. This possibility is also supported by 
estrogen implant studies on ovariectomized rats (175). Since lesions of the 
cortical nucleus or destruction of the stria terminalis elevated plasma LH, and 
estrogen i!JI.Plants·in the corticomedial nucleus maintained high plasma LH in spite 
of high plasma estrogen, estrogen may suppress an inhibitory influence by the 
amygdala on LH secretion, thereby facilitatin~ LH secretion. Further evidence 
for an ovarian steroid effect on the amygdala is that ovariectomy abolishes the 
cyclic changes in seizure threshold noted in the medial and lateral amygdala, 
and a single injection of estrogen reinstates the cyclic changes With these 
two regions out of phase (268). In addition, oxygen metabolism of the amygdala 
was found to be accelerated by estrogen (246), thus supporting the studies 
,. 
t 
~ 
~ ~: 
·.indicating estrogen can alter the physioiogy of the·amygdala. Although the 
amygdaloid neurons may be directly influenced by hormones, it would be difficult 
to distinguish direct from indirect hormonal influences since the amygdala h~s 
both afferent and efferent fibers (see section I.E.). 
Even though the amygdala seems to be involved in the secretion of the 
pituitary gonadotrophins, massive les~ons of the amygdala in the rabbit do not 
interfere with coitus-induced ovulation (241). As discussed previously, how-
ever, the amygdala has both facilitatory and inhibitory influences on gonado-
trophin secretions; therefore this effect may indicate that the net results of 
the amygdala 1s absence can be compensated for by other brain structures. 
Ablation of specific inhibitory or facilitatory regions of the amygdala may 
not be so easily overcome. 
Few studies have been performed on intact cycling rats to determine a 
functional role of the amygdala (211 45). One short report (45) indicates 
that more cornified vaginal smears per cycle may result following amygdaloid 
, lesions, indicating somewhat proloneed estrogen secretion, and thus higher 
plasma gopadotrophin levels, thus offering indirect evidence that in the in-
tact cycling rat the amygdala may have a tonic inhibitory influence over 
gonadotrophin secretion. The other short report indicates that rats devel-
oping precocious puberty a~er corticomedial lesions show normal cyclicity, 
mating, pregnancy, and· rearing of young, whereas lesions of the anterior 
amygdala do not disturb cyclicity, but do interfere with pregnancy, delivery, 
and care of young (21). These reports, however, offer no details. In a later 
study, using the deennouRe, Eleftheriou and Zolovick (74) placed lesions in 
the basolateral region of the amygdaloid complex. The animals were autopsied 
one, two, or three weeks later and their plasma and pituitQry LH levels mes-
sured. Elevated plasma LH and lower pituitary L9 were found; however, all of 
t 
l ~ 
~ 
~ 
r 
i 
~t 
the lesioned animals were pseudopregnant, and.no control plasma and pituitary 
LH values were provided. Thus it is impossible to relate these data to cyclic 
data. 
\ 
Chapter II 
STATEMENT OF THE PROBLEM 
The amygdala is emerging as an important component in the regulation 
of gonadot!ophin secretions. Especially with the recent report of Koves and 
Halasz (168), it is apparent that extrahypothalamic brain regions must play a 
stabilizing role in the maintenance of the estrous cycle rhythm. Although the 
in~olvement of the amygdala is hinted at by a large amount of data (see Chapter 
I.r'.), an understanding of the dynamic role of the amygdala in the spontane-
ously ovulating rat is hampered since most data are derived from the naturally 
persistent-estrous rabbit (167) and cat (254),, or from the experimentally-
induced persistent•estrous rat (35, 272), all of which appear to exist in a 
more or less static gonadotrophic state. The fact that the all\Ygdala may have 
,_. 
r;· two regions functioning in opposition to one another (35, 76, 141, 268) is 
~·'. 
t . . 
also a complicating factoro 
Since so little was known about the functional importance of the amyg-
dala in maintaining the estrous cycle of the spontaneously ~vulating animal, it 
seemed critical to perform experiments evaluating amygdalar involvement in the 
maintenance of the estrous cycle. The corticomedial region of the amygdala was 
chosen for study since its ablation has been demonstrated to affect the matura-
... 
tion of the ovulatory surge system (76). In addition, if its inhibitory in-
fluence.were preserved into adulthood, as it seemed it might (45, 175), lesion-
ing of the region may induce a persistent-estrous state relatively easily 
assessed against other type~ of persistent-estrus (32). Preliminary experiments, 
however, indicated that lesioned animals showed vaginal cyclicity up to four 
t· 
~-
months after lesioning. With this information, emphasis was then placed on 
experiments which would evaluate some of the dynamic internal parameters of the 
estrous cycle following amygdala lesions to determine whether there.were any 
shifts in the relative timing of events. 
L 
A. Animals 
Chapter III 
METHODS 
.. 
Sprague-Dawley-derived rats from Simonsen Laboratories, Gilroy, 
California, were used for all experiments. Received at 6o days of age, the 
animals were immediately placed in the environmental rat room for a l.4-day 
I 
acclimatization period, after which daily vaginal smears were commenced and 
continued until autopsy. Lighting was on from S AM until 7 PM. Rockland 
Mouse Breeder Diet (used in place of Rat Chow to minimize variations of 
natural plant estrogenic contamination in the food) and tap water were avail-
able to all rats ad libitum. 
----
B. · Stages of the Estrous Cycle 
The stages of the animals' estrous cycle, as first defined by Long 
and Evans ciet)J were determined from unstained vaginal smears, which were 
taken by saline lavage, and then examined microscopically. Both the daily 
smear cytology and the past history of vaginal smear cycles were used to pre- . 
diet the ~ycle.stage on a given day. When necessary, because of an unclear 
. . 
smear or smear history, animals were laparotomized under ether anesthesia during 
the morning (10-11 AM) and inspected for either uterine ballooning, indicative 
of proestrus, or for a swollen ampullar segment in the oviduct, indicative of 
ovulation and therefore estrus. otherwise, with a clear smear and cyclic 
history, the animal was inspected just prior to autopsy for a swollen oviduct 
or uterus. 
c. Experimental Groups 
,. 
Four basic experiments were conducted; throughout' the dissertation they 
shall be referred to as : 1) three-cycle study (3-C), 2) two~month study (2-M!J,), 
3) four-month study (4-M), and 4) ovarian compansatory hypertrophy study (OCH). 
All studies contained the three major groupings of control, sham, and lesioned 
animals. These groups are further subdivided as explained below. Animals were 
included in a study on the basis of their pre-surgical cyclicity. 
lo Three-Cycle Study 
Animals were selected for the three-cycle study only if they demonstrated 
three consecutive four-day cycles just prior to lesioning and could be used with-
in the first ten cycles. They were sacrificed on or about the third estrus 
after lesioning or sham lesioning. Control animals were sacrificed in a cor-
responding age range. Four time periods during the estrous cycle were studied: 
proestrus 2:30-3:30 PM, estrus 10:00-ll:OO AM, estrus 2:30-3:30 PM, and metestrus 
2:30-3:30 PM. Bilateral lesions were placed.in the cortical amygdaloid nucleus 
(Table I). 
2. Two-Month Study 
Animals were selected for the 2-M study only if 1) they demonstrated 
at least four consecutive four-day cycles immediately preceding surgery, 
2) they had no episodes of three consecutive five-day cycles, 3) they had no 
episodes of pseudopregnancy, and 4) they could be used within the first ten 
cycles. These criteria were decided upon after the four-month study was al.most 
completed and it became apparent that no obvious alteration in vaginal cycli-
city was induced. In case the changes in cyclicity were subtle, the rigid 
criteria outlined above were adopted.in an attempt to obtain a population of 
rats with functionally homogeneous neuroendocrine networks governing their 
cyclic pattern. Autopsies were performed as close to 60 days after lesioning 
or sham lesioning as possible; control animals were autopsied during a cor-
' 
. 
responding age range. The animals were autopsied during three time periods of 
the estrous cycle& proestrus 2&30-3:30 PM, estrus 10:00-11:00 AM, and estrus 
2:30-3:30 PM. Bilateral lesions iJ1 this study group were placed in the cortical 
nucleus or lateral nucleus of the amygdala, or in the dorsal arch of the stria 
terminalis (see Table 1). 
3. Four-Month Study 
Animals showing a cyclic pattern of either four- five-day cycles 
uninterrupted by pseudopregnancy were used in the 4-M study. Autopsies were 
performed as close to 120 days after lesioning or sham lesioning as possible; 
control animals were autopsied during a corresponding age range. Two time periods 
during the estrous cycle were looked at in detail: proestrus 2:30-3:30 PM, and 
estrus 2:30-3:30 PM. Bilateral lesions were placed in the cortical nucleus of 
the amygdala. ~i!rl'iida~ lesions were placed in regions other than the 
amygdala (Table 1) to evaluate possible non-specific effects of ions deposited 
during lesioning, and to evaluate the physiologic significance of the lesion size. 
Ovarian Compensatory Hypertrophy Study 
Animals for the OCH study were selected from among those which were 
showing four- or five-day vaginal cycles but which did not meet the rigid re-
quirements for inclusion in one of the cyclic studies. Some had undergone a 
previous period of pseudopregnancy, but had at least three four- or five-day 
cycles a~erwards. These animals were uniterally ovariectomized (le~ ovary) 
the same day they were lesioned or sham lesioned. Ten days later they were 
.autopsied; the right ovary was removed and weighed. Lesions were placed in 
the cortical nucleus of the amygdala, the stria terminalis, or one millimeter 
below the surface of the cerebral cortex (Table I). 
. , 
' ' 
'!'he following chart defines the coordinates tor the various bilateral. lesions 
according to de Groot's atlas · (~).. 
Site of Lesion 
Preoptic-Suprachiasmatic 
Region (POA) 
Anterior-Lateral Region 
of .Amygdala (ALA) 
Dorso-Medial Nucleus of 
the Thalamus (DMNT) 
Stria Terminalis (ST) 
Internal Capsule (IC) 
Cortical Region of the 
Amygdala (ACO) 
Cerebral Cortex 
Hippocampus (Hipp.) 
D . ·: 0 ..• Lesioning 
l. Electrodes 
TABLE I 
LESION COORDINATES 
·Anterior Dorso-Vent. 
7.4. -2.1 
s.4 -2•!3 
s.o +0.5 
4.6 +l.7 
4.6 .-o.5 
4.6 -3S 
h.6 l mm 
below cortex 
3.0 -2.3 
Lateral 
o.5 
s.2 · 
loO 
4.o 
-4.o 
4.o 
4.o 
4.o 
Lesions were placed using unipolar concentric electrodes constructed of 
stainless steel wire (6 mils, o.JS millimeters) threaded through 26 gauge 
stainless steel hypodermic tubing. After three coatings of epoxylite were 
baked onto one end, a lead was soldered onto the wire protruding from the lll'l-
coated end. The junction was reinforced with De Khotinsky cement and a piece 
ot shrink tubing. The protruding wire from the coated end was trimmed so that 
one millimeter extended out from the hypodemic tubing. After a half-millimeter 
,, 
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. 
of the protrud~ng wire had been scraped free of epoxylite, the electrode 
insUlation was tested using an Ohmmeter by passing the electrode (clipped to 
~·. one lead of the Ohmmeter through the electrode lead) through a saline film 
~·. 
t 
'!' 
!;::'• 
~~' 
•: 
l [: 
formed in a wire ring clipped to the other lead of the Ohmmeter. 
2. ProcedU!'es 
Only metestrous animals.were chosen for lesioning; they were anes-
[. thetized with 35 mg/kg of sodium pentobarbital (!i'embutal, Abbot laboratories) 
~ 
L 
l' ~.· 
!. 
~·· 
~ 
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f. 
intraperitoneally~ If the animal seemed light after cutting through the 
scalp and clearing away the fasciB.e, 1% xylocaine. was applied to the scalp 
for several minutes b~fore dontiriuing. If the bregma reading was not in 
accordance with the atlas (60), an attempt was made to reposition the ear 
bars. The animal was used as a control if this did not 9orrect the bregrna 
reading. After two holes were drilled in the skull, dorsal coordinate 
readings were taken of the exposed dura and_ the penetration distance cal-
, culated from the instrument zero. If this distance did not correspond to 
the penetration distance calculated from the atlas, the animal was usually 
used as a sham. The electrodes were lowered after puncturing the dura 
.. with a fine probe. After erounding the animal by placing a saline-coated 
tapered bras~ rod into the rectum, one-mAmp d.c. was passed bilaterally 
for 15 seconds. The brain electrodes were then disconnected from the 
power supply and removed from the brain; after this the rectal electrode 
was removed. The sk\lll was blotted free of bone dust and fraements before 
the skin was sutured. Survival was excellent, i.e., less than l% mortality. 
Sham lesioning involved the same procedures as lesioning, except 
that no current was passed through· the lowered electrodes·. 
Control animals received no operative procedures on the skull. 
E. Y~asurements 
lo Cyclic Studies 
a. Indirect evaluations or hormone levels 
During the specif.ied time periods, the animals were weighed and 
sac:rificed under ether anesthesia. The thyroid, left adrenal and avary, 
uterus, and the anterior pituitary were removed and weighed. The right 
: · ovary with attached oviduct was kept for possible later histological sec-
tioning. Dry uterine weights (24 hours at 45-50oC) were also taken. The 
mean and standard error of the mean were routinely calculated for all organ 
weights. Significance between twa means was accepted if Student•s t-test 
indicated a "p-value" less than .05. It no significant differences were found 
among the different cycle stages within the control, sham, or les.ioned groups, 
the weights from all cycle stages were combined into one group and the three 
resulting major experimental groups were tested for significance. 
Egg counts were routinely made in estrous animals. The oviduct, 
isolated from the ovary, was placed under a dissection microscope. Either 
the swollen ampullar segment was cut tree from the rest of the oviduct and 
the eggs expressed from one end, or the ampulla on the intact aviduct was cut 
open with a pair of iridectomy scissors and the eggs expressed into the sur-
rounding saline droplet. 
Lumenal fluid from the uteri of proestrous animals was weighed by 
first carefully dissecting out and trimming the uterus free of extraneous 
tissue. After the uterus was weighed1 it was cut open and the fluid drained 
out, then reweighed. Subtraction of the second weight1 the wet uterine weight, 
from the first weight, gives an estimate of the amount of uterine lumenal 
fluid. This information, along with a; .cal~ulation of the per cent dry weight 
of the uterus (100% X dry.weight/wet weight) was used as a qualitative 
. •· 
measure of plasma estrogen levels {13). 
bo Direct evaluation of hormone levels 
Plasma and pituitary luteinizing hormone {LH) levels were measured 
using 1 !- and 4-hour modifications, respectively, of the ovarian ascorbic 
acid depletion {OAAD) bioassay developed by Parlow {224, 225). The specifi-
city of this assay for LH has been shown by Parlow {224, 225) and ~Cann (l9~). 
Adrenocorticotrophin {ACTH), FSH, and prolactin are either ineffective or are 
one thousand to ten thousand times less potent in causing OAAD than is LH. 
FSH and LH do not synergize. Commercial oxyt.ocin (Pitocin) am synthetic 
oxytocin {Syntocin) are undetectable by the bioassay (19,). However, 
commercial·vasopressin {Pitressin), and lysine and arginine vasopressine 
(synthetic vasopressins), are detectable by OAAD, but only when administered. 
in pharmacological doses. Neither hemorrhage nor injections of Nicotine 
·· induce OAAD (199.).' 
Recipient rats for the OAAD bioassay were obtained from ARS/Sprague-
Dawley 1 Madison, Wisconsin at 22 days of age, and were housed in the same roOlll 
as the experimental donor rats •. Rocklam Rat and Mouse Chow, and tap water, 
were available ~ libitum. At 26 days of age, these rats received 50 IU 
Pregnant Mare Serum (Equinex, Ayerst) subcutaneously in 0.5 cc saline; at 
28 days of age, they received 25 IU o£ Human Chorionic Gonadotropin (Antuitrin 
us 11 , Parke-Davis) subcutaneously in 0.5 cc saline; at 35 days of age, the rats 
were used forthe bioassay. The format of the bioassay procedure, as described 
below, depends on whether the test substances are pituitary nomogenet~ ~~plasma 
samples. 
l) Plasma !JI 
Blood from each rat was collected using a modification of the method 
·of Lushbough and Moline (191). With the etherized rat on its right side, a 
. , 
flap was cut in the chest wall exposing the heart and descending aorta. The 
descending aorta was held with a pair of forceps and quickly dissected free 
from the dorsal wall with a blunt probe. After the aorta was cut on the distal 
side of the forceps, the central end was placed within a heparinized centrifuge 
tube and the occluding pressure exerted by the forceps released. The blood 
was centrifuged for 5-7 minutes, and the supernatant pl.isma was collected; 
this procedure generally yielded 2.5-4.5 ml of plasma. After its volume was 
recorded, the plasma was put into a second tube and quick-frozen in a dry ice-
acetone bath. Samples were stored in the freezer until the day of assay 
{within three weeks of collection). Plasma was never pooled at the time of 
collection.. Occasionally during the assay the minimwn 2.0 ml needed was not 
available for a given injection; in such cases, enough plasma (0.05-0.25 ml) 
was taken from a similar sample to make up the difference; such cases are 
indicated in Appendix VI. In addition, plasma remaining after individual 
2o0 ml samples were injected was occasionally pooled with like sanples to 
permit an additional measurement to be made. Pooling was done only in these 
two special circumstances. 
The plasma assay procedure consisted of removing the left ovary as a 
control, weighing it and placing it in 10 ml of 2.5% metaphosphoric acid. A 
2.0 ml sample (saline, NIH-IH-s13., or plasma) was immediately injected into. 
the tail vein of the recipient rat under ether anesthesia. The right ovary 
was removed 1 i hours later, weighed and placed in another 10 ml volwne ~f 
2.5% metaphosphoric acid. The ovaries were homogenized and allowed to stand 
at least 10-15 minutes before being filtered. The supernatant was analyzed 
for ascorbic acid content using the spectrophotometric method of Midlin and 
Butler (2.0B)o From the asco~bic acid content and the ovarian weight, the 
OVarian ·ascorbic acid concentration {pg/mg ovary) was calculated. The per 
ovarian ascorbic acid depletion (OAAD) was then calculated: 
[OAA]1 •left ovary ascorbic acid Cvg/mg) 
[OAA)R • 1?-ght overy ascorbic acid (pg/mg) 
%/.OAAD •::.·p~r;.:cent depletion in ascorbic acid 
Plasma LH was estimated by comparing the per cent depletions of ovarian ascorbic 
acid due to the individual test plasma samples to a standard curve (determined 
with each assay) of_ the mean per cent depletions induced by five injections each 
of saline and three dilutions of a purified standard LH preparation supplied by 
the Endocrine Study Section of the National Institutes of Health (.0625,, .25, 
and 1.00 µg,, NIH-LH-s13/2 ml). Because this method is not fully quantitative, 
each plasma LH value obtained was used as an independent data point even if the 
same plasma sample was used to obtain more than one data point. The data were 
. . 
then evaluated by calculating the mean and standard error,, and comparing data: 
between groups using Student.ts t-test for group comparison (significance at p405). 
. 2) Pituitary LH 
At autopsy pituitaries were removed by a ventral approach. The neuro-
hypophysis was dissected off and discarded; the anterior pituitary was weighed 
and placed in a homogenizing tube and then frozen by placing the tube in a dry 
ice-acetone bath. The frozen pituitary was stored in the freezer until assay 
(within six months). Pituitaries were assayed individually,, except during 
metestrus and estrus in the three-cycle study when, due to the::1ow'"LH con-
tent,, it was necessary to pool two pituitaries. 
The pituitary assay procedure consisted of injecting,, via the tail vein, 
saline or one of two. concentrations of the pituitary homogenate having poten-
cies approximating those of the two LH standard. concentrations, 0.!1 and 1.6 pg 
r 
I' . t.~. ~:-[ 
~o 
'. 
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NIH-LH-S13/mi, which were also tested in each ~ssay. Four hours after injecting 
the samples (n=5 for each treatment) the recipient rats were autopsied and the 
OAA concentration in the left ovary was determined as described above. The 
right ovary was usually discarded; in several assays it was kept to run a para• 
llel check on the results calculated from the left ovary (the OAA concentration 
~· · of the two ovaries is virtually identical). 
~{ 
The pituitary LH potency and 95% confidence limits were calculated 
using the statistical method and bioassay design of Bliss (25). Homoeeneity 
or heterogeneity within a given group, or between groups, was tested by a 
Chi-Square analysis (25); the individual pituitary potencies within a given 
experimental group were then statistically combined to arrive at the weighted 
mean potency (25). 
c. Functional state of neuroendocrine network 
Vaginal cyclicity was evaluated in the two-month study by finding the 
average cycle lengths for the. entire experime.ntal period and comparing these 
in the control, sham, and lesioned animals. In addition, the two-month study 
was divided into two 30-day periods; the average cycle lengths of these two 
periods were then compared with each other and to their counterparts in the c ;) 
control, sham, or lesioned groups. 
2. Ovarian Compensatory Hypertrophy Study 
Immediately after lesioning or sham lesioning, the le~ ovary was re-
moved and weighed; the ovary was then dried and reweighed. At autopsy,· ten 
days later, the right ovary was removed, and wet and dry weights were obtainedo 
The per cent difference of the right ovary compared to the left ovary lfl4S cal-
culated according to the following formula: 
WR • weight of right ovary 
w1 • weight of left ovary 
OCH • per cent ovariai compensatory hypertrophy 
The time course of the OCH response in controls was evaluated by constructing 
a control chart showing th.e degree of OCH at o, 10, and 15 days after removal 
of the le ft ovary. 
The average OCILand its standard error were calculated for each of the 
control, s~m, and lesioned groups, Significance between these groups was then 
evaluated using Student's t-test for group comparison. 
. .. 
'· 
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The Three-Cycle Study 
CHAPl'ER IV 
RESULTS AND COMMENTS 
The data from the individual rats used in this study are tabulated in 
Appendices III, VI, and VIII. Lesion placement in these animals was very 
accurate, in most cases involving the medial-posterior portion of the ACO and 
some of the lateral-posterior aspect of the medial amygdaloid nucleus (AME) 
(Figure 2). In a few animals the lesion seemed confined to the posterior ACO 
with little or no involvement of the AME. The anterior-most part of thel'ACO 
was never involved in the lesions. Control animals.in this study were 83 to 
140 days of age at autopsy; the sham-operated rats were autopsied at 101 to 
142 days of age, ll to 37 days postoperative. The lesioned animals were 105 
to 151 days old at autopsy, 11 to 42 days after the lesioning procedure. 
Although body weight-(Table II) was somewhat depressed in the sham (p<.Ol) 
and lesioned (p c.o5) animals 1 there were no overt signs of inadequate nutrition; 
while the animals' food intake was not closely watched, it was not obviously 
81.tered. General pituitary funct:i.on had not been grossly disturbed, as indi-
cated by the normal pituitary, thyroid, adrenal, axn ovarian weights (Tables 
II and III). 
1. Indirect Assessment of Circulating Ovarian Steroid Levels 
a. Vaginal smear cycles 
Following lesioning, animals either continued cycling or lapsed into 
a period of pseudopregnancy (leukocytic vaginal smears) lasting 12 to 1$ days. 
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FIGURE 2. 
· . Diagramatic Representation of the ACO Lesion Site. 
abl - basolateral arnygdaloid nucleus 
abm - basomedial amygdaloid nucleus 
ace - central amygdaloid nucleus 
aco - cortical amygdaloid nucleus 
al - lateral amygdaloid nucleus 
mne - medial amygdaloid nucleus 
arh - arcuate nucleus of the hypothalamus 
cc - corpus callosum. 
ci - internal capsule 
cla - claustrum. 
cpu - caudate nucleus and putarnen 
dmh - dorsomedial hypothalamic nucleus 
fx - f ornix 
hpc - hippocampus 
ot - optic tract 
pmv - ventral premammilary nucleus 
st - stria terminalis 
v - ventricle 
vmh - ventromedial hypothalamic nucleus 
Modified from De Groot (60). 
CONTROL 
SH.AM-ACO 
LESION-ACO 
., 
TABLE II 
BODY AND THYROID WEIGHTS AND AUTOPSY AGES IN THE 3~CYCLE STUDY 
Body Weight 
(gm) 
300±4 (4l)tab 
281±5 (26)a 
286±5 (36)b 
Thyroid Weight 
(mg) 
Age at Autopsy 
.(Days) 
Days 
Postoperativ_e 
15. 9±0. 6 (34) ~15.8±1.7 (43) ------
17.7±0.9 (26) 119.8±2.1 (28) • 18.2±1.5 (28) 
16.0±0.4 (36) 121.2±1.8 (36) 22.8±1.3 (36) 
tMean ± SEM (Number of Animals) 
a p<.01 
b p<.05 
In this and all subsequent tables, 
means with similar superscripts are 
significantly diff~rent at the level 
indicated in the table footnotes . 
TABLE III 
PITUITARY, ADRENAL, AND OVARIAN WEIGHTS '(mg) INTHE'3~CYCLESTUDY"ANIMALS 
CONTROL 
SHAM 
LESION 
CONTROL 
SHAM 
LESION 
CONTROL 
SHAM 
LESION 
PROESTRUS 
12.8±0.9 (lO)t 
11. o±o. ab< n 
12.4±1.0 ( 9) 
29.4±2.2 ( 9) 
29.6±1.9e( 7) 
32.7±1.6 ( 9) 
37.6±3.0 ( 9) 
3 7. 9±2. 7 ( 7) 
36.1±2.8 ( 9) 
ESTRUS - AM 
Pituitary '.:c·.:"-':_:: 
14.1±0.Sa( 8) 
11.3±0.Sat 7) 
12.1±0. 9 ( 7) 
Adrenal. ::·:.c:i.g'..::.s 
31. 7±2.1 ( 8) 
32.1±1. 8- < 7) 
32.2±2.1 (•7) 
Ovarian :-:et~, .. :~~ 
35. 5±1.4 ( 8) 
37 .6±1.8 ( 7) 
37.1±2.4 ( 7) 
ESTRUS - PM 
._, 
12.6±0.9 (10) 
14. 3±1. Obt 7) 
12.2±0.9 (10) 
{r.~f'" ~ 
29.6±1.34(10) 
. dt 35 .6±1.6 7) 
31. 7±1.6 (10) 
.'~;·.:i:;) 
39·.2±2.3 (10) 
41.1±2 .6 ( 7) 
42.0±2.8 (10) 
tMean ± SEM (Number of Animals) 
abce p<.05 
d''p<.02 
(' 
,< 
METESTRUS 
13.1±0.7 (15) 
11.6±1.2 ( 7) 
11.5±0. 9 (10) 
. 31.5±1.2 (15). 
33_;3±1.4 ( 7) 
32.l±l.5 (10) 
39.1±1.2 (15) 
. 37. 9±1.4 ( 7) 
36. 8±2 .·1 (10) 
~ 
- 1 
No· unusual numbers of cornified cells were noticed during the three cycles 
allowed before autopsy, indicating no marked changes in plasma ovarian steroid~ 
which would be reflecte~ by increased incidence of vaginal cornification (88, 
252). 
b. Uterine changes 
The uterine data summarized in Tables IV and V provide very reliable, 
although indirect, assessment of ovarian steroid levels during the estrous 
cycle (12, 13, 274). As reported previously by others (lli.8, 248, 274), uterine 
weights fluctuate significantly during the estrous cycle; in the control ani-
mals uterine wet and dry weight is maximal at proestrus and minimal at metestrus 
(Table IV). By the afternoon of estrus, uterine wet weight had dropped signifi• 
cantly {p<.Ol) from the high proestrous weight; by metestrus a further drop 
occurred such that the metestrous~rMuterine weight was significantly lower 
(p <.01) than that at proestrus, estrus•AM, or estrus-PM• Although the dry 
weights did not drop significantly by estrus-r:M, the metestrous dry ute~ine 
weight was significantly lower (p<.01) than at the three earlier time periods 
tested. The uterine tissue lost water between proestrus and metestrua. Com-
pared to the proestrous values, the percent dry weight (the values in Table IV 
are the averages calculated from the individual values) became progressively 
gre~ter. during the cycle_, estruS•AM {p<.05) 1 estrus-FM {p(.02) 1 and metestrus 
(p(.01). These measurements (drop in uterine weight and tissue fl~d) indicate 
plasma estrogen levels have dropped between proestrus and metestrus (13, 274). 
Although a general trend toward lower uterine weight and tissue fluid 
was apparent in the ACO-Sham lesioned animals between proestrus and metestrus, 
a significant {p(.02) drop in wet weight from the proestrous high was not seen 
until metestrus, and no significant drop developed in the dry weights. The 
lack of an earlier significant drop in the wet weight and tissue fluid was 
CONTROL A. 
B. 
·c. 
SHAM-ACO A. 
B. 
c. 
LESION-ACO A. 
B. 
c. 
, 
TABLE IV 
UTERINE DATA IN THE 3-CYCLE STUDY 
PROESTRUS ESTRUS - AM ESTRUS·-·PM · 
525.6±29.la~lO)t 451". 7±21. 2c ( 8) 427.4±12.la~lO) 
108. 0±10. 2m( 5) 92.7± 3.6°( 8) 88.5± 3.0°( 6) 
19.6± 0.48 tu5) 20.6± 0.38°'F8) 20.9± 0.2t~ 6) 
523.1±54.le( 7) 443. 7±18. 2f ( 7) 429. 9±.15. 08 ( 7) . 
83. 3±11. 5 ( 3) 87.8± 3.9 "( 6) 84.7± 3. 4 ( 4) 
19.3± 0.8 ( 3) 19.4± 0.4~ 6) 19. 8± 0 • 3X ( 4) 
502.6±19. 7h~j9) . h~ . 431.4±23.3 7) 424. 9±24. 71ho) 
91.9± 4.9P( 5) 88.4± 6.2q( 6) 88.3± 6.3r( 7) 
19.2± o. 3zi~s) 20.3± 0.3'Z~ 6) 20.3± 0.3°~ 7) 
tMean ± SEM (Number of Animals) 
·. · · · METESTRUS · 
332 .1±14: ob~~5 > · 
72.9± 3.lm~~3) 
21. 6± 0. 3u113) 
353.1±27.9e~g7) 
"76.3± 9.5 ( 4) 
20.8± 0.2Y( 4) 
317.4±14.5j~to) 
68.0± 3.7pir7) 
21.2± 0.3~~V'7) 
A. Wet Weight (mg) B. Dry Weight (mg) C. %·Dry Weight 
a-d,j-p,u,~ p<,.01 e,f,q,r,t.p< .. 02 
. . r ..• '-··-
\J'\ 
\() 
:·~·' 
TABLE V 
UTERINE INTRALUMENAL FLUID AND NUMBER OF TUBA~. 
OVA IN THE 3-CYCLE STUDY ANIMALS 
Uterine Intralumenal 
Fluid (mg) Tubal Ova* 
60 
PROESTRUS ESTRUS - AM ESTRUS - PM 
CONTROL 217.8±28.6 ( 9) 6. 7±1.1 ( 8) 
SHAM-ACO 252.2±32.4 ( 7) 6.1±0.9 ( 7) 
LESION-ACO 236.1±56.7 ( 8) 5.6±0.4 ( 7) 
tMean ± SEM (Number of Animals) 
*Number of ova expressed from 
dissected oviduct 
7.5±0.7 (10) 
7.3±0.3 ( 7) 
7.1±0.7 (10) 
,..,,, 
I '• 
,. 
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probably due to the large variability associated with the proestrous wet weight 
and percent dry weight. Inspection of the individual data in Appendix III 
indicates the lack of a significant drop in dry weights was due to the low 
number of dry uterine weights which were unfortunately at the low end of the 
t data population. 
t 
However, these few animals may have had low tissue respon-
Thus, the ACO-sham lesioned animals seem to have under-·siveness to estrogen. 
gone a drop in plasma estrogen levels similar to that of the control animals. 
The significantly lower percent dry weights at estrus-AM and estrus-PM compared 
to their respective control values may indicate the estrogen drop was somewhat 
slower than in controls, or that progesterone levels were somewhat lower than 
controls. However, the normal loss of intralumenal fluid from sham animals 
indicates a rise of progesterone between proestrus and estrus closely resem-
bling that i.n unoperated animals {more details below) 0 That diestrous steroid 
levels inducing these uterine changes were close to control levels was indicated 
by the comparable proestrous uterine weights and tissue fluid (174, 248, 251) 
between control and sham animals. 
The uterine wet weights underwent a very obvious decline in the le-
sioned animals, i.e., estrous-AM, estrous-PM, and metestrous animals all bad 
uterine weights significantly lower than those at proestrus (pi::.05, p<o05, . 
P<oOl, respectively). The metestrous uterine wet weight was also significantly 
lower (p-c.01) than both the estrous·-AM and estrous-PM weights. The dry weight 
data do not demonstrate as obvious a change as did the wet weights. No signi-
ficant drop from proestrus occurred during estrus but there was a marked reduc-
tion in dry weights by metestrus-PM (p<oOl). A significant difference between 
rnetestrus and estrus-AM (p<.02) or estrus-PM (p<.02) was seen in the dry weight 
data as well as in the wet weight data. A drop in estrogen titers was also re-
flected by the fact tr.at the· uterine tissue fluid was less, compared to that at 
,. 
62:: 
proestrua, during the estrous-AM {p<.0.5), estrous-PM {p<.OS), and metestrous 
{p<.Ol) autopsy periods. In addition, at both estrus-AM and estrus-PM the 
uteri had more tissue fluid than at metestrus (p<.05). These data strongly 
indicate that plasma ovaTian steroid levels throughout the cycle were very 
similar in both control and lesioned animals~ The diestrous steroid levels 
' inducing the uterine weight and tissue fluid changes (174, '2481 251) appear !:·r 
J·:.· normal in lesioned animals, as does the change in circulating steroids during 
~ estrus and metestrus. 
t 
~ ~ 
t:'. 
Table V summarizes the data on the uterine lumenal fluid content at 
proestrus. There was no statistical difference in the amount of fluid among 
the experimental groups. No lumenal fluid was found during either estrus or 
metestrus. It seems, therefore, that the diestrous steroid levels inducing 
the accumulation of lumenal fluid {12, 251), as well as the post-ovulatory 
steroid changes inducing loss of the lumenal fluid {12, 190) had not been 
seriously influenced by the lesioning procedure. 
Co Pituitary weight 
It is appa~nt from the pituitary data summarized in Table III that 
no weight changes occurred during the cycle in either the control or lesioned 
. animals; par were there any significant differences between control and J ·~~ 
lesioned animals• pituitaries on respective days of the cycle. Pituitary 
weight on the morning of estrus in the controls was significantly greater 
{p<o0.5) than that in the sham group autopsied at the same time, but virtually 
identical to that in the shams at estrus-PM. The elevated estrous-PM weight 
in the sham animals was significantly higher than both the proestrous {p<.05) 
and estrous-AJ.f {p<.05) weights in the sham group. It is not known whether 
these differences reflect significant physiological changeso In that chroni-
, . 
cally ldgh estrogen titers reportedly elevate pituitary weights (106), the 
r. 
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elevated pituitary weights may indicate high circulating estrogen levels at 
estrus. This is unlikely, however, since it is doubtful whether estrogen levels 
could change rapidly and greatly enough to induce the significant increases seen 
.during estrus; furthermore the uterine weight and tissue fluid measurements 
(Table IV) indicate that highest estrogen levels were during proestrus. 
d. Adrenal weight 
Table III, section B, summarizes the adrenal data. Neither the control 
nor lesioned animals showed significant fluctuations during the estrous cycle. 
The sham animals, however, had a_ significantly greater (p<.05) estrous-PM 
adrenal weight compared to that at proestrus; it was also significantly greater 
than that ill estrous-PM controls (pc.02). Lesioning did not induce any increase 
in adrenal weight; in that conditions of elevated estrogen have been reported. 
to elevate adrenal weights (223), it is apparent that secretion of chronically 
high levels of estrogen have not been induced in lesioned animals. Even though 
the adrenal weights may indicate elevated estrogen levels in sham animals at 
estrus-PM, the more reliable uterine date indicate normal estrogen levels. The 
significance of the elevated adrenal weight is therefore doubtful. 
2. Indirect Assessment of Circulating Gonadotrophin Levels 
a. Ovarian weig]J.t 
Table III summarizes the ovarian weight data. Examination of the control, 
sham, and lesion data reveals no significant fluctuations within any respective 
groups during the cycle. There were no statistically significant differences 
among the control, sham, or lesioned animals at respective cycle stages. 
b. Ovulation 
Table V summarizes the data on the number of tubal ova (unilateral) 
in estrous animals. No ova were found during other stages of the cycle. The 
nUJnber of eggs in the oviduct during estrus-AM compared to estrus-PM was not 
,. 
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significant in any of the groups, nor was there any significant difference among 
groups during respective estrous time periods. It seems reasonable to conclude 
from these data that ACO•lesions did not induce marked changes in mean cyclic 
plasma gonadotrophin titers maintaining the normal ovarian weights, or in the 
basal and surge levels of plasma gonadotrophins needed for folliculogenesis, ~· 
r steroid secretion, and ovulation.(86);) 
t' 
c. Ovarian histology 
Examination of the ovarian histology revealed that full luteinization 
apparently did not occur in the ACO-lesiohed ahimals~ Ih control animals, 
large follicles were occasionally seen at estrus but they were never comparable 
in size or number to follicles found at proestrus (Figure 3)5' the center of 
many fresh corpora lute~ was not densely infiltrated by cells. Fresh eggs 
were visible in the ampullar segment of the oviduct (Figure 3). At metestrus 
follicular development is noted and all corpora lutes were solid (figure 3). 
The ovaries of sham or lesioned animals during estrus contain several stimu-
lated follicles comparable to those seen during proestru.s (Figures 4 and 5). 
During metestrus, sham ACO lesioned animals have corpora lutea much like those 
of control animals (Figure U). In lesioned animals however, although cellular 
infiltration of the corpora lutea is underway, many corpora lutea still retain 
a distinct fluid center (Fifure 5). Some of the larger follicles remaining 
through estrus in lesioned animals apparently may become luteinized, trapping 
the ova within (Figure ~). These histological findings suggest that plasma 
gonadotrophin concentrationac'during the cycle may be inadequate for normal 
luteinization. 
3. Direct Assessment of Plasma and Pituitary IJI 
Table VI summarizes the plasma LH data. The data points d.n- Appendix VI 
•are given in the units directly found from the assay Cvg/2 ml) and the converted 
,. 
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A. B. 
D. 
c. 
FIGURE 3 
Sections of Ovaries from Control 3-Cycle Study Animalso BOX. 
Ao Proestruso Two developed follicleso Anima1l SB8o 
B. Estruso Fresh corpus luteum. Animal SB37o 
C. Estrus. Egg in oviduct (x) and developing follicle (z)o Animal SBJ7. 
D. .Metestrus. Corpus luteum which looks most like those found in sham or 
lesioned animals. Animal SB22o 
,. 
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A. B. 
c. 
FIGURE 4 
Sections of Ovaries from ACO-Sham Operated Animals in the 3-Cycle Study. 80X. 
A. Estrus. Fresh· corpus luteum. Animal SB34. 
B. ' Estrus. Highly stimulated follicle; luteinization is evident and ovum 
and surrounding granulosal cells are free within follicular fluid. 
Animal SB37. 
Co Metestrus. Fresh corpus luteum. Animal SB15. 
,. 
A. 
c. 
:-· . 
r - .tr.. , --
)• 
l 
D. 
FIGURE 5 
8. 
E. 
Sections of Ovaries from ACO-Lesioned Animals in the 3-Cycle Study. 801.. 
A. Estrus. Two fresh corpora lutea, each with lumen. .Animal SB25. 
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B. Estrus. Large stimulated follicle comparable to those seen during proestrus. 
Animal SB25. 
c. ~testrus. Corpus luteum with entrapped ovum. .Animal SB18. 
D. Metestrus. Corpus luteum with large lumen. Animal SB18. 
E. l~testrus. COl1JUS luteum with large lurnen . Anill1.al SB35. 
•• 
TABLE VI 
PLASMA LH CONCENTRATIONS (ng/ml) IN THE 3-CYCLE STUDY 
PRO ESTRUS ESTRUS - AM ESTRUS - PM 
CONTROL 32.2±5.9a~l6)t 
. . 
10.8±3.6a~9) 
SHAM-ACO 24.1±7.4*( 7) 11. 2± 7. 4 ( 5) 
LESION-ACO 24.3±8.3£( a) 26.9±11.l (11) 
tMean ± SEM (Number of Animals) 
ab p<.02 
c-f p<.05 
*Values below 31.3 ng/ml were obtained 
_by extrapolation of the standard curve 
below the lowest standard tested (31.3 
ng/ml), assuming a linear log-dose 
response down to zero. Zero ng/ml were 
assumed if no ovarian ascorbic acid 
depletion occurred. 
METESTRUS 
40.9±10.5c~l3) 
54.1±22.6 ( 5) 
29.0±17.6 ( 8) 
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units used in Table VI (ng/ml)o Plasma LH during the experimental autopsy 
period (2:30-3~30 PM) in proestrous control animals was significantly less 
(p<.01) than that found during the 5 :OO-?:OO PM time period [2ol.3ill.8.5 (SEM) 
ng/ml (seven data points) (Appendix VI)). Since the latter was obtai.ned using 
. . 
five-day animals and,, since most experimental animals were fo\lr-day ~yclers) ·.ill 
this may not be the best comparison (248)o Using four-d.ay proestrous animals 
from the same supplier as used in the present study, Lawton (173) has recently 
noted a plasma IJI concentration of 61.3.±1216 ng/ml (191) between 6:00 and 7:00 
PM and a concentration of 84.5±23.2 ng/ml (199) between 8:00 and 9:00 PM, 
indicating that the peak plasma IH concentration occurred later than the 2:3~-
3:30 PM time period noted in Sprague-Dawley rats from another supplier (176). 
The experimental autopsy time used for this study was tlius·appfirently several 
hours earlier than ~he true critical period. Nevertheless,, as seen in Table 
VI,, IJI release has already begun,, in that plasma LH at this time is signifi-
cantly. higher (p<.02) than values found during the morning and afternoon of· 
estrus. One unexpected finding was the significantly elevated plasma LH con-
centration in metestrous controls compared with that found during estrus (p(.05); 
the value is not significantly different from that at proestrus. 
In the sham-lesioned animals,, plasma LH was high at proestrus,, as in . 
controls, but failed to show a significant drop by the morning of estrus,, even 
though estrous-AM levels were ·similar to those in controls. Failure to demon-
strate significance was probably due to the greater variability and smaller 
sample number. The estrous-PM concentration,, while statistically higher 
(P<,05) than the control estrous-PM value, was not statistically higher than 
the sham estrous-AM value. The sham estrous-PM and proestrous ~oncentrations 
seemed identical. It thus appears that the plasma LH titers may be slightly 
elevated during the afternoon of estrus in the sham-lesioned animals. 
··"· 
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The lesioned animals demonstrated a significant (p<.05) drop in plasma 
UI between proestrus-PM and estrus-AM. Although estrous-PM and metestrous 
concentrations appear identical to those at proestrus 1 they are not signifi•·'.. ·: · 
cantly higher than the value at estrus-AM. Failure to demonstrate signifi* 
cance is probably due to the wide variability. The metestrous value, although 
lower than both control and sham values, is not significantly lower. 
Although the statistics do not bear out a consistent trend, these data 
offer suggestive evidence that plasma LH was elevated on the afternoon of estrus, 
but not on the moriling of estrus or on the afternoon of metestrus 1 in sham and 
lesioned animals. There is a slight indication in the data from the metestrous 
animals that the sh8Jll. procedure may elevate plasma LH, but that the lesion may 
reduce the plasma LH during metestrus, although there was not statistical evi-
dence for this separation. The morning-afternoon differences in the sham and 
lesioned animals may be better detected with more time periods evaluated and 
an assay method which allo~s less variability. These data also indicate that 
the LH surge had not been advanced by either the sham or lesioning procedures 
to such an extent-that it could be detected by the 2:30-3:30 PM autopsy period. 
The weighted mean pituitary LH potencies during the various stages oft. 
the estrous cycle are presented in Table VII; the individual pituitary LH 
values are tabulated in.Appendix VII. Pituitary LH content in control 
animals dropped from a high at proestrus-PM to a low at estrus-AM (p<.01) 1 
and remained significantly lower (p<.01) through metestrus-PM. Contents on 
the morning and afternoon of estrus were virtually identical. While replen-
ishment ·of pituitary LH seemed to occur by metestrus-PM1 not enough of a 
recovery had been accomplished to yield a significant increase compared to 
- . 
estrus-AM. Sham and lesioned animals also.showed a sharp drop in pituitary LH 
content from proestrus-PM to estrus-AM (p<.01). In both groups, however, 
CONTROL 
A CO-SHAM 
ACO-LESION 
TABLE VII 
PITUITARY LH POTENCY 3 CYCLES POST-LESION· 
PRO ESTRUS 
PM 
24.6*ab 
(18.6 - 32.4)t 
3~ 
18.6c 
·(15.3 - 22.7) 
3 
22.0d 
(17.3 - 27.9) 
3 
ESTRUS 
AM 
8.5a 
(6.·8 - 10,~ 6) · 
3 
9.2c 
(7. 6 - 11.1) 
3 
12.od 
(9.7 - 14.8) 
3 
PM 
9.5be 
( 7.2 - 12.5) 
3 
13.4 
(10.8 - 16.7) 
3 
17.8e 
(14.2 - 22.3) 
4 
*Weighted Mean Potencies [µg(NIH-LH-s 13)/pituitary] 
t95% Confidence Limits 
fNumber of Pituitaries Combined 
a-e Potencies Significantly Different (p<.01) 
METESTRUS 
PM 
11.8 
( 8.8 - 15.8) 
3 
13.4 
(10.6 - 17.1) 
3 
16.8 
(13.9 - 20.2) 
3 
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estrous-PM and metestrous levels were no longer significantly lower than their 
respective proestrous values; neither were they significantly higher than their 
respective estrous-AM levels. Thus, in both sham and lesioned animals, pitui-
tary LH seems to be increased to somewhere between the proestrous high and the 
estrous-AM low by estrus-PM and remains there into metestrus-PM. The accumula-
tion of pituitary LH seems to have occurred more efficiently or more rapidly in 
the lesioned animals, since the content at estrus-PM was Significantly higher 
than in the controls (Table VII). The sham estrous-PM content appears to be 
somewhere in between the control and lesion contents; it was not significantly 
different from either of them. To further test the difference between sham 
and lesiop:'.animals ,:_pi.tui tary LH.:·content'.for~'all·. estrous· and metestrous ani-
~al.S. were· pooled Within a given experimental group (control, sham, and lesion) 
and the potencies evaluated for statistical.significance (Figure 6). The re-
sults of this procedure emphasize the more rapid accumulation of LH in the 
pituitaries of the ACO-lesioned animals than in control or sham-lesioned ani-
mals. The combined estrous-rnetestrous content was significantly greater (p(.05) 
in the ACO-lesioned animals than in either control or sham animals; however, 
pituitary LH in the control and sham groups was similar. It thus appears that 
the pituitaries of ACO-lesioned animals had an increased rate of replenishment 
of LH as compared to control or sham animals• J..lthough ACO-lesioning en-
couraged a more rapid accumulation of pituitary LH, the presence of the lesion 
did not alter the maximum level attained prior to the ovulatory discharge of 
gonadotrophins. 
,. 
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FIGURE 6 
The weighted mean potency and 95% confidence limits (25) of LH in pituitaries 
of control (C), shmn-lesioned (S), and LCO-lesioned (L) rats autopsied at 
estrus and metestruso 
.. 
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B. The Two-Month StudY; 
The data from each rat used in this study are compiled in Appendices 
I, IV, VI, and VII. Placement of lesions in the ACO was very accurate. For 
the most part, significant damage was done to the ACO with some encroachment 
on the medial nucleus (AME) (Figure 2); in a few cases, the lesion seemed con-
fined to the ACO with little or no encroachment on the AME. The lesions were 
confined to the posterior portion of both the ACO and AME, with no obvious 
damage to the anterior part of the ACO or the AME. Lesion size ranged from 
0.75 mm-1.75 mm. Lesions directed· at the ST were in all cases inadequate. In 
no case was bilateral damage inflicted. The placements were o.5-1.00 mm too 
' ' 
ventral, such that even the spread of tissue damage out from the major lesion 
site did not generally reach the ST. Instead, the caudate nucleus, putamen, 
and internal capsule received various amounts of damage. Lesion placements in 
the AL, while not being unifonn1y direct, always involved the lateral por~ion 
of the nucleus along with extensive damage to the claustrum • 
• That the general health of the lesioned animals in the present study 
did not deteriorate was judged from their good general appearance and from the 
maintained body and organ weights (Tables VIII-:- XII). Body weights (Table VIII) 
were similar in 7 of the 8 groups studied; the AGO-lesioned rats were signifi-
cantly heavier than their sham controls. Table IX summarizes the pituitary 
weights as a function of the cycle stage at autopsy. The weights do not vary 
in any group except the AL-sham group; since controls, ACO-shams or AL-lesion 
~nirnals did not show this significant (p<e05) rise in pituitary weight between 
proestrus and estrus, its physiological significance is questionable. The 
significantly (p<.02) lower AL-sham proestrous pituitary weight compared to 
controls, and the lower estr9us-PM value compared to both the control (p<.05) 
and ACO-lesion (p<.OS) groups are likewise doubtful. It is possible, however, 
,. 
TABLE VIII 
BODY WEIGHT;,; AND-AGE":AT-AUTOPSY. OF.TlIE 2:...MONTH' STUDY ANIMALS 
CONTROL (26)t 
ACO-SHAM'. (2.7) 
ACO-LESION (28) 
ST-SHAM .( 9) 
ST-LESION (15) 
AL-SHAM (12) 
AL-LESION ( 8) 
BODY . AGE AT 
WEIGHT AUTOPSY 
(gm) . (days) 
312±4t 150.5±2.1 
310±3a 148. 8±1. 4 
322±5a 149. 9±1. 6 
315±11 154.9±0.8 
319±5 147. 6±1. 4 
314±5 163. 7±1:2 
313±13 160. 7±0. 7 
tMean ± SEM 
~Number of Animals 
a p<.05 
DAYS 
POST-OPERATIVE 
61. 0±0. 7 
60.4±0:6 
61. 6±0. 5 
60.9±0.4 
61. 7±0. 6 
60.7±0.7 
,. 
CONTROL 
SHAM-A CO 
LESION-ACO 
SHAM-ST 
LESION-ST 
SHAM-AL 
LESION-AL 
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TABLE IX 
PITUITARY WEIGHTS (mg) IN THE 2-MONTH STUDY ANIMALS 
PRO ESTRUS ESTRUS - AM 
16. 5±0. 68 ( 8)t 16.1±1. l. ( 9) 
16.0±0.8 ( 7) 16.4±0.7 ( 9) 
15. 3±1. 0 (10) 16.3±1.0 ( 8) 
16.0±1.1 ( 9) 
16.0±1.1 ( 5) 16.3±0.5 ( 5) 
l3.4±0.98 t 5) 18. 4±1. 6dc 6) 
14. 6±1. 2 ( 5) 15. 9±1. 8 ( 4) 
tMean ± SEM (Number of Animals) 
a p<.02 
bcdp<.05 
ESTRUS - PM 
17.5±0.9b( 9) 
15. 0±0. 7btll) 
17. 9±1. oc (10) 
16.5±1.5 ( 5) 
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that the sham procedures may have had some undisclosed unique effects of their 
own. 
Thyroid weights (Table X) did not vary significantly during the estrous 
cycle in control, ACO-lesioried, AL-sham, or AL-lesioned animals. In the ACO-
sham and 11ST 11-lesioned animals, however, thyroid weights at proestrus were . 
significantly (p<.05) greater than at estrus. The significance of these 
variations, especially those of the latter group, is unclear since 11ST"-
lesions involved the caudate, putamen, and internal capsule. Thyroid weight 
at proestrus in the ACO-sham group was greater than that in the control (p<.05) 1 
AL-sham (p<.05), and AL-lesion {p~oOl) groups. In the AGO-lesion group thyroid 
weight was significantly greater (p<.05) than in animals with AL-lesions at 
both proestrus and estrus; although it also appeared to be greater than that 
in controls, the difference fell short of significance. The significantly 
divergent effects of ACO and AL lesions on thyroid weight suggest opposing 
roles for these two amygdalar sites in the regulation of thyroid stimulating 
hormone (TSH) secretion. 
Adrenal weights (Table XI) did not show any significant variation 
during the estrous cycle in any group except the ACO-lesion group, in which 
the adrenals were significantly heavier (p<.01) on the afternoon of estrus 
than in the morning. The estrous adrenal weights in the ACO-lesion animals 
were not significantly different from those in controls. However, this 
estrous-PM adrenal weight was also significantly higher than that in the 
shams (p<.02), whereas the estrous-AM weight was significantly lower than the 
sham ACO weight (p<.05). Although the physiological significance of the 25% 
increase in adrenal weight over a Jl hour period in the lesioned rats is not 
apparent at the present time, it may refle~t a marked elevation in the circa-
dian peak of adrenocorticotrophic hormone (112), or an elevation in circulating 
,. 
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TABLE x·: 
THYROID WEIGHTS (mg) IN THE 2-MONTH STUDY ANIMALS 
PRO ESTRUS ESTRUS - AM ESTRUS - PM 
CONTROL 16.5±L3a( 8)t 16. S±i. 0 ( 9) 17 .6±1.5 ( 9) 
SHAM-A CO 19.8±0.5a~c9) 17.1±1.0b( 9) 16. 6±0. 9 c(ll) 
LESION-ACO 19. l±L 0 (lo/ 18.2±0.7 ( 8)g 17.7±0.8 (lO)h 
SHAM-ST 16.1±2.3 ( 8) 
T.·; :··: T · ·:· 
( 5)i ( 5)hi LESION-ST 18. 4±1.1 16.8±0.5 ( 5) 14. 5±1. 0 
SHAM-AL 17.9±0.6dt 5) 18.4±1.6 ( 6) 
., ..... :·r;·, 
LESION-AL 15.5±0. 7ef 5) 14. 7±1. 3 ( 4)g 
tMean ± SEM (Number of Animals) 
,a-ip<.05 
... 
CONTROL 
SHAM-ACO 
LESION-ACO 
SHAM-ST 
LESION-ST 
SHAM-AL 
LESION-AL 
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TABLE XI 
ADRENAL WEIGHTS (mg) IN THE 2-MONTH STUDY ANIMALS 
PRO ESTRUS ESTRUS - AM 
27. 5±1. 2 
29. 4±1. 0 
30. 3±1.4 
28. 5±1. 5 
29.7±1.8 
25. 8±1. 8 
( 8)t 29.1±1. 8 ( 9) 
( 7) 29.7±0.9 ( 9)a 
(10) 26. 4±1. 3 ( 8)ab 
32. 8±1. 9 ( 9)d 
( 5) 26. 9±1.1 ( 5)d 
( 5) 30.2±2.8 ( 6) 
( 5) 28. 3±1. 9 ( 4) 
tMean ± SEM (Number of Animals) 
adp<.05 
bp<.01. 
c p,<. 02 
ESTRUS - PM 
30.8±2.3 (9) 
29.1±0.8 (1.l)c 
32.9±1.3 (lO)bc 
30.8±3.4 ( 5) 
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· !strogens ( 223) • 
l. Indirect Measures of Plasma Ovarian Steroids 
a. Vaginal smears 
Estrogen levels.were not markedly decreased or increased since estrous 
'cycles proceeded normally (Table XII; Appendix I) and the incidence of corni-
fied smears did not differ from normal. Full vaginal cornification was found 
during only one day of the cycle, estrus. 
b. Uterine weights and lumenal fluid 
· Tables XIII and XIV summarize the uterine weight, tissue fluid, and 
intralumenal fluid data. The original data are tabulated in Appendix IV. As 
can be seen from Table XIII, both wet and dry weights in control animals on the 
afternoon of proestrus were significantly higher than on either the morning or 
afternoon of estrus. The uterine tissue fluid (as measured by the percent dry 
uterine weight) had also significantly dropped from proestrous levels during 
estrus. These uterine indicators, reflected a similar dynamic change of 
plasma estrogens in ACO-sham-lesioned animals, with the possible exception of 
a slower drop in uterine tissue fluid. A significant drop was not evident 
until estrus-PM, although both the wet and dry weights were significantly 
lower by estrus-A.\f. Animals bearing ACO-lesions also demonstrated the ex-
pected drop in uterine wet weight from the high proestrous level by both 
estrus-AM and -PM, 'Although the dry weights were lower at estrus than at 
proestrus, the difference was not significant. Uterine tissue fluid in the 
lesioned rats· had dropped significantly by the morning of estrus, but then 
.. 
rose again by estrus-PM; estrous afternoon levels,. statistically equivalent 
to proestrous levels, were significantly higher than morning levels and sham 
estrous-PM levels. These differences may ~fleet subtle alterations in 
estrogen and/or progesterone secretion during the cycle (13). However, since 
. r 
CONTROL 
SHAM-ACO 
LESION-ACO 
SHAM-ST 
LESION-ST 
SHAM-AL 
LESION-AL 
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TABLE XIL 
AVERAGE CYCLE LENGTH FOR RATS IN THE 2-MONTH STUDY 
P_-::_30 Days 
- . Post :.-Lesion··· . 
t4.08±0.03(29)abc~ 
4.24±0.05(30)b 
4.16±0.04(30) 
4. _62±0 .11 '(10) e 
4.19±0.08(15)e 
4·. 28±0.10(12)d 
4.09±0.04(10) 
31-60 Days 
Post Lesion 
4.28±0.07(29)a 
4.26±0.08(30) 
4. 21±0. 06 (30) 
4. 41±0. 22 (10) 
4.18±0.08(15) 
4.19±0.11(12) 
4.11±0.10(10) 
tMean ± SEM (Number of Animals) 
bcep<.Ol 
0-60 Days 
Post Lesion 
4.18±0.04(29) 
4.23±0.05(30) 
4 .17±0. 04 (30) 
4.40±0.15(10) 
4.21±0.08(15) 
4.20±0.09(12) 
4.11±0.06(10) 
-i.• 
Ba 
TABLE XIII· 
UTERINE DATA IN THE 2-MONTH STUDY ANIMALS 
CONTROL 
ACO-SHAM 
ACO.,...LESION 
ST-SHAM 
ST-LESION 
AL-SHAM 
AL-LESION 
PRO ESTRUS 
763.9±67_.9c~ 7) 
139. 3±13 .1 i~ 7) 
18.2±: o.·3m( 7) 
622. 0±33. oeho) 
113.2± 6.9 (10)' 
18.2± 0.3°(10) 
590.8±48.8 CS) 
108.6± 8.9 ( 5) 
18.4± o.1rt 5) 
619.3±43.7 ( 5) 
113.5± 6.8 ( 5) 
18.4± 0.4 ( 5) 
594.7±42.3 ( 5) 
105.4± 9.5 ( 5) 
17.6± 0.3 ( 5) 
*Mean ± SEM (Number of Animals) 
a. 
'.Uterine Wet Weight (mg) 
2
uterine Dry Weight (mg) 
3 Percent Uterine Dry Weight 
ESTRUS - AM 
494. 6±28. 6a ( 9) 
94.6± 5.5g( 9) 
k 
. 19.1± 0.3 ( 9) 
543.8±32.9c( 9) 
101.5± 5.3i( 9) 
18.8± 0.4 ( 9) 
505.1±40.le( 8) 
99.5± 7.9 ( 8) 
19.7± 0.2°~ 8) 
536.6±39.2 ( 9) 
100.2± 6.8 ( 9) 
18.7± 0.8 ( 9) 
494.4±40.4 ( 5) 
98.8± 6.8 ( 5) 
20.3± 0.3r( 5) 
502.5±48.8 ( 7) 
95.8± 8.7 ( 7) 
19.1± 0.3 ( 7) 
464.2±46.7 ( 3) 
93.8± 8.6 ( 3) 
20.2± 0.3 ( 3) 
ESTRUS - PM 
503.6±37.6b( 9) 
95.5± 5.8h( 9) 
19.1± 0.31 ( 9) 
507.8±31.2d(ll) 
98.8± 5.8j (11) 
19. 5± O. 2mi11) 
524. 6±21. 4 f (10) 
98.4± 4.5 (10) 
18.7± 0.2n~~O) 
451. 7±44. 5 ( 5) 
90.1± 8.6 ( 5) 
20.0± 0.4qt 5) 
p<.01: cdijmoqrst 
p<;o2: anp 
p<.05: befghkl 
CONTROL 
SHAM-ACO 
LESION-ACO 
SHAM-ST 
LESION-ST 
SHAM-AL 
LESION-AL 
TABLE XIV 
UTERINE INTRALUMENAL FLUID AND NUMBER OF EGGS 
IN THE 2-MONTH STUDY ANIMALS 
Uterine Intralumenal 
Fluid (mg) Number of Eggs* 
PROESTRUS ESTRUS - AM ESTRUS - PM 
274.8± 32.5 ( 8)t 6.3±0.7 ( 9) 6.7±0.5 ( 9) 
605.9±194.3 .( 7) 5.9±0.8 ( 9) 6.9±0.7 (11) 
238.1± 46.5 ( 9) 4.9±0.8a( 8) 7.9±0.7a(l0) 
6.2±0.6 ( 9) 
347.3± 83.9 ( 5) 6.6±0.7 ( 5) 6.2±0.8 
457.6±118.2 ( 5) 7.7±0.5 ( 6) 
332.7± 69.2 ( 5) 7. 0±1. 2 ( 4) 
''. 
.... 
tMean ± SEM (Number of Animals) 
a p<.02 
* Except for animal SD32 in which no ova were 
found in the right duct, one ova found between 
the ovary and the capsule in the histological 
sections of the left ovary and used for the 
. ..... 
ova count of this animal, the number of ova 
expressed from the dissected right oviduct were 
used. 
... 
( 5) 
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,• ,, 
proestrous and estrous wet and dry weights and tissue fluid in the s,ham and 
lesioned groups were equivalent to control values, plasma estrogen levels 
apparently were physiologically equivalent. 
In the "ST"-lesioned animals, uterine wet and dry weights at proestrus 
and estrus were similar to those in controls. Although a significant decrease 
of tissue ~luid was evident between proestrus and both estrus-AM and estrus-PM, 
the proestrus-to-estrus drop in wet and dry weights was not significant, per-
-
haps because of the small population of animals (225). 
The findings of the AL study closely par~llel those of the ~ST 11-study.· 
/ 
Although there were no differences in uterine wet or dry weights in the sham 
or lesioned rats when compared with controls, the difference between the pro-
estrous and es~rous-AM uterine wet and dry weights was not significant. Again, 
however, there was a significant reduction in uterine tissue fluid between pro-, 
estrus and estrus-AM, with the respective values being indistinguishable from 
their control values. 
The accumulation of intralumenal fluid was not significantly disturbed 
by any of the sham or lesion procedures (Table XIV). Luinenal fluid was found 
only during proestrus. This indicates that 1) relatively normal low proges-
terone plasma levels were present prior to and during early proestrus; allowing 
the accumulation of uterine lumenal fluid, and 2) a relatively normal increase 
of progesterone occurs between proestrus-PM and estrus-AM (12). 
c. Pituitary weights 
Pituitary weights (Table IX) offer further evidence that estrogen 
levels were not grossly altered. In that estrogen elevates pituitary weights 
(106), if estrogen levels were elevated throughout the estrous cycle after 
lesioning, one would expect higher pituitary weights than in controls. Such 
an increase was not seen for any experimental group. 
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20 Indirect Measures of Gonadotrophin Secretion 
a. Ovarian weichts 
Inspection of the ovarian weight data (Table XV)) reveals no significant 
fluctuati~ns between proestrus and estrus in the control, the AC0-1 "ST"-1 or 
AL-lesion, or AL-sham group. Only the ACO-sham group had a lower mean ovarian 
weight at proestrus than at either estrus-AM or estrus-PM, and any physiological 
significance is unlikely. Comparison of the control, ACO-lesion, and ACO-sham 
data reveals that two months after lesioning., ovarian weights, and thus plasma 
gonadotrophin levels., have not been shifted. Ovarian weights in the 11STtt and 
AL groups were also statistically indistinguishable from those in the controls. 
Therefore, a gross shift in plasma gonadotrophin concentrations during the 
estrous cycle did not appear to exist two months after lesioning. 
b. Vaginal smear cycles 
Vaginal smear cyclicity was not obviously altered by the lesions 
(Table XII; Appendix I), offering additional evidence that plasma gonadotrophin 
levels were not grossly altered. 
The average cycle length of the AGO-lesioned animals was statistically 
comparable to both the control and ACO-sham lesioned animals during the first 
and second thirty day periods of the experiment, as well as the entire 60-day 
experimental period. Although the control animals developed a significant 
shift toward five-day cycles in the second half of the experimental period, 
none of the other experimental groups developed this shift in average cycle 
length. Since virtually all operated animals showed either a period ot 
pseudopregnancy (12-16 days of diestrous vaginal smears) which was discounted 
in figuring the average cycle lengths., or a lengthening of the cycle inune-
diately after lesioning from the previous four to a five-day cycle, it is felt 
the somewhat longer cycles during the first thirty days were a reflection of 
,. 
CONTROL 
SHAM-ACO 
LESION-ACO 
SHAM-ST 
y ·: ... , r · .. 
... . ) 
LESION-ST 
SHAM-AL 
LESION-AL 
. ., 
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TABLE xv·;: 
OVARIAN WEIGHTS (mg) IN THE 2-MONTH STUDY ANIMALS 
PROESTRUS ESTRUS - AM 
36.2±2.28 ( 8)t 39.4±2.7 ( 9) 
29.5±2.0a~c~) 38.3±1.2d( 9) 
36 .1±1. 5 b (10) 36.0±2.3 ( 8) 
.-.. ~-. --~-~ ,' ,..! 36.8±2.0 ( 9) 
38.8±2.7 ( 5) 36~7±2.1 ( 5) 
37.3±5.9 ( 5) 33. 9±1.5 ( 7) 
33.7±2.3 ( 5) 37.7±2.8 ( 3) 
tMean ± SEM (Number of Animals) 
d p<.01 
ESTRUS - PM 
36 • 3±1. 6 ( 9) 
38.3±2.9c(10) 
39.8±2.7 (10) 
32.6±3.2 ( 5) 
--
p 
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the operative trauma. The average cycle length during the entire 60-day period 
in the experimental animals shows no tendency to differ from controls. Mainte-
nance of estrous cy~les following ACO and AL lesions indicates that the amyg-
dala regions lesioned are not essential 'CNS components for the maintenance of 
the estrous cycle or for establishment of the period of the cycle. 
c. Ovulation 
Although the comparable nwnber of tubal ova in the control, sham-lesioned, 
and lesioned animals (Table XIV) ~ the afternoon of estrus further substantiates 
equivalent plasma gonadotrophin levels among the various groups, the signifi-
cantly lower number of eggs at estrus-AM compared with estrus-PM in ACO-
lesioned animals suggests a delay.in ~he ovulation process. The lack of such 
a_difference in the ACO-sham or in the "ST 11-lesioned group indicates the delay 
could not be attributed to nonspecific brain damage following electrode place-
·mentor lesioning. In that the nwnber of eggs at estrus-AM was comparable be-
tween control and ACO-lesioned animals, an actual delay in ovulation is not 
definite without further evidence (see below - OVarian·histology}. 
d. Ovarian histology 
Ovarian follicles at estrus in control animals do not compare in either 
size, general shape, or number with the larfe stimulated follicles seen during 
proestrus (Figure ?). In the sham ACO-lesioned estrous animals most of the 
follicles observed were similar to those in the controls (Figure e); however, 
a few larger proestrous-type follicles were also found (Figure 8) 0 In the 
AGO-lesioned estrous animals these large stimulated follicles seemed more pre-
valent (Figure 9); nevertheless, new corpora lutea and tubal ova were also 
found in the same ovaries. Occasionally heavily luteinized follicles were 
found which contained entrapped ova (Figure 9), surrounded by granulosa cells 
and floating free within the follic:ular fluid. In no case was such extensive 
I • 
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A. B. 
c. D. 
FIGURE 7 
Sections of ovaries from control animals in the 2-Month Study. 80Xo 
A. Proestrus. Two developed follicleso Degenerating corpus luteum in lower 
left. Anim~l SD15. 
B. Estrus~ General type of follicle found in control estrous animalso 
Animal SD34o 
c.. Estrus. J,n unusually hic;hly stimulated. follicle rarely found d'Jring 
estrus {x). Corpus luteum with lumen (z)o Animal SDJ. 
D. Estrus. Corroro. lu"t.ea with prominent lumenal cavities. Animal SD 3Bo 
,. 
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A. 
8. 
FIGUF.E 8 
Sections of ovaries from .ACO-sham lesioned animals in the 2-Month Study. 80Xo 
Ao Estrus. Large follicle with separating ovum surrounded by granulosal 1 
cells (x). Corpus luteum with large lumen (z) • . Animal SD40o 
c;. 
B~ Estrus. Follicle with Ovum surrounded by granulosal eel},, free within 
follicular fluid (x). Egg within oviduct (z). Animal SES. 
" 
8. 
A. 
c. D. 
FIGUBE 9 
Sections of ovaries from ACO-lesioned animals in the 2-Month Study. 80X .• 
A. Estrus. Highly stimulated follicles. This animal had 3 oviductal eggs 
and 5 hirhly stimull-i ted follicles. Animal SD59. 
B. Estrus• Hiehly stimuJ.;~ted follicle; ovu.'TI sun·ounded b:,r r:ranulosr<l cells 
is separated and floating free within the follicular fluid. Animal SDJ2. 
c. Estrus. The only egg ovulated by .Animal SDJ2. It is still within the 
ovarian j.ntraccipsnlar space. 
D. Estrus. Fresh corpus lnteum ·with prominent lumen. .An:t:nal ST17. 
,, 
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follicular luteinization found in estrous ovaries of control animals. In one 
ACO-lesioned animal (Figure 9) ova were not found in the oviduct, but one was 
located between the ovary and the ovarian capsule. Not all follicles found in 
estrous ACO-lesioned animals were heavily luteinized, nor did all lesioned 
animals have these large follicles. One ACO-lesioned animals (SD7) autopsied 
during estrus had no follicles co~arable to those found during proestrus. 
These histological data, in conjunction.with the difference noted in 
the number of ova during estrus-AM and estrus-PM in !CO-lesioned animals (Table 
XIV) suggests that the o~ulatory process wys disturbed in animals with lesions 
in the .ACO. 
3. Direct Measurement of Luteinizing Hormone (LH) 
Plasma LH was not significantly different among the three time perioqs 
studied in any of the experimental groups (Table ~I), despite the fact that 
proestrous levels were somewhat higher than estrous levels throughout •. No 
significant differences were noted, either, among the experimental groups when 
respective time periods were compared. It thus seems evident that peak release 
of the ovulat~ry surge of LH in the control was still occurring later than 
3_:30 PM and that two months after lesioning the ACO, AL, or nsT 11 1) the low 
base-line LH levels were not grossly altered, and 2) the critical period for 
LH release had not been advanced so as to be apparent within the autopsy time 
period. 
Pituitary LH content in control animals was found to be significantly 
lower on the moriling of estrus than it was at proestrus, confirming the fact 
that an ovulatory sfil.ge of LH had been released. By estrus-PM a buildup of new 
pituitary LH stores seemed underway; the afternoon estrous level did not diffe~ 
significantly from either the proestrous or estrous morning values (Table XVII). 
The same pattern was seen in pitUitary LH content in the ACO-sham lesioned 
.. 
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TABLE XVI 
PLASMA LH CONCENTRATIONS IN THE 2-MONTH STUDY ANIMALS 
PROESTRUS ESTRUS - AM ESTRUS - PM 
CONTROL * .44.3±19.3 ** ( 8) .. 18. 7± 9. 3 ( 6) 46.8±17.8 (10) 
ACO-SHAM 65.7±27.1 ( 6) 50.6±19.1 ( 9) 32.6± 7.7 (12) 
ACO-LESION 47.9±15.3 (11) 18.1± 7.7 ( 9) 21.4± 8.3 (10) 
ST-SHAM 16.9± 7.1 ( 9) 
ST-LESION 53.1±18.0 ( 5) 43. 7±16 .. 4 ( 3) 30.4±11.4 ( 4) 
AL-SHAM 21. 9±13. 0 ( 8) 12.8± 4.4 (10) 
AL-LESION 20.4± 8.1 ( 6) 11. 7±11. 7 ( 2) 
*ng/ml (NIH-LH-s13) 
**Mean ± SEM (Number of Animals) 
I' 
r-. 
CONTROL 
ACO-SHAM 
ACO-LESION 
ST-LESION 
, 
TABLE XVII 
PITUITARY LH CONTENT IN THE 2-MONTH STUDY.ANIMALS 
PRO ESTRUS ESTRUS - AM ESTRUS - PM 
23.1~ a 13.3a 16.2 
(18.8 - 28.4)t (10.4 - 16.9) (13.0 - 20.2) 
3f 3 3 
22.5b 13.4b 17.0 
(18.3 - 27.5) (10.1 - 17. 9) (13. 5 - 21. 4) 
3 3 3 
17.9 14.3 19.2 
(15 .1 - 21.1) (11. 2 - 18. 2) (15.4 - 23.8) 
4 3 4 
15.8 11. 7 15.0 
(12.3 - 20.2) ( 9.1 - 15.0) (10. 5 - 21. 0) 
3 3 3 
*Weighted Mean Potency [µg(NIH-LH-s 13)/pituitary] 
t95% Confidence Limits · 
~Number of As.says Combined 
ab Potencies Significantly Different (p<.05) 
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animals. The anesthesia, surgery,: and CNS tissue damage inflicted by the sham 
procedure apparently h~d not seriously disturbed the reproductive neuroendo-
crine network. However, pituitary LH content in the AGO-lesioned animals was 
not found to fluctuate between proestrus and either estrus-AM or estrus-PM. 
The low proestrous content most probably accounts for the absence of any signi-
ficant drop between proestrus and estrus-AM. This content, however, was not 
significantly lower than that in the controls. Pituitary LH content in the 
"ST"-lesioned animals followed a pattern similar to that in the AGO-lesioned 
group. 
r 
c. The Four-Month Study 
The data obtained from individual animals is recorded in Appendices 
v, VI, and VII. As in the previous studies, lesion placement was very accurate. 
Most lesions involved the posterior-medial part of the ACO and some of the 
lateral-posterior portion of the AME {Figure 2~lc Lesions in the internal cap-
sule, and hippocampus were not histologically verified. Lesions directed at 
the DMNT and the POA-SchN were found to.be appropriately placed. 
Inspection of Table XVIII reveals that.body, pituitary, thyroid, and 
adrenal weights were not altered from those of controls in either the ACO-sham 
or -lesioned animals. This, along ltj.th the excellent appearance of the animals, 
indicates general health was good. The pituitary was functioning reasonably 
normally as indicated by maintenance of its weight and that of the thyroids, 
adrenals, and ovaries. Autopsies were performed at 208-250 days of age in con-
. trols, 202-248 days in the shims, and 202-247 days in the ACO-lesioned animals. 
Sham animals were autopsied 116-140 days after the operative procedures. Le-
sioned animals were autopsied 112-132 days after placement of lesions. 
19 Indirect Assessment of Circulating Ovarien Steroid Levels 
a. Vaginal cyclicity 
Vaginal cycles in the ACO-, DMNT-, Hipp-, and IC-lesioned animals were 
not obviously different from·those seen in control or sham ACO-lesioned animals. 
The vaginal smear was only cornified during estrus and no abnormally high 
amounts of cornified cells were found during other stages of the cycle (Appendix 
II). Lesions in the preoptic area in the vicinity of the suprachiasmatic nu-
cleus stopped the cycle and induced a state of vaginal persistent estrus (Appen-
dix II). This demonstrates that the size of the lesion was physiologically 
effective. 
A detailed analysis of post-lesion cyclicity was not made in this study 
.. 
. CONTROL 
SHAM 
LESION 
... 
Body Weight 
(gm) 
371±11 (13)t 
370±12( 8) 
361± 9 (19) 
TABLE XVIII 
BODY, PITUITARY, THYROID, AND ADRENAL WEIGHTS, AGE, 
AND DAYS POSTLESION AT AUTOPSY OF THE 4-MONTH STUDY ANIMALS 
Pituitary Weight 
tmg} ~ 
15.7±1.0 (12) 
16.3±1.2 ( 8) 
15. 6±1. 0 (19) 
Thyroid Weight 
tmg)) 
20. 0±1. 5 (13) 
22.0±1. 7 ( 8) 
18· 9±1. 2 (19) 
Adrenal Weight 
Wet (mg)) 
31.1±1. 6 (12) 
31. 7±1. 4 ( 8)· 
31. 2±1. 6 "(19) 
tMean ± SEM (Number of Animals) 
Age at 
Autopsy 
(Days) 
231 (13) 
. 231 ( 8) 
220 (19) 
Days 
Post-Operative 
123 ( 8) 
121 (19) 
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' because the pre-lesion cyclic history had not been rigidly controlled. Some 
animals were regular four-day cyclers, some regular five-day cyclers, but most 
were irregular four- and five-day cyclers. The rigid criteria were imposed on 
the two-month study after it was apparent from this study that no obvious dis-
turbance had occurred after the ACO-lesions were performed. 
b. Uterine changes 
Although uterine wet weights in all groups were lower on the afternoon 
of estrus than at proestrus, in no case was the difference significant (Table 
XIX). Uterine dry weights also did not show a significant drop at estrus-PM 
compared to proestrus; however, in the lesioned animals, uterine dry weight at 
estrus-A..~ was significantly lower than at proestrus (p<o05). No significant 
difference was found between the control proestrous and estrous-PM percent dry 
weights~ The !CO-lesioned data demonstrate a significantly greater (p~.05) 
. 
percent dry weight during estrus than at proestrus-PMo 
Table XX contains summarized data on the uterine lumenal fluid content 
at proestrus. There was no difference in the amount of uterine lurnenal fluid 
at proestrus among the experimental groups. No lumenal fluid was found during 
estrus. It seems, then, that the diestrous steroid levels inducing the accumu-
lation of lumenal fluid (12, 251) are not seriously altered four~months after 
ACO lesioning, and that the postovulatory steroid changes are not markedly 
affected by the lesions (121 190). 
c. Pituitary and adrenal weights 
The lack of a significant difference in pituitary or adrenal weights 
between control and ACO-lesioned animals also indicated no markedly changed 
(elevated or reduced) estrogen levels in the ACO-lesioned animals (1061 223) 0 
.. 
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TABLE XIX 
. \ 
rr· :\ 1.: i·i' UTERINE· DATA :IN'•-THE.- 4..;,MONTIC STUDY 1 ANIMALS 
PROESTRUS ESTRUS - AM ESTRUS - PM 
CONTROL A. 640.0 ±45.0 ( 8)t 493.0 ±55.6 ( 5) 
B. 114.2 ± 5.5 ( 4) 112. 7 ±21.8 ( 3) 
c. 19.7'± 0.8.( 4) 20.8' ± 0.8 .. ( 3) 
SHAM-ACO A. 586.2 ±63.4 ( 3) 578.6 ±49.7 ( 5) 
. B. 131.0 ( 1) 121. 5 ±12. 2:: ( 4) 
c. 18. 8 ~·::: ( 1) 21. 5 ± o. 8 ( 4) 
LESION-ACO A. 633. 0 ±51. 7 ( 5) 518.5 :!30:4 ( 4) 550.0 ±34.9 (10) 
B. 129.1 ± 0.1 .. \( 2) 100. 5 ± 5. 2' ( 4) 108.7 ± 9.2 ( 8) 
c. 17. 4 •± 0. 4: ( .· 2) 19.4:± 0.4 : ( 4) 19.8 :± 0.5 ( 8) 
tMean ± SEM (Number of Animals) 
Awet weight (mg) 
B Dry Weight (mg) 
~ercent Dry Weight (Dry Weight/Wet Weight X 100%) 
.. 
CONTROL 
SHAM-A CO 
LESION-ACO 
• 
TABLE _xx· 
UTERINE INTRALUMENAL FLUID AND NUMBER OF ovk: 
Uterine Intralumenal 
Fluid (mg) 
PROESTRUS 
530.6±103.5 ( 6)t 
(224.8-965.9)* 
144.0± 43.4 ( 2) 
(100.6-187.4)* 
526.5±271.7 ( 3) 
(151.0-1054.4)* 
Tubal Ova 
ESTRUS - AM 
7. 5±1. 3 ( 4) 
tMean ± SEM (Number of Animals) 
.*Range 
. ' 
ESTRUS - PM 
6.6±1.0 ( 5) 
9.5±1.9 ( 4) 
6.9±0.6 (10) 
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20 Indirect Assessment of Plasma Gonadotrophin Levels 
a. Ovarian weight 
Significant differences in ova~an weight were not found within the 
cycle for any experimental group or among groups at a given stage of the cycle 
(Table XXI). This indicates no marked increase or decrease in circulating 
gonadotrophin levels was present four months after lesioning (88). 
bo Ovulation 
Table XX summarizes data on the number of tubal ova (unilateral) 
counted in estrous animals; ova were not found during any other stage of the 
cycle. The number of ova does not differ significantly in any of the groups. 
It thus seems that four months after lesioning the ACO, the plasma gonadotro-
phin levels needed for folliculogenesis.and ovulation (88) have not been 
seriously altered. 
c. Ovarian histology 
Study of the ovarian histology reveals that the control and ACO-
lesioned animals had corpora lutea with large lumen (Figure 10) during estrus. 
3. Direct Assessment of Plasma and Pituitary LH 
Plasma LH concentrations (Table XXII) at proestrus and estrus were not 
significantly different in the controls. A significant difference (p<.01) be-
tween proestrus-PM and estrus-PM was found in the sham AGO-lesioned animals, 
but the respective values were not diff~rent from those in control animals; 
the proestrous value however approached significance (.OS<P<ol)o Analysis of 
the data from ACO-lesioned animals shows statistical significance between the 
proestrous and estrous-PM titers (p<.01) 1 while the proestrous plasmD. titers 
in the lesioned rats were significantly (p<oOl) higher than in controls. The 
proestrous data of the sham.and lesioned animals were not significantly dif-
ferent. The values during estrus-PM in both control and sham animals do not 
,. 
1, 
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TABLE XXI 
OVARIAN WEIGHT DATA (-mg) IN THE 4-MONTH STUDY ANIMALS 
PROESTRUS ESTRUS - AM ESTRUS - PM 
CONTROL 41. 2±1.5 ( 8)t 43.4±3.5 ( 5) 
SHAM-ACO 41. 2±4.4 ( 3) 44.2±2.3 ( 5) 
LESION-ACO 38.9±3.2 ( 5) 41. 5±1.1 ( 4) 40.9±3.3 (10) 
tMean ± SEM (Number of Animals) 
,. 
-
-- -.- -· 
A. 
B. 
FIGURE 10 
Ovaries from the 4-Month Study. All 80X. 
A. Control/Estrus. Corpus luteum with large lumen. Animal SA7. 
102 
B. ACO-lesioned/Estruso Corpus luteum with large lumen. Animal SA27. 
TABLE xxn 
PLASMA LH CONCENTRATIONSf ·IN THE 4-MONTH STUDY ANIMALS 
CONTROL 
ACO-SHAM 
ACO-LESION 
. PROESTRUS 
12.8±9•4 c(6)t 
:.67. 2±30. 9t3) 
be 
137. 0±61. 8 (3) 
tMean SEM (Numl;>er of Animals) 
fng/ml (NIH-LH-s13) 
abcp~~os 
ESTRUS - PM 
().0±0.0 (5) 
0.0±0.08 (7) 
13. 3±:nAb~( 9) 
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. 
necessarily indicate an absence of LH in the plasma, but rather that the amount 
present was at, or lower than, the minimal detectable level of the assay tech-
nique. These data offer evidence that the critical period had been advanced in 
these ACO-lesioned animals; a marginal effect was indicated in the sham animals. 
Table XXIII summarizes pituitary LH content in control, sham, and le-
sioned.animals. No differences were found as a function of cycle stage or among 
control, sham, and lesioned animals at a given cycle stage. 
r 
CONTROL 
ACO-SBAM 
ACO-LESION 
' 
TABLE XXIII 
PITUITARY LH POTENCY 4~MONTHS POSTLESION 
PRO ESTRUS ESTRUS 
AM 
21.9 
(!6.2'.·- 29.5) 
1 
PM 
16.5* 
(13. 7 - 20. O) t 
3f 
15.6 
(12.2 - 19.9) 
2 
18.7 
. (14. 4 - 24. 3) 
2 
AM 
10.1 
( 7. 2 - 13. 8) 
1 
14.0 
( 8.7 - 22.5) 
1 
*Weighted Mean Potency 
t95% Confidence Limits 
·+Number of Assays 
·, • >'. 
PM 
15.2 
(11.5 - 19.9) 
3 
15.8 
(12.3 - 20.3) 
3 
14.7 
(11. 7 - 18. 6) 
4 
METESTRUS 
PM 
14.2 
( 9.1 - 22.7) 
1 
lo6 
D. The Ovarian Compensatory Hypertrophy (OCH) Study 
Table XXIV summarizes the results from this study. Appendix VIIl_. 
documents the original data. If 10, JS, or 20 days were allowed to intervene 
between removal of the left and right o~~ries, the percent difference in wei~t 
(% OCH) was significantly greater than that observed if both ovaries were re-
moved on the same day. Although there were no significant differences among 
the 10-, 15-, and 20-day OCH responses1 the difference between the 10- and 20-
day OCH response approached significance (.05<p<.l). The experiments were 
carried out with the 10-day OCH response because the response was still in a 
dynamic state (Control data, 78), and it was felt that an evaluation in the 
dynamic state would yield more information than if the OCH response were mea-
sured after an equilibrium had been established. This seems justified when 
the following general representation of a dynamic system is considered: 
G(t) • Aogo + A1d'/dt' gl + A2d"/dt" g2 + •••• 
G(t) • An arbitrary time-depentient phenomenon 
•••• • Arbitrary coefficients 
•••• • Arbitrary time response functions which G(t) 
is dependent on 
d' d" /dt' 1 /dt" 1 • ••• • time derivatives · 
At equilibrium, all time derivatives are zero and. G(t) • AoE:o• If G(t) is now 
designated the OCH response, only the steady-state term (A~0) would be evalu-
ated tor normalcy, were the rats autopsied during a static condition. However, 
if the evaluation is made during the response period, (an unspecified number of) 
the time derivative terms would also be included in the evaluation, possibly 
giving a better indication of whether the system is disturbed but no hint as to 
the functional origin of the disturbance. 
Placement of lesions in the ACO were excellent with one exception 
(Appendix VIII; Misplaced Lesions). In this animal I: the left ACO was destroyed 
,. 
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TABLE XXIV 
OVARIAN COMPENSATORY HYPERTROPHY STUDY 
DAYS BETWEEN REMOVAL % OCH 
OF THE MEAN ± SEM 
FIRST & SECOND OVARIES (Number of Animals) SIGNIFICANCE 
CONTROL 0 3.55±3.70.(27) abcdef 
10 35.68±4.71 (18) agh 
15 45.33±10.21( 9) b 
20 51.54±6.98 (10) c 
ST-SHAM 10 41. 35±8.18 ( 9) di 
ACO-SHAM 10 34.63±4.14 (10) ej 
,,·:· 
ST-LESION 10 2.38±4.54 ( 6) gik 
ACO-LESION 10 4.00±5.97 ( 8) hjl 
CEREBRAL CORTEX-LESION 10 33.06±9.59 ( 6) f kl 
a through h = p<.01 
i and j = p<.02 
k and 1 • p<.01 
,. 
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but the right ACO was left intact; the lesion was very small (0.2-0.5 mm) and 
in the cortex surrounding the medial nucleuso This animal~:was not used in 
evaluation of the OCH response in ACO-lesioned animals. 
More·precise plac~ment of STelesions was achieved in this study than 
in the 2-month study because of a o.5 mm more dorsal placement. In three cases 
(SD54, SDl.24, and SG)) the ST was extensively damaged bilaterally, in three 
other cases (SGl, 5021 and 5020) the ST was badly damaged on one side while 
. . 
partial damage was inflicted on the other side. (Figure 11) •. The ST lesions in 
two animals (SD92 and SI.58) were judged inadequate. While the ST on the left 
side was lesioned, that on the right incurred no obvious destruction in animal 
SD92 (Figure 12). The lesions in animal SI58 were both too dorsal and neither 
ST was damaged. The ST appears to be a high resistance path and thus less 
readily destroyed by.electrolytic lesioning than the surrounding tissue. This 
was especially dramatized with placements very close to, and on the border o£1 
the ST; the spread of tissue damage into the ST was not as great as that in 
other directions away from the ST. Even with lesions directly in the ST, less 
.. 
extensive damage was done to the adjacent ST tissue than to adjacent non-ST 
tissue (Figure 12). 
As can be seen in Table XXIV, lesions of the ACO prevented the 10-day 
OCH response from occurring. Damage to the ST also blocked the 10-day OCH 
response, whereas, lesions in the cerebral cortex did not. In that sham pro-
cedures (ST and ACO) did not interfere with the OCH response, trauma due to 
anesthesia, surgery,c·or,·brain-damage incurred by lowering the electrOdes were 
apparently negligible. Since neither lesions of the cerebral cortex nor the 
misplaced lesions bad any significant influence over the OCH response, possible 
diffusion ot iron deposited at the lesion site into the general and/or cranial 
circulation (Figure 13) also probably had little if any influence over the OCH 
. ,. 
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A. c. 
B. D~ 
FIGURE 11 
Photornicrographs of stria terminalis lesions in rat SG20 (ST-Lesion/10 Day OCE). 
The left ST (A and B) was extensively damaged; the right ST (C and D) had in-
curred damage but not as extensively. (A and C are BOY. ; B snd D are 200X). 
A. 
B. 
FIGURE 12 
Photomicrographs of stria terminalis lesions in rat 
The left stria terminalis was significantly damaged 
was not. (A and C are BOX, B is 200X). 
c. 
SD92 (ST-lesion/10 Day OCH). 
(A and B) while the right (C) 
A. 
• 
. .... . 
. ,: . . 
=. _.,.,. __ ~-:c~_...:;_hc, ' - - '·' -
ACO Lesiotff'.Wit.1.J Iron Stain 
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B. 
ACO lesion in r3t LG2; both photomicrographs are 200X. A. section stained 
with cresyl echt violet. Several prominent nerve cells are readily observed 
on the far left; 3 region devoid of the prominent nerve cells is found before 
the fflajor lesion site as the photomicrograph is inspected from left to rirht. 
B. section stained by Gomori's Iron Reaction using nuclear fast red as the 
counter stain. Note that the extent of iron deposition does not extend beyond 
the boundaries of the major lesion site into the region devoid of large nerve 
cells. 
,. 
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response. 
Since the right ovaries were remo4i'ed ten days after the lesioning-
unil.ateral ovariectoD17 procedure, animals were in various stages of the estrous 
c~le at autopsy. Some of those in estrus were checked for ovulation and the 
·number of eggs counted (Appendix VIII). Animal SD119 had 13 eggs at autopsy 
{Appendix VIII: ACO-~sion 10-days OCH). 
.. 
CHAPTER V 
DISCUSSION AND CONCLUSIONS 
A. General Considerations 
Deposition of iron (Figure 13) was found in all lesion sites, whether 
in the acute 3-cycle study or the chronic 4-month study. Since electrolytic 
deposition of iron in the brain has been shown capable of stimulating gonado-
trophin secretion (89, 91), the possibility that the lesion sites may have 
acted as stimulative foci must be considered. It.is felt the lesions in this 
series of studies were not stimulative because: 1) the lesion effects were 
seen for more than a week after placement (no studies were found in the liters• 
ture showing effects of electrolytic stimulation lasting more than several 
hours), 2) lesions of the ST had the same effects as iesions in the ACO region 
(OCH study), 3) the region of iron deposition was infiltrated by connective 
tissue and a border around the deposition was heavily infiltrated bf glial 
cells and very few if any nerve cells (Figure ]J), and 4) a functional dif-
ference between electrolytic lesions arxi electrical stimulations in the amyg-
dala has been reported (221 76). ). Thus it is felt that the ACO lesions 
induce a reduction of ACO neural efferent traffic, impairing the information-
processing potential and/or efficiency, and subsequently_ removing the func-
tional role which this region may play in physiological systems. 
The mild effects of sham lesions may result from destruction of CNS 
tissue as the electrodes were loweredo Lawton and Sawyer (175) have demon-
strated that inadverteQt destruction of ST tissue by the electrodes can induce 
.. 
changes in the sham animals similar to those in !CO-lesioned rats. In the 
11:3 
,. 
present experiments 26 Gauge hypodermic tubing wes used in an attempt to 
eliminate the interference previously found (175) using 24 Gauge tubing. 
Even smaller gauge tubing may be preferable when working in the amygdalar 
region since some effects due to sham lesioning seem apparent, although 
not nearly as marked as when 24 Gauge tubing was used (175). Although 
sham effects were apparent in the 3-cycle study, they were absent in the 
acute OCH-study. This discrepancy may reflect differing sensitivities 
U4 
of the FSH and.LH systems to the destruction of nonspecific and/or specific 
CNS tissue in the path of the electrode. 
The specifi~ location of CNS lesions was important as demonstrated 
by the pro~ound effects of POA-SchN lesions on the estrous cycle which 
were not seen following ablation of the other sites {Appendix II). The 
difference in the OCH response following lesioning of the A.CO and cerebral '; 
cortex also demonstrate that 11nonspecificn lesions do not necessarily have 
effects on the measured physiologic end point. 
Although thyroid weights in lesioned animals were not sienificantly 
altered from control in any of the three cyclic studies, data from ... the 
2-month study suggests ths.t the ACO and AL have opposing influences (inhi-
·bi tory and stimulatory, respectively) on the·maintenance of thyroid weights. 
Thyroid weight has been reported to be reduced _following medial amygdaloid 
lesions in the male deermouse (75); however, effects beyond 16 days post-
lesicn were not 'studied. It is thus possible that at 2-months post-lesion, 
the beginning or end of a phase in which the ACO lesioned rats have higher 
weiehts and the AL-lesioned animals have lower weights than controls for 
some period is present. At 2-months.post-lesion enough of a drift was 
present to see a signi-ficant weight' difference between the ACO- and AL-
lesioned rats. These findings strengthen 
... 
the notion that the various changes observed following lesioning in the present 
series of experiments were dependent upon ablation of specific CNS sites rather 
than ·upon ion deposition since the ACO and AL lesions involved regions of the 
brain barely one millimeter apart. 
The suggestion that lesions of the corticomedial region of the amygdala 
may elevate thyroid weight seems in direct opposition to the results of Elef-
theriou and Zolovickl (75). This difference, however, may be explained by 
' 
species differences, sex differences, duration of experiment, and/or specifi-
city of lesion localization since lesions in the male deermouse were apparently 
confined to the medial nucleus while very little damage was done to the medial 
nucleus in .the present studies. 
B. Circulating Estrogen and Progesterone Titers 
The increase in uterine weights and tissue fluid, and the cornification 
of the vaginal epithelium normally observed during proestrus result from an 
increase in ovarian steroid concentrations in the blood during diestrus (12, 131 
174, 248, 251). The accumulation of uterine lumenal fluid during proestrus de-
pends not only on high estrogen levels but on relatively low circulating proges-
terone levels as well {12, 251); if progesterone titers are too high (<40 ugm), 
uterine fluid will not accumulate in the presence of estrogen concentrations 
that would otherwise be effective (12). In all three cyclic studies, the 
lesioned animals demonstrated normal proestrous uterine weights, tissue and 
lumenal fluid values, and vaginal cornification. It thus appears that ovarian 
steroid titers at diestrus were not grossly different from nonnal values. 
Furthermore, a normal time course for reduction of estrogen levels and increase 
of progesterone levels was indicated by the decreasing uterine weights and 
tissue fluid during estrus an~ metestrus (13, 248, 251, 274), the loss of the 
uterine lumenal fluid (12, 251), the appearance of a lukocytic vaginal smear 
i· . 
... 
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by metestrus (88), and the normal duration of the estrous cycles (88). If 
progesterone titers had been deficient following the ovulatory surge of 
gonadotrophins, one would have expected to find lumenal fluid during estrus 
and possibly even metestrus (12), as well as a prolongation of the estrous 
vaginal smear (88). In as much as increases in pituitary (lo6) and adrenal 
(22.3) weights can reflect increased plasma estrogen levels, the .failure to 11·:.t 
note any consistent significant changes post-lesioning in the present experi-
ments further supports the absence of any major alterations in circulating 
estrogen levels. 
The data .from these studies, therefore, strongly indicate that plasma 
estrogen and progesterone concentrations throughout the cycle had not been 
seriously altered by ACO- or AL-lesions. Although elevated numbers of corni-
fied cells have been reported in vaginal smears following amygdaloid elec- , 
trolytic lesions (45), the lack of details in that abstract makes it difficult 
to reconcile this difference. 
c. Gonadotrophin Levels 
Maintenance of ovarian weight in all experiments (Tables III, XV, and 
XX!) indicates there was no dramatic increase or decrease in basal gonadotro-
phin secretion due to the ACO- or AL- lesions. This is in contrast to a recent 
paper (2.3) in which Bekhtereva reports increased ovarian weights following 
lesions of the medial !!!!_ lateral smygdala; however, since many animals in 
that study were apparently pseudopregnant when autopsied, the larger corpora 
lutea of pseudopregnancy (.30) could account for the elevated ovarian weights. 
The comparable number of ova found in control and experimental animals in all 
studies also indicates that adequate FSH and LH titers were present to stimu-
late folliculogenesis (981 190), estrogen s~cretion (98, 190) 1 and ovulation (88). 
Direct assessment of LH secretion also failed to indicate any consistent eleva-
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tion of LH secretion throughout the cycle either acutely {2-3 weeks) or chroni-
cally {2 or 4 months) following ACO lesioning, in contrast to other studies 
indicating marked elevations of plasma LH two (23, 74) to three weeks {175) 
after lesioning. In that these results were obtained from pseudopregnant {23~ 
74) and ovariectomized rats (175) the findings cannot be expected to closely 
correlate with the results of the present studies performed on cyclic animals, 
in which steroidal feedback influences upon gonadotrophin secretion are quite 
different and poth basal and cyclic secretion of gonadotrophins and steroids 
are operative. The lack of any consistently prominent elevation in plasma,::1.H 
in cyclic animals of this study was probably due to feedback influences of the 
normal or near-normal ovarian steroid levels; such feedbacks were altered 
{23, 74) or inoperative (175) in the other studies. A careful assessment of 
gonadotrophin secretion by indirect and direct means at specific times during 
the various stages of the estrous cycle in control and lesioned animals, how-
ever, did reveal several definite indications of subtle changes, as discussed 
below. 
Histological studies of the ovaries revealed retarded luteinization in 
most of the !CO-lesioned animals. The signs of reduced luteinization were 
apparent at metestrus - even after apparently mildly elevated plasma LH during 
estrus-PM in the 3-cycle study. These data, along with the retarded ovulation 
seen in ACO-lesioned animals in the 2-month study, although possibly being 
suggestive of hyposecretion of LH at proestrus in !:CO-lesioned animals, is 
not so in~erpreted. The fact that luteinization has started, uterine lumenal 
fluid is absent at estrus, the estrogen plasma levels are dropping by estrus-AM, 
and a normal quota of ova are released, indicates that high plasma LH levels 
most likely occurred (121 i.3, 98, 1901 2091 274). More !mportantly, the signi-
ficantly lower pituitary LH content at estrus-AM than at proestrus in the 
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J-cycle study although indirect, indicates the occurrence of an LH ovulatory 
discharge similar to that of controls elevating1plasma IB between proestrus-PM 
and estrus-AM. It is thus curious why full luteinization did not occur. 
The retardation.may be due to follicular refractoriness to the ovula-
tory levels of gonadotrophins; abnormal maturation of the follicles may occur. 
This may also explain the discovery of large non-ovulated follicles in the 
ACO-lesioned estrous animals. The abnormal maturation may have its origin in 
the disturbed FSH-ovarian steroid feedback mechanism - i.e., FSH titers may be 
marginally sufficient for folliculogenesis (98, 190). Even with FSH reduced, 
adequate LH and a minimal amount of FSH could allow follicular maturation 
(98, 190), but abnormal in some biochemical way as a result of low FSH, thus 
resulting in ruptured follicles which do not C0'1J.Pletely luteiilize by metestrus. 
Although there is no direct evidence, low levels of prolactin may be implicated 
since it is apparently luteotrophin in rats (88). 
An additional subtlety induced by the !CO-lesions.was the accelerated 
reaccumulation of pituitary LH found in the 3-cycle study. This may reflect an 
increased release of LH-RF (23). This also extends the inhibitory action of the 
posterior basal amyedala over gonadotrophin secretion seen in specialized non-
cyclic rats (22, 23, 74, 76, 77; 175) to the cyclic rat. 
Since the estrous-PM pituitary LH content in controls of the 2-month ~, :-. 
studz was not significantly different from that in lesioned animals but was 
significantly higher (p<.02) than that in the estrous-PM controls in the 
3-cycle study controls (Tamle ..nv)';, aging of the animals alon~ may induce 
an increased storage rate of pitUitary IB similar to that in youneer rats 
With ACO lesions. The 4-month study estrous-PM pituitary conten~ however, 
was not significantly greater (.05<P<ol) than that in the J-cycle study. 
(Table XX:v);). This is in agreement with Labhsetwar•s data (171) indicating 
.. 
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TABLE xxv··c 
COMPARISON OF ACO-LESIONS ON ESTRUS-PM.PITUITARY LH CONTENT 
CONTROL 
ACO-SHAM 
ACO-LESION 
AMONG THE THREE CYCLIC STUDIES 
3-CYCLE 
STUDY 
*b 9. s~·a 
( 7 • 5 ;+ 12 • 5) t 
13.4 
(10. 8 - 16. 7) 
3 
17.88 
(14.2 - 22.3) 
3 
2-MONTH 
STUDY 
16.2b 
(13.0 - 20.2) 
3 
17.0 
(13.5. - 21.4) 
3 
19.2 
(15.4 - 23.8) 
4 
*Weighted Mean Potency 
t95% Confidence Limits 
tNumber of Assays 
4-MONTH 
STUDY 
15.2 
/(11.5 - 19.9) 
3 
15.8 
(12.3 - 20.3) 
3 
14·. 7 
(11. 7 - 18.6) 
4 
8Fotencies Significantly Different (p<.01) 
b Potencies Significantly Different (p<.02) 
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an increased pituitary LH storage in older adult female rats than younger 9nes. 
ACO-lesioning1 however, did not augment the "age-dependent" rise in pituitary 
LH, and did not elevate the preovulatory content at proestrus in the younger 
animals. The ACO may have spontaneously lost the specific physiologic effect 
of reducing the rate of accumulation of pituitary LH it had in the younger rats 
by the time the older rats were autopsied, thus leaving the ACO-lesions without 
any relative effect on pituitary storage of LH. Alte?Tlatively, the ne\iroendo-
crine network regulating LH may have & limit as to how fast and high it can in-
duce pituitary accumulation of LH; thus, regardless or whatever other factors 
are responsible for.the noted age effects, the ACO-lesion is functionally 
ineffective in altering pituitary LH storage because some other effect was 
driving the network at a maximum rate of pituitary LH reaccumulation. 
D'. Functional Properties of the Reproductive Neuroendocrine Network 
· 1. Circadian Elevation of Plasma LH 
Evidence for a period of increased LH release in intact cyclic female 
rats daily.during the estrous cycle has recently been presented _(116). The 
elevation in plasma LH level~ generally corresponds in time to the afternoon 
. - . 
elevation of plasma LH found in proestrous rats and in rats biiaterally 
ovariectomized for five months (176), although it is less marked. This cir-
cadian LH release rhythm was not obvious in the control animals of the .3-cycle 
study, but its presence wss suggested in the sham and lesioned animals by the· 
elevated.estrous-PM plasma LH measurements. These latter two groups had 
estrous-PM plasma LH concentrations which were identical to one another, but 
were larger than their respective estrous-AM.concentrations as well as being 
larger than the control estrous-PM titers. However, in spite of this consis-
tent trend, only the sham g~oup had estrous-PM LH levels which demonstrated 
a significant elevation by being statistically greater than the estrous-PM 
• .. ·. . .;, 
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control values. The slight circadian rise in plasma LH during the afteznoon 
in intact animals (116) therefore appeared augmented in ACO-lesioned and sham-
lesioned animals, suggesting that the circadian stimulus may have been llllder 
less of a restraint than normal9 The loss of some neural inhibitory influence 
was also indicated by the more rapid accumulation of pituitary LH after le-
sioning the ACO in the )-cycle study. This more rapid accwnulation of pituj_-
tary LH may reflect a general elevation of LH-RF secretion, inasmuch as a 
.reduced hypothalamic LH-RF has been reported concurrent with increased plasma 
and pituitary LH in arnygdaloid lesioned rats (23). 
The significant elevation in proestrous plasma LH concentration in the 
ACO-lesioned rats of the 4-month study over control and estrous-PM lesion 
values may indicate the critical period has b~en·advanced; although, the proes-
trous titers in 4-month ACO-lesioned animals were~.not significantly greater 
than those of either the J-cycle study((p>.1) or those in the 2-month study 
(.05(p<.l). This advancement of the critical period in the 4-month ACO-
lesioned animals may reflect in a more dramatic way a heightened I.JI secretory 
potential in ACO-lesioned anirnals indicated in the 3-cycle study. 
The reduced restraint over I.JI-RF may be in the form of either l) the 
loss of a tonic inhibition, or.2) the loss of a circadian depressor effect 
over LH-BF secretion by the _corticomedial aJ!ijTgdala: which may have an inhibi-
tive effect during the afternoon. This latter possibility is suggested by the 
recent work of Terasawa _!! !!• (268) indicating cyclic activity in the am;ygdala 
associated with the estrous cycle and ovarian steroids. 
2. Ovarian Steroid Feedback on FSH Secretion 
If .indeed the OCH response is a renection of elevated plasma FSH (24) 
induced by the reduction of ovarian steroi~s (24, 142) 1 the neuroendocrine 
network regulating FSH secretion has been seriously impaired by ACO lesions. 
-
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The network has either become so sluggish that more than ten days were required 
for augmented FSH release and development of ovarian hypertrophy, or the sys-
tern had become more sensitive to ovarian steroid feedbacks and a new lower 
level of ovarian steroids was able to maintain plasma FSH at normal or near-
normal concentrations. 
The absence of the OCH response in POA-SchN-lesioned animals apparently 
reflects an abnonnality in the steroidal feedback mechanism regulating FSH. 
This is inferred from two experimental facts. Administration of ovarian ster-
oids after unilateral ovariectomy in non-lesioned animals not only impairs the 
hypertrophy.of the remaining ovary (24, 142) but prevents the postcastration 
rise in FSH (24); thus compensatory hypertrophy is most likely a response to 
lowered ovarian steroid levels immediately following unilateral ovariectomy. 
Secondly, the abnormality is also indicated by demonstrations that while exo-
genous estrogen can diminish phenomena associated with FSH in non-lesioned 
animals, it cannot do so in POA-SchN-lesioned aidmal.s (104, 266). The lack oi 
the 10 day-OCH response in ACO-lesioned rats is thus likely indicative of an 
impairment in the·neuroendocrine network regulating FSH. Lesions of the ACO 
region may selectively destroy components involved directly or indirectly in 
the steroid feedback regulation of FSH. It is also possible that lesions of 
the_ACO did not influence the ovarian feedback loop~!!, but rather altered 
the characteristics of the internal feedback of FSH on its own secretion. That 
such a possibility is real can be interpreted from a recent paper by Lawton 
and Sawyer (175). Although the paper dealt with LH, the implication may be 
true of other gonadotrophins alsoo Having shown that ovariectomized rats with 
ACO lesions had plasma LH concentrations above those of non-lesioned controls, 
it is possible that the ACO is involved in .the mediation of LH negative feed-
back on itself. Thus, the possibility of both "subsystems" (steroid and 
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gonadotroph:ic) being altered by ACO-losions is possible, as well as a dis• 
turbance of a "purely neural" origin.· 
Since POA lesions inhibiting the OCH response also induce persistent 
estrus (57 1 lo6), such lesions may either modify components in canmon to both 
1) the ovulatory system (20, 64, 65, 66, 127, 145, 273) and 2) the FSH ovarian 
steroid feedback system (57, 106), or may modify several components which are 
independently associated with one or the other neuroendocrine networks. il-
though the FSH regulating system was apparently seriously interfered with after 
ACO lesions as well, the neuroendocrine network associated with LH regulation, 
functioned very close to normal if not enhanced. These data offer evidence for 
a diametric functional separation of these systems in ACO lesioned female rats 
and support the possibility that the neuroendocrine network maintaining the 
estrous cycle may be composed of several relatively independent "subsystems" 
dissectable at the CNS level. 
'l'his defect in FSH regulation was also found after ST-lesions, indica-
ting that a part, if not all, of the informational link between the cortico-
medial amygdala and the hypothalamus involved in FSH regulation utilizes the 
ST pathway. 
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Since cyclicity and ovulation proceed in animals with an isolated POA-
.hypothalamic-pituitary unit (168) 1 the maintenance of relatively normal cycli• 
city following destruction.of the ACO is not too surprising. The ACO does 
appear to be exerting a net inhibitory influence over the functioning of the 
hypothalamic-pituitary axis as also indicated by other studies (221 231 741 761 
77 1 175). The present experiments extend the functional suppression by the 
ACO to the cyclic rat. Many of the data seem consistent with the following 
scheme. The POA-hypothalamic-pituitary unit has the functional capacity to 
cycle (168) and the circadian "ovulatory" signal (87 1 88) is functionally a 
part of the.unit. The ACO normally suppresses both the basal secretion of 
LH-RF and the effectiveness of the circadian release of a surge LH-RF. This 
may be accomplished by 1) a single direct inhibition of the hypophyseotrophic 
area's control over basal or tonic secretion of LH1 2) a single direct inhi-
bition of the circadian signal, or 3) both of these by multiple inhibitory 
inUuences. The first two of these may roughly correspond to separate in-
fluences on the two neural levels theorized to be involved in the control of 
LH secretion (18). If1 indeed, the circadian stimulus of pituitary LH secre-
tion ds augmented, as it seems to be, the ACO may be involved with the develop-
ment of the favorable set of conditions leading up to the discharge of an 
. ovulatory surge of gonadotrophins (181 120). The important role played by 
hormone levels is emphasized since apparently even an increased neural stimu-
lation of the LH release mechanism cannot advance the ovulatory discharge of 
LH, even though the pituitary contains a quota essentially identical to that 
of proestrus by metestrus in the 3-cycle study. In older animals, however, 
neural influences may play a proportionately ·greater role in lesioned animals 
as evidenced by the advanced critical period in ACO-lesioned animals four 
12S 
months after lesioning. Some aspects of the effectiveness of the intact 
corticomedial amygdala of the normal rat may dwindle with age or be overridden 
by other influences as seen from the similarity of elevated estrous pituitary 
LH content between 11old" control and "young" ACO-lesioned rats. The FSH regu-
latory mechanism is also disturbed by the ACO-lesions, but rather than being 
more efficient as is the LH system it is suppressed and functioning below 
capacity. 
F. Conclusions 
The following points should be emphasized: 
. 
A. Secretion of gonadotrophins, estrogen, and progesterone is not 
grossly disturbed by ablation of corticomedial or lateral portions of the 
amygdala as evidenced by cyclicity, organ weights, and LH bioassay. 
B. Subtle changes occur ~n the regulation of gonadotrophins in 
ACO-lesioned rats: 
1. Gonadotrophin release at proestrus in the lesioned animals is 
sufficient to induce ovulation but full luteinization does not occur. 
2. Within the first month after lesioning of the ACO, pituitary 
storage of LH is more rapid. 
3. The circadian release of LH appears amplified. 
c. The ACO is implicated in the more rapid pituitary LH storage 
associated with the aging of the animals. 
D. The ACO is essential for the regulation of FSH secretion. 
E. The estrous cycle can be maintained despite dysfunction in the 
FSH neuroendocrine regulatory network• 
F. The ACO is not critically involved in determining the cycle lengtho 
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x x x x x 
x x x x x 
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x . x 
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x :·. 
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x 
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x .. 
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x 
x 
x 
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x 
x 
x x 
xx 
x 
x x 
x x 
x x 
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X X· 
x x 
x 
x x 
.0 
::.? 
ANIMAL NO. 
SE4 
SE14 
SE43 
SE47 
SG8 
SGlO 
SG16 
SG17 
SGll 
SG9 
SG13 
SG2l 
SE19 
SE28 
SE29 
SE35 
SE36 
SE38 
SE49 
SE54 
SG6 
SG18 
x 
x 
_x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
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SHAM - AL 
x x x x x x x x x x x x 
x x x x x x x x x x 
xx x x x x x x xx x x xx x 
X X X X X X X X X X· X X X X X 
xx xx 
xx 
x 
x 
x 
x 
.. XX. 
x 
x 
x 
x 
x 
- x 
x 
x 
x 
x 
x 
x x 
x x ~ 
x 
x 
x 
xx 
xx 
xx 
x 
x 
x 
x 
x 
x xx xx 
x 
xx 
x 
x 
x x 
x x 
x x 
x x x 
x x 
x 
x x x x x 
x x x x x 
x xx xx xx 
xx x x x x 
x x x x x x x x x 
x xx x x xx 
x x x x x 
x 
x 
x 
x 
xx 
xx 
x 
x x 
LESION - AL 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
xx 
x x xx 
x x x 
x x x x 
x x xx x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
xx 
xx 
xx 
x x 
x xx 
x x 
x xx 
Legend: Same as APPENDIX I, page J.26 
x 
x x 
x ,. x 
x 
xx 
x 
x x x x 
x x x x 
xx xx xx xx 
xx xx xx 
. x x x x 
x 
x 
x 
x 
x 
x 
x x 
x xx 
xx xx 
xx x 
x 
x 
x 
x 
xx 
xx 
xx 
x 
x 
x 
xx 
x x x x 
x 
x 
x 
x x x xx 
x xx x x 
x x xx xx x 
x 
x 
x 
xx 
xx 
x 
x 
x 
x 
Animal No. 
SD4 
SD76 
SD17 
SD48 
SD57 
SD88 
SE15 
·sE22 
SD15 
SD79 
SE41 
SD23 
SD38 
SD82 
SD60 
SD74 
LG38 
SE34 
SD3 
SD114 
SD55 
SD36 
SD71 
SD94 
SE7 
SEl 
SD28 
SE53 
SE34 
SD19 
SD20 
SD49 
SD61 
SD69 
SD116 
SE46 
SD8 
SD99 
SD26 
SD30 
SD42 
SD58 
SD67 
SD90 
SE40 
SE5 
SE25 
SDS 
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Average Cycle Length Average Cycle Length 
0-30 Days 31-60 Days 
Average Cycle Length 
0-60 Days 
ESTROUS 
4.00 
4.00 
4.00 
4 •. 00 
4.00 
4.00 
4.43 
4.00 
4.14 
4.14 
4.29 
4.14 
4.57 
4.00 
4.14 
4.00 
4.00 
4.00 
4.00 
4.00 
CYCLE LENGTHS OF CONTROL ANIMALS 
4.00 
4.00 
4.00 
4.00 
4.00 
4.00 
4.60 
4.00 
4.80 
5.00 
4.83 
4,.00 
4.67 
4.00 
_4.00 
4.50 
4.17 
4.00 
4.00 
4.00 
AVERAGE CYCLE LENGTHS OF CONTROL ANIMALS 
4. 00 4. 67 
4. 00 4. 00 
4.00 4.17 
4. 00 4. 00 
4.12 4.00 
4.12 4.14 
4.14 5. 00 
4.17 5.00 
4.00 4.50 
AVERAGE CYCLE LENGTHS OF 
4.14 
4.14 
4.57 
4.00 
4.14 
4.14 
4.12 
4.29 
4.29 
4.14 
4.00 
4.14 
4.14' 
4.00 
4.00 
4.67 
4.29 
4.12 
4.14 
SHAM ACO-LESIONED ANIMALS 
4.00 
4.00 
5.20 
4.00 
4.00 
4.43 
4.00 
4.14 
4.43 
4.00 
4.00 
4.00 
5.17 
4.57 
4.00 
4.17 
4.29 
4.00 
4.00 
(continued) 
4.00 
4.00 
4.00 
.4.00 
4.00 
4.00 
4.58 
4.00 
4.38 
4.46 
4.54 
4.07 
4.62 
4.00 
4.07 
4.21 
4.07 
4.00 
4.00 
4.00 
' 
4.29 
4.00 
4. 07 
4.00 
4.09 
4.13 
-4.54 
4.78 
4.21 
4.07 
4.07 
4.83 
4.00 
4.07 
4.29 
4.07 
4.21 
4.36 
4.07 
4.00 
4.07 
4.54 
4.36 
4.00 
4.30 
4.29 
4.07 
4.09 
-APPENDIX I: CYCLIC HISTORIES-OF 2-MONTH STUDY ANIMALS (continued)_ 132 
Animal No. Average Cycle Length Average Cycle Length Average Cycle Length 
SD41 
SD65 
SD77 
SD81 
SD109 
SEll 
SE12 
SE27 
SD40 
SE23 
SD6 
SDlO 
SD22 
SD64 
SD53 
SD105 
LG53 
SE31 
SE26 
SE59 
SD31 
SE21 
SE24 
· SD2 
SD95 
SD98 
SE6 
SE51 
SD7 
SD32 
SD59 
SD9 
SDll 
SD50 
SD80 
SD113 
SD120 
SE13 
SE16 
SE2 
SElO 
SD12 
SD21 
SD27 
SD33 
SDJS 
SD~6 
SD56 
SD66 
0-30 Days 31-60 Days 0-60 Days 
AVERAGE CYCLE LENGTHS OF SHAM ACO-LESIONED ANIMALS 
4.14 
4.14. 
4.00 
4.00 
5.00 
4.57 
4.00 
4. 72. 
9.14 
4.57 
4.00 
4.00 
4.00 
4.00 
4.14 
4.33 
4.00 
4.67 
4.00 
5.40 
(continued) 
4.07 
4. 07 
4.00 
4.00 
4.25 
4.46 
.4.00 
4.69 
4.07 
4.92 
AVERAGE CYCLE LENGTHS OF ACO-LESIONED ANIMALS 
4.00 
4.14 
4.14 
4.00 
4.29 
4.57 
4.00 
4.00 
4.33 
4.00 
4.00 
4.43 
4.00 
4.14 
4.00 
4.00 
4.25 
5.00 
4.00 
4.29 
4.67 
4.14 
4.00 
4.00 
4.00 
4.14 
4.14 
4.14 
4.00 
4.29 
4.29 
4.00 
4.00 
4.00 
4.00 
4.00 
5.00 
4.33 
4.00 
4.75 
4.00 
4.17 
5.00 
5.00 
4.00 
4.00 
4.00 
4.00 
4.17 
4.67 
5.00 
4.00 
4.00 
4.33 
A.00 
4.33 
4.33 
4.17 
4.00 
4.00 
4.00 
·4.00 
AVERAGE CYCLE LENGTHS OF ST-LESIONED· ANIMALS 
4.00 4.83 
4.14 4.00 
4.00 4.29 
4.29 4.00 
4.25 4.00 
. 4. 00 4. 67 
4.29 4.00 
4.29 4.14 
4.00 
4.07 
4.07 
4.00 
4.14 
4.75 
4.18 
4.00 
4.67 
4.00 
4.09 
4.58 
4.50 
4.07 
4.00 
4.00 
.4. 09 
4.14 
4.36 
4.54 
4.20 
4.07 
4.18 
4.00 
4.44 
4.21 
4.14 
4.07 
4.00 
4.14 
4.14 
4.50 
4.07 
4.18 
4.14 
4.09 
4.40 
4.14 
4.21 
(continu~e~d~>~~----··~~~~~~~~~~~~~-
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Animal No. Average Cycle Length Average Cycle Length Average Cycle Length 
0-30 Days 31-60 Days 0-60 Days 
AVERAGE CYCLE LENGTHS OF ST-LESIONED ANIMALS (continued) 
SD73 4.00 4.00 4.00 
SD78 4.00 4.00 4.00 
SD83 4.29 4.00 4.14 
SD96 4.00 4.00 4.00 
SD97 4.00 4.00 4.00 
SDlOO 4.14 4.00 41i07 
SD115 5.20 4.80 5.18 
AVERAGE CYCLE LENGTHS OF AL-SHAM LESIONED ANIMALS 
SE4 4.14 4.00 4.07 
SE14 5.00 4.00 4.12 
SE43 4.00 4.00 4.00 
SE47 5.00 5.25 5.14 
SG8 4.00 4.00 . 4.00 
SGlO 4.25 4.00 4.08 
SG16 4.25 4.43 4.36 
SG17 4.14 4.00 4.07 
SGll 4.14 4.00 4.07 
SG9 4.14 4.57 4.36 
SG13 4.29 4.00 4.14 
SG21 4.00 4.00 4.00 
AVERAGE CYCLE LENGTHS OF AL-LESIONED ANIMALS 
SE19 4.33 4.12 4.18 
SE28 4.00 4.12 4.08 
SE29 4.00 4.00 4.00 
SE35 6.00 4.00 4.00 
SE36 4.14 4.00 ,4. 07 
SE38 4.00 5.00 4.60 
SE49 4.14 3.86 4.14 
SE54 4.25 4.00 4.08 
SG6 4.00 4.00 4.00 
SG18 4.00 4.00 4.00 
. ,., 
DAYS POSTLESION 
ANIMAL NO. 
SA2' 
SA7 
SA9 
SAll 
SA14 
SA15 
SA16 
SA22 
SA24 
SA30 
SASS 
SA59 
SFl 
SF2 
SF3 
SF6 
SF7 
SF8 
SF9 
SF17 
SA4 
SA6 
SA14 
SA23 
SA28 
SA34 
SASO 
SFll 
SF12 
SF14 
SF22 
SF24 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
x 
x 
x 
x 
x 
x 
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CONTROL 
x x x x X X· X x x x x x x x 
x x x x x x x x x 
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x 
x 
xx 
x 
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xx 
x 
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x 
x 
x 
x xx 
x 
x 
x 
x 
x 
x 
x 
xx 
x x 
SHAM - ACO 
x x 
x x 
x 
x 
x 
xx 
xx 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
xx 
x 
.. x ~ x 
x 
x x 
x x 
x~ x 
x x x 
x x ·: x 
x x x 
xx xx x 
x 
x 
x 
x 
x 
x 
xx 
x 
x x 
x x 
x ... x 
x x 
x x 
xx xx 
x 
x x 
xx 
x x 
x 
x x 
x 
x 
x 
xx 
x 
x 
x 
.X 
xx 
x 
x 
x 
xx 
.. XX 
xx 
x 
x x 
x 
x 
x 
x 
x 
x 
x ~ 
x 
x 
xx 
x 
x x x x x x 
x 
x x x x 
x x 
xx 
x 
:: x 
x 
x 
x 
:: x x 
x 
x ., x x x x x x x x x 
x x X X X X X X X ·X 
x x x x x xx x x x x x 
X. X x x x x x x x x 
x x xx x x x x. x xx x 
x x x x x x x x x xx x 
x x ·:. x x x x x x x x x 
x :·. x .x x x x x x x x 
x x x x x x x x x x x 
Legend: Same as APPENDIX I 
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DAYS· POSTLESION 
MNM~~~~OOmOMNM~~~~OOmOMNM~~~~OOmOMNM~~~~oom88g~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~oooooooooooooooooooommmmmmmmmmMMMMMMMMMMMMMMMMMMMMM 
ANIMAL NO. · 
SA2 
SA7 
SA9 
SAll X 
SA14 
SA15 
SA16 
SA22 
SA24 
SA30 X 
SA58 
SA59 
SFl 
SF2 
SF3 X 
SF6 
SF7 
SF8 X 
SF9 
SF17 
SA4· 
SA6 
SA14 
SA23 X 
SA28 X 
SA34 
SASO X 
SFll 
SF12 
SF14 
SF22 
SF24 
x 
x 
x x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
x· 
x x 
x 
x 
x 
xx 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
x x 
x x 
x x 
x x 
x x 
x x 
x 
x 
x xx 
x xx 
x x x 
xx x 
x xx 
x x 
x x 
x xx 
x 
x 
x xx 
x x 
X ·X 
x x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
xx 
x 
x 
x 
x 
x 
x 
x x 
x 
xx 
x 
xx 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
xx xx 
x x x 
x ... x x x 
x x x x x 
x 
x 
x x 
x x 
x 
xx 
x 
x x 
x 
x 
x 
xx 
x 
x x 
xx 
x 
x x 
xx 
x 
xx 
xx 
x 
x 
xx 
xx 
x 
xx 
x 
x 
x x 
x 
x 
CONTROL (continued) ;. 
x x . x 
x 
x x 
x 
xx 
x 
xx 
xx 
x 
x 
x 
xx 
x x 
xx 
x x 
x x x 
x x x x 
x x xx x x 
x x xx x 
x 
x 
x 
x 
xx 
x 
xx 
x 
x 
xx 
xx 
x 
x x 
x 
xx 
x x 
xx 
x 
xx x 
x 
x 
x 
x x 
x 
x 
xx 
SHAM - ACO (continued) 
x 
x 
x x x x 
x x x x 
x x x 
.x 
x xx 
·x 
x 
x 
x x 
xx x 
x 
x x 
x x 
xx 
x 
x xx 
xx 
x 
xx 
x x 
x 
x xx x x x x 
x x 
x x 
x 
x x 
x 
x x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
x x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x x 
x 
x 
x x 
x x 
xx 
x 
x 
x 
x 
x 
x 
x x 
xx 
xx 
xx 
xx 
x 
x 
x 
x 
x 
x 
xx 
x x 
xx 
xx 
x 
x 
x 
xt 
XI 
x 
x 
x 
Xlt 
XI 
xj 
I 
x x xx x 
x· 
x x x x x x x x x x x x x 
x x 
x 
xx 
x 
x 
x x 
x x x x 
x 
x 
x 
xx 
x 
xx x 
x 
x x 
xx 
xx 
x 
xx x 
x 
xx 
x x 
x x x x 
xxxxxx 
x x 
x x 
xx x 
x x x x 
x 
x 
x x 
x 
xx x 
x 
xx 
x 
x 
x x 
xx 
x x 
x 
x 
x x 
xx 
xx 
x x 
x x 
xx 
xx 
x 
x 
x 
x x 
x x 
x 
xx xx xx xx x 
ANIMAL NO. 
SAl 
SA3 
SA12 
SA19 
SA25 
SA29 
SA27 
SA33 
.SA38 
SASS 
SA57 
SA60 
SA48 
SA56 
SFS 
SF16 
SF18 
SF23 
SF46 
SAlO 
SA17 
SA40 
SA18 
SA20 
SA41 
SA21 
SA35 
SE39 
SESO 
SE37 
~SE45 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
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LESION - ACO 
x x x x x x x x x 
x x x xx x xx x 
x x x x x· x x x x 
x 
x 
x x x x x x x xx x x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx 
x x x x x 
x x x x x 
x x x x 
x x x x 
x x x x x 
x 
x 
x 
x 
x 
x 
x 
xx 
x x x 
x x x 
x x x 
x x x 
x x . x 
x x x 
x x x 
xx xx 
x x x 
x x x x 
x x x x 
X· X X X 
x x xx x 
x 
x 
x 
xx 
x 
x x x x x x x 
x x x x x 
x 
x 
x 
~ x x 
xx 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x .. 
x 
x v 
x 
x x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
HIPP LESION 
x 
x x 
x 
DMNT LESION 
x x 
x 
x x 
IC LESION 
xx 
x x 
SHAM - POA 
x x x 
x x 
LESION - POA 
x x x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
xx x 
x 
x 
x 
x 
x 
x 
x 
x x 
x 
x 
x 
x 
x 
xx 
x 
x 
x 
x 
x 
x 
xx 
x 
xx 
x xx 
x x 
x x 
x x 
x x 
xx 
x x x 
x x x 
x x x 
x x x 
x xx x 
x 
x 
x 
x x x 
x 
xx 
x 
x 
x 
x 
x 
x· 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x xx x xx x x x x x x x x x xxxxxxxxxxx xxxxxxxxx 
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 
APPENDIX II: INDIVIDUAL CYCLE HISTORIES FROM THE 4-MONTH STUDY (continued) 
DAYS POSTLESION 
· o~NM•~~~oomo~NM•~~~mmo 
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THE FOLLOWING ABBREVIATIONS ARE USED CONSISTENTLY IN APPENDICES III, IV, AND V: 
BW •••••• Body Weight (gm) 
AP •••••• Anterior Pituitary Weight (mg) 
Thy •.•.• Thyroid Weight (mg) 
Adr ••••• Adrenal Weight (mg) 
Ovr ••••• Ovarian Weight (mg) 
UWW ••••• Uterine Wet Weight (mg) 
UDW ••••• Uterine Dry Weight (mg) 
·' % DW •••• Percent Uterine Dry Weight 
ULF ••••• Uterine Lumenal Fluid (mg) 
Ova ••••• Num~er of Eggs Found in Single Oviduct 
Age ••.•• Chronological Age of Animal (Days) 
DPO ••••• Number of Days Between Lesioning or Sham-Lesioning and Autopsy, 
"Days Post-Operative" (Days) 
C~ ••••• Cycle Length at Autopsy 
-:'-:.···. 
°' 
APPENDIX III: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 3-CYCLE STUDY 
~ 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age DPO CLA 
CONTROL PROESTRUS 
SF50 315 16.5 23.3 40.1 49.8 483.0 93.8 19.42 123.2 117 4 
SF49 320 14.6 19.3 26.3 51. 7 716.6 146.3 20.41 264.1 117 4 
SF47 345 15.7 17.6 35.0 31.1 467.0 88.5 18.95 187.0 117 4 
SB32 323 14.2 13. 7 28.0 33.6 520.8 267.0 122 4 
SB38 278 9.6 16.0 27.0 31.1 465.4 315.0 105 4 
SB12 285 10;7 23.2 32.2 399.2 116.3 102 4 
SB8 280 12.0 21.4 31.0 487.4 343.2 100 4 
SH17 304 7.9 11. 8 26.2 31.4 548.2 102.9 18. 77 221.2 131 4 
SH36 344 13.9 14.0 37.4 46.4 529.6 108.6 20.50 123.0 128 5 
LGl 13.0 638.8 Yes 83 4 
SH61 293 13.2 16.1 36.3 
CONTROL ESTRUS - AM 
36.8 436.1 "87.7 20:1 5 130 4 
SF34 290 12.2 14.4 26.0 41.8 417.0 ,. 90~ 1 21.60 13 111 4 
SH27 297 13.2 17. l 31.4 33.6 407.9 ·80~4 19. 71 6 122 4 
SH21 298 13.4 12.5 33.6 35.0 515.5 104.7 20. 71 9 124 4 
SH4 319 13.1 . 16. 2 30.5 34.0 564.0 110.0 19.50 6 124 5 
SI49 274 12.8 15.6 25.1 28.2 460.4 95.2 20.67 4 140 5 
SHl 278 18.7 13.1 27.4 37.0 384.3 82.3 21.41 4 132 4 
SF37 335 16.2 16.8 43.~ 37.3 428.4 91.1 21.27 7 111 4 
CONTROL ESTRUS - PM 
SB2 280 9.1 11. 9 25.8 34.6 413.0 7 109 4 
SF43 316 15.4 38.8 50.9 463.8 95.5 20.59 12 119 4 
SH26 279 13.0 14.2 30.0 36.0 425. 6. 5 124 4 
SH58 312 9.6 13.8 28.1 42.1 426.6 91.3 21.40 6 127 
---
4 
SH7 295 14.9 16.6 33.1 46.8 458.0 93.0 20.30 6 132 4 
SI9 260 13.8 15.6 27.8 38.1 348.6 75.3 21.60 7 117 5 
SI20 256 13.3 15.4 29.2 37.4 448.5 91.1 20.31 9 115 4 
SH19 279 16.9 13.0 25.1 25.6 398.3 84.6 21.24 11 127 4 
SB7 280 8.1 31. 2 44.8 411.0 6 101 4 
SB21 261 12.2 14.7 27.2 35.4 481.0 6 102 4 
SH5 292 13.4 18.4 34.7 
CONTROL METESTRUS 
38.8 401.1 86.9 21.66 125 4 
SH45 314 14.4 15.6 36.6 38.1 296.6 62.0 20.90 124 4 
SH55 338 12.4 26.3 35.5 44.1 302.1 60.9 20.15 124 4 
SB4 278 6.4 36.6 38.4 340.8 100 4 
SB22 230 8.1 22.2 37.6 251.4 100 4 
SE57 325 15.2 17.0 30.0 34.4 416.4 82.8 19.88 103 4 
SE62 13.7 14.9 35.8 37.4 344.6 82.3 23.88 116 4 
SF4 310 12.1 18.4 26.0 48.4 271.2 60.7 22.38 . 111 4 
SF25 335 12.6 . 29.4 35.3 327.2 69.3 21.17 111 --- 4 
SF35 314 12.3 16.1 24.2 32.4 310.2 71.6 23.08 111 4 
SF40 307 15.6 22.1 33.0 37.3 319.6 70.1 21. 93 111 4 
SF44 300 13.8 13.4 32.8 40.0 326.0 72.9 22.36 111 4 
SF38 334 17.8 33.8 48.1 450.2 96.1 21.34 110 4· 
SF41 318 14.8 10.5 30.5 38.0 285.6 61. 2 21.42 110 4 
SH53 324 14.2 15.0 31. 2 38.3 338.4 71.1 21.01 124 4 
Abbreviations Same as on Pa2e 1 ~A 
APPENDIX III: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 3-CYCLE STUDY {continued) 
Animal No. BW AP Thy Adr Ovr uww UDW % DW .. ULF Ova Age DPO'· CLA 
SHAM - ACO PROESTRUS 
SB9 310 14.9 13.8 37.5 38.2 776. 4 360.8 122 11 4 
SBlO 274 10.4 16.0 24.8 31.8 557.5 236.1 109 11 4 
SBll 280 8.1 24.4 48.3 580.0 318.4 101 11 5 
SB19 298 12.2 18.8 33.4 40.2 446.0 226.8 113 24 4 
SH6 265 10.8 20.9 29.5 41. 7 561.0 106.0 18.89 322.7 110 15 4 
SH57 303 11.2 10.7 31.5 39.2 365.0 75.6 20.71 175.5 127 22 4 
SI13 228 9.2 11.3 25.9 26.0 375.5 68.3 18.18 124.8 108 12 4 
SHAM - ACO ESTRUS - AM 
SH34 320 11.8 16.7 26.2 36.8 475.3 95.3 20.03 7~ 142 37 5 
SI40 259 11.3 15.4 32.4 41.8 403.3 76.6 18.99 58.2 8 121 24 4 
SI43 245 9.1 14.6 39.3 38.3 465.8 83.9 18.01 7 130 :: 12 4 
SI45 252 7.9 17.0 29.5 34.1 383.9 78.4 20.42 6 121 24 4 
SI60 244 13.6 22.7 29.9 30.2 491.6 93.0 18.91 9 126 14 5 
SI17 279 14.1 15.0 30.0 44.5 393.4 4 141 24 4 
SI56 268 11.4 32.2 37.4 37.8 492.6 99.6 20.22 2 126 14 5 
SHAM - ACO ESTRUS - PM 
SB37 312 11. 7 16.1 34.0 37.6 391. 2 8 128 30 5 
SB34 . 310 13.6 12.0 35.5 32.0 495.2 7 139 27 4 
SH41 16.0 17.8 44.0 41.1 473.2 95.8 20 .. 24 7 110 12 4 
SH49 310 18.5 22.8 38.0 51.3 458.5 87.3 19.04 6 140 36 4 
SI36 265 10.6 17.5 31. 9 35.5 370.8 75.1 20.25 7 130 12 4 
<l SH50 273 14.6 20.2 33.3 :;42; 0 409.2 81.8 19.99 8 llO 12 4 SH35 318 10.2 19.4 33·.4 47.4 423.4 83.4 19.69 Yes 118 12 4 
SB16 316 14. 8 . 16.0 32.4 48.2 418.0 8 114 23 4 
SHAM - ACO METESTRUS 
SB28 252 6.1 13.4 28.4 35.0 308.8 104 13 4 
SB15 312 12.7 14.2 33.8 41.0 353.4 116 26 4 
SB40 317 10.8 21.8 37.0 43.4 335.2 123 25 4 
SH13 268 14.7 37.4 40.8 305.0 65.1 21.34 109 13 4 
SH48 256 12.3 22.1 30.0 36.1 264.2 55.4 20.96 109 13 4 
SH28 295 9.8 20.1 36.5 33.0 466.7 95.1 20.37 110 56 5 
SH22 15.0 21.0 30.1 35.9 438.7 89.4 20.37 118 13 4 
Abbreviations Same as on Page 138 
{continued) 
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APPENDIX III: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 3-CYCLE STUDY (continued) 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age DPO CLA 
LESION - ACO PROESTRUS 
SB20 290 15.3 15.4 30.1 35.2 486.4 273.8 113 24 4 
SB27 310 16.6 15.4 29.6 37.2 558.6 584.0 __ .. 114 24 4 
SB39 330 15.2 19.4 35.2 48.6 506.2 Yes 119 23 4 
SB42 335 13.4 16.0 42.0 35.3 571.6 331.0 129 11 4 
~I44 262 9.4 12.1 36.2 37.2 393.4 79.9 20.31 159.3 ~-- 106 11 4 
SI54 230 12.4 19.8 25.8 26.6 562.7 108."0 19.19 110. 0 108 11 4 
SI29 250 9.4 17.2 31.0 21.6 518.9 94.6 18.23 120.1 110 13 4 
SI18 283 9.4 14.2 33.9 46.6 441.6 83.7 18.95 155.2 --- 120 23. 4 
SI32 275 10.5 18.5 30.8 36.6 484.1 93.2 19.25 155.6 120 25 4 
LESION - ACO ESTRUS - AM 
SH12 318 12.2 19.6 42.1 35.6 491.0 101:7 20.71 ~ --- 5 122 27 4 
SH18 361 16.4 15.1 32.9 39.5 503.3 107. 3 . 21.31 7 130 25 4 
SI34 268 13.6 18.5 35.4 49.0 452.0 87.1 19.26 6 120 24 4 
SI6 266 12.2 13.5 26.5 39.1 322.4 64.7 20.06 6 139 25 4 
SI2 269 10.2 19.5 26.4 34.2 444.1 89.3 20.10 6 121 24 4 
Sil 268 9.0 12.3 29.9 31. 9 394.9 '80.0 20.25 5 118 23 4 
SIS . 282 11.4 17.1 32.1 30.3 412.2 4 151 37 5 
LESION - ACO ESTRUS - PM 
SB24 313 19.6 16.0 29.2 46.4 440.6 6 128 39 4 
SBl 319 12.0 11.4 28.1 31. 2 330.8 6 140 42 4 
SH54 295 13.9 16.5 42.1 57.4 420.0 90.6 21.57 9 109 12 4 
SH44 315 9.8: 16.6 34.0 47.4 447.5 92.6 20.69 7 122 25 4 
SI28 260 9.4 16.8" 30.2 42.1 307•5 64.3 20.87 3 122 25 4. 
SI31 253 10.4 13.4 34.4 30.8 384.2 77.0 20.04 6 121 24 4 
SI33 255 12.4 17.2 26.2 40.0 565.2 112.4 19.88 6 121 25 4 
SI3 284 11.4 13.5 28.0 37.6 399.2 77. 7 19.46 ·10 141 27 4 
SI41 275 .13.2 21. 2 28.3 45.2 521. 3 103.r 19.79 11 128 24 4 
SB25 308 10.1 11.8 36.2 38.4 432.4 7 105 13 4 
LESION - ACO METESTRUS 
SB35 283 14.9 17.4 37.8 40.6 303.4 109 13 4 
SB26 286 13.2 15.2 31. 2 47.6 282.4 115 26 4 
SB18 319 13.6 15.4 29.6 33.2 312.0 139 28 4 
SH37 310 13.4 15.9 36.2 42.1 327.7 67.2 20.51 122 25 4 
SH42 346 12.0 17.l 34.3 37.8 358.2 78.6 21.94 127 30 4 
SI24 238 1.2 11. 7 21.5 23.2 310.1 66.1 21.32 110 13 4 
t!-SI47 238 6.7 12.2 33.2 42.1 222.0 49.5 22.30 108 13 4 
.... 
SI57 253 9.2 16.2 28.1 22.3 309.4 66.9 21.62 111 14 5 
SI12 268 11.6 13.8 36.~ 34.1 374.8 77 .8 20.76 12~ ~b 2 8137 290 12.9 20.5 33. 45.2 '" 347.4 ;69.9 20.12 12 
Abbreviations Same as on Page 138 
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APPENDIX IV: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 2-MONTH STUDY 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age DPO CLA 
CONTROL PROESTRUS 
SD4 305 17.2 17 .3 24.6 44.3 712.1 -13Ll · 18.41 400.4 139 4 
SD76 304 16.8 14.0 24.6 26.1 562.3 106.6 18.95 205.0 143 4 
SD17 288 18.5 22.3 26.2 44.7 589.2 103.4 17.54 294.5 140 4 
SD48 324 14.5 20.4 31.4 33.8 709.8 125.2 17.63 374.2 140 4 
SD57 317 18.6 17 .3 28.1 32.5 666.4 124.2 18.64 209.0 146 4 
SD88 295 14.3 11. 3 25.0 39.2 487.4 92.1 18. 89. 352.3 165 4 
SE15 284 15.2 13.2 33.5 33.0 527.4 94.2 17.86 197.9 151 5· 
SE22 315 16.5 16.0 26.4 35.8 828.6 141.3 17.05 165.4 150 4 
CONTROL ESTRUS - AM 
SD23 330 18.9 20.3 37.8 52.4 584.4 99.3 16.99 7 138 4 
SD38 288 15.2 14.7 29.4 36.8 478.5 97.4 20.35 4 180 4· 
SD82 320 11. 3 14.2 31.9 41.0 399.2 77 .5 19.41 8 158, 4 
SD60 262 11.3 14.0 19.5 27.2 380.1 :'68.1 17.91 9 138 4 
SD74 312 17.5 19.0 25.5 50.9 552.1 108.1 19.57 ·4 150 4. 
LG38 348 18.0 22.0 30.1 38.2 554.2 108.9 19.64 5 155 4 
SE34 313 22.0 13.7 33.7 34.4 619.6 . 119.1 19.22 9 158 4 
SD3 306 16.4 14.2 28.4 33.4 433.2 85.0 19.62 4 141 4 
SD114 324 14.4 16.2 25.2 40.6 450.2 387-. 9 19.52 7 153 
---
4 
CONTROL ESTRUS - PM 
SD55 282 18.7 22.4 27.8 31.6 507.4 94.2 18.56 5 . 141 5 
SD36 315 19.2 22.3 35.7 39.0 480.1 89.0 18.53 --- 7 141 ·4 
SD71 306 21. 2 17.5 29.7 40.6 507.6 96.5 19.01 8 138 .. -- 4 
SD94 358 17.4 24.7 43.4 40.1 525.8 96.4 18.33 8 166 4 
SE7 304 15.0 16.0 26.5 38.1 349.6 73.6 21. 05 5 160 ·5 
SEl 348 18.6 14.1 34.6 33.5 469.8 91.5 19.47 7 155 5 
SD28 324 18.8 15.8 34.3 30.6 686.7 125.4 18.26 5 151 4 . 
SE53 325 12.4 13.5 20.3 30.1 357.3 73. 8 . 20.65 6 158 5 
SE34 316 16.6 12.4 25.2 43.2 648.0 119. 0 18.36 9 158 4 
Abbreviations same as on page 138 
(continued) 
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APPENDIX IV: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 2-MONTH STUDY (continued) 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age DOP CLA 
SHAM - ACO PROESTRUS 
SD19 309 13.1 17.8 28.2 28.3 658.3 117.6 17.86 319.4 141 59 4 
SD20 305 14.8 20.2 27.8 27.4 712.3 125.4 17.60 193.9 142 59 4 
SD49 291 16.0 17.9 29.8 21. 7 478.0 91.1 19.05 455.8 --- 143 61 5 
SD61 305 14.0 20.4 27.3 32.3 863.7 155.4 17.99 292.1 149 61 4 
SD69 305 18.3 20.9 27.6 25.3 752.9 138.2 18.35 522.1 146 5'9 4 
SD116 346 17.3 21. 2 30. 5 35.0 1052.9 202.1 19.19 1692.2 165 63 5 
SE46 324 18.8 20.4 34.7 36.8 829.5 145.1 17.49 765.8 153 '~59 4· 
SHAM - ACO ESTRUS - AM 
SD26 301 18.1 17.3 28.4 37.2 628.2 106.7 16.98 .8 138 57 4 
SD30 300 13.3 21.1 30.3 35.8 601.5 113.4 18.85 9 141 59 4 
SD42 348 17.3 13.2 31.9 42.0 539.6 96.1 17.80 5 141 60 4 
SD58 314 17 .4 16.3 28.2 42.0 589.6 109.1 18.50 ---- 6 140 59 5 
SD67 330 19.0 15.9 32.0 38.1 419.4 : 85. 9 20.48 4 152 65 5 
SD90 334 17.0 15.9 31.3 36.5 707.0 134.1 18.96 
---
7 148 61 4 
SE40 320 16.6 19.6 29.4 38.4 519.3 93.9 18.08 7 155 64 5 
SES 288 13.4 13. 7 23.8 32.0 405.2 86.1 21.24 1 165 73 4 
SE25 320 15.6 21.1~ 32.4 42.9 484.7 88.1 18.17 6 152 60 4 
SHAM - ACO ESTRUS - PM 
SD5 312 11. 7 18.5 26.3 52.5 397.3 77. 7 . 19. 55 5 152 70 4 
SD41 289 14.4 19.5 29.4 40.8 614.4 116.0 18.88 9 142 60 4 
SD65 310 18.2 19.5 28.3 52.1 478.2 92.8 19.40 4 142 60 4 
SD77 326 16.2 17.5 28.5 37.4 453.8 92.1 20.29 11 155 60 4 
SD81 296 16.2 14.4 27.6 34.7 438.0 84.0 19.17 6 145 59 ·4 
SD109 279 12.6 .15.2 31.6 30.1 410.0 84.4 20.58 7 155 60 4 
SEll 315 17.3 15.4 28.9 31.2 566.1 108.5 19.16 5 149 57 5 
SE12 304 .12.6 12.4 29.7 32.3 417.2 81. 0 19.41 5 153 60 4 
SE27 320 16.4 14.7 35.5 46.0 482.6 91.l 18.87 ., 7 153 60 4 
SD40 281 11. 7 21.3 27.6 708.2 136.7 19.30 6 143 60 4 
SE23 303 17.4 13.7 27 .-() 26.4 620;1 122.7 19.78 11 158 63 5 
Abbreviations same as on page 138 
(continued) 
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APPENDIX IV: AtrrOPSY DATA FROM INDIVIDUAL RATS IN THE 2-MONTH STUDY (continued) 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age DOP CLA 
LESION - ACO PROESTRUS 
SD6 305 10.9 20.8 27.2 25.9 555.0 101.5 18.28 138 55 4 
SDlO 296 11. 7 15.5 25.2 36.8 592.2 101. 7 17.17 202.4 140 59. 4 
SD22 284 11.2 15.6 27.6 34.0 520.4 92.0 17,67 214.3 142 59 4 
SD64 316 15.6 16.5 37.0 36.7 735.8 138. 2 18.78 537.6 148 60 4 
SD53 346 17.8 15.8 27.6 36.4 723.5 138.6 19.15 346.2 153 65 5 
SD105 321 20.0 21.4 37.4 38.9 795.5 150.9 18.96 225.0 167 65 5 
LG53 322 16.5 18. 7 35.2 40.9 485.7 94.9 19.53 212.4 155 . 65 5 
SE31 309 15.8 20.9 27.6 37.6 609.0 . 103. 2 16.94 249.0 151 58 4 
SE26 362 19.1 23.6 31.0 41.8 669.3 117.9 17.61 80. 2 151 59 5 
SE59 300 14.9 22.5 27.4 31.6 533.7 93.2 17.46 '76. 0 ' 153 59 4 
LESION - ACO ESTRUS - AM 
SD2 320 13.9 17.3 22.1 28.2 351.6 .68~5 19.48 6 138 57 4 
SD95 342 15.1 15.1 30.0 45.3 448.0 '.'92. 0 20.53 4 157 70 4 
SD98 328 15.9 18.8 21.0 40.6 465.2 95.6 20.55 5 144 59 4. 
SE6 324 19.1 17.5 29.5 33.4 610.9 114.2 18.69 8 149 57 .4 
SE51 369. 20.4 20.8 30.0 43.3 425.3 82.5 19.39 6 149 57 5 
SD7 330 11.4 20.6 26.6 28.7 676.4 135.6 20.04 6 143 60 5 
SD32 304 16.6 19.0 24.0 31.3 450.0 86.1 19.13 1 141 58 5 
SD59 329 18. 3 . 16.7 27.7 37.5 613.5 121.5 19.80 3 - 159 60 4 
LESION - ACO ESTRUS - PM 
SD9 307 20.3 22.0 32.8 33.0 567.8 103.3 18.19 5 142 60 4 
SDll 348 19.6 19.0 31.5 33.1 470.4 87.3 18.55 7 141 58 4 
SD50 310 11.8 16.6 29.6 30.1 552.5 105.1 19.02 7 143 60 4 
SD80 296 18.0 19.6 32.8 37.2 401.5 75.0 18.67 ; ,·--- 12 145 59 4 
SD113 367 21.0 18.l 35.4 48.4 551.0 100.8 18.29 7 161 62 4 
SD120 320 21.l 16.8 37.0 45.0 645.3 127.0 19.68 11 164 61 4 
SE13 330 15.5 . 13.4 35.6 52.7 562.7 102.8 18.26 10 153 60 4 
SE16 312 18.2 15.8 38.2 46.3 493.4 86.7 17.57 6. : 149 58 4 
SE2 275 19.9 20.0 31.3 28.3· 530.2 104.9 19.78 6 160 65 4 
SElO 362 13.1 16.0 24.5 43.8 471.6 91.6 19.42 8 160 65 4 
Abbreviations same as on page 138 (continued) 
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APPENDIX IV: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 2-MONTH STUDY (continued) 
Animal No. BW AP Thy Adr Ovr uww UDW % DW 'ULF Ova Age DOP CLA 
SHAM - "ST" ESTRUS - AM 
SD13 300 17. 7 30.1 40.l 488.2 101. 7 20.83 7 152 62 5 
SD14 278 13.2 14.5 28.0 35.8 409.3 78.5 19.17 4 153 64 4 
SD44 304 18.5 16.2 33.0 36.2 637.4 9 153 64 4 
SD84 274 11. 7 12.2 24.8 39.1 . 492. 3 99.5 20.21 6 155 60 4 
SD104 318 13.7 14.3 37.3 29.0 395.6 80.3 20.29 8 155 60 4 
SD108 323 14.2 15.0 40.1 37.2 450.2 90.9 20.19 7 156 61 4 
SD117 318 16.1 20.3 31.3 26.6 731.1 138.3 18.91 7 160 61 4 
SE17 382 15.9 7.3 29.8 41. 2 653.4 123.0 18.82 5 155 61 4 
SE44 339 23.0 29.2 41.2 46.3 572.1 107.0 18.70 3 155 61 5 
-------------------------------------------------~------------------~-----------------------------------------LESION - "ST" PROESTRUS 
SD21 305 13.4 18.2 31. 7 38.4 486.5 88.2 18.12 206.8 141 59 4 
SD73 332 14.6 20.3 31.5 33.1 684.2 124.4 18.18 399.0 149 61 4 
SD78 306 17.7 14.4 24.2 37.4 587.0 108.1 18.41 318.9 146 59 4 
SD97 325 19.5 18.8 26.3 49.2 480.0 89.9 18. 72 li0.6 146 59 4 
SD56 302 14.9 I 20.2 28.6 36.0 716.2 .132..> ·18.50 641.1 148 60 4 
LESION - "ST" ESTRUS - AM 
SD33 329 15.2 16.2 24.8 40.4 472.4 97.4 20.61 4 144 61 4 
SD35 322 17.3 17.8 27.1 37.6 358.9 ~·75 ~ 8 21.12 7 142 59 4 
SD96 296 14.9 18.1 30.0 40.9 607.5 116.4 19.16 6 148 61 4 
SDlOO 332 17.5 15.4 24.2 29.2 519.0 107.5 20. 71 8 146 60 4 ·~ SD115 320 16.8 16.6 28.4 35.5 514.0 102.0 19.84 8 160 61 5· 
LESION - "ST" ESTRUS - PM 
SD83 348 11. 9 17.3 27.8 43.7 428.9 89.0 20.75 6 151 . 65 4 
SD66 325 18.2 15.0 24.6 26.7 414.0 77 .8 18.79 9 145 62 4 
SD46 328 19.2 13.8 38.7 33.0 400.0 82.5 20.62 6 144 62 5 
SD27 335 19.1 15.3 39.1 34.1 627.4 123.3 19.65 6 145 ::62 4 
SD12 275 14.1 11. 3 24.0 25.6 388.1 77. 8 20.04 4·· ·: 159 63 5 
Abbreviations same as on page 138 
(continued) 
~ 
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APPENDIX IV: AUTOPSY DATA FROM INDIVIDUAL.RATS IN THE 2-MONTH STUDY (continued) 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age ···DoP CLA 
SHAM - AL PROESTRUS. 
SE4 322 16.8 17.8 27.8 31. 2 666.3 H.6.9 17.54 436.0 158 59 4 
SGS 294 11.8 18.0 24.6 31. 7 683.0 125.0 18.30 341.2 162 64 4 
SGlO 285 12.5 18.4 30.4 39.2 718.3 129.2 17.98 218.6 166 63 4 
SG16 321 12.6 15.8 30.1 25.2 506.1 92. 7 18.31 907.9 160 60 5 
SG17 318 13.4 19.7 35.7. 59.0 523.0 103. 9 19.86 384.2 166 63 4 
SHAM - AL ESTRUS - AM 
SE14 297 14.5 16.0 21.4 35. 0 420.9 81.0 19.24 7 158 59 4 
SE43 300 16.7 13.8 28.2 36.4 757.2 141.7 18. 71 7 164 61 4 
SG9 338 13.4 16.0 30.2 26.2 482.1 .. ~ 92~ 7 19.21 8 163 60 5 
SGll 324 13.5 24.5 27.5 37.3 573.2 ., 109. 8 19.15 9 165 64 4 
SG21 319 14.5 20.0 32.1 37.2 485.6 87.4 17.99 9 165 64 4 
SG13 328 15.3 20.0 41.8 33.2 427.4 81.0 18.95 6 174 62 5 
LESION - AL PROESTRUS 
SE28 300 12.7 17.4 26.0 33.2 566.0 97.7 17.22 288.4 158 63 4 
SE36 298 . ·19.0 13. 7 19.8 25.1 648.1 . 112. 8 17.40 517.8 159 59 4 
SE49 299 15.5 15.8 30.3 38.2 731.3 138.7 18.96 448.7 162 59 4 
SG6 292 13.2 16.5 24.5 37.2 527.4 92.2 17.46 123.6 160 60 4 
SG18 270 12.8 14.3 28.2 34.7 500.6 85.6 17.09 285 .1 ·. 160 58 4 
LESION - AL ESTRUS - AM 
SE35 331 14.4 14.5 25.8 41.5 519.8 105.5 20.29 5 160 60 4 
-~ SE38 387 21.0 18.4 33.7 39.2 501.4 99.0 19.74 10 164 65 5 
SE19 327 12.7 13.4 28.0 32.3 371.4 77. 0 20.73 .: 5 163 61 4 
SE54 322 . 15.7 12.4 25.7 36.0 546.6 107.6 19.69 ''.8 164 :61 4 
Abbreviations same as on Eage 138 
APPENDIX V: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 4-MONTH STUDY 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age DOP CLA 
CONTROL PROESTRUS 
SAU 352 15.9 28.1 33.3 47.8 710. 6 224.8 209 5 
SA24 278 13.2 24.4 24.0 39.3 608.6 612.0 208 --- 5 
SA30 407 12.0 12.3 26.7 39.2 563.6 212 4 
SASS 397 12.0 .: ~~- 42~4. 495.6 106.0 2L39 205 5 
SA59 415 9.0 17.3 38.2 37.5 676.6 129.0 19~07 538.1 234 5 
SF2 365 14.6. 29.7 31.9 45.5 598.8 105.8 17.67 483.2 240 4 
SF3 388 20.0 18.5 29.6 42.3 559.3 115.8 20.70 359.5 250 4 
SF19 354 20.6 25.1 35.7 35.4 906.8 965.9 242 5 
CONTROL ESTRUS - PM 
SA7 417 14.4 19.4 29.6 48.4 390.6 9 239 5 
SA15 355 19.4 19.2 . 37. 2 37.7 468.9 5 230 4 
SA22 402 17.4 18.7 26.0 53.8 373.4 72. 3 19.36 5 231 4 
SF7 380 26.6 15.4 38.6 . 42. 2 672. 0 147.1 21.89 9 244 
---
4 
SF8 314 15.0 19.3 22.6 34.8 .559.7 118.8 21.23 5 247 4 
SHAM - ACO PROESTRUS 
SA14 358 13.8 26.6:; 27.6 38.4 483.4 187.4 248 129 5 
SA23 390 13.4 18.5 31.2 35.5 701.8 131.9 18.79 100.6 221 119 5 
SA28 323 11.6 17.3 34~1 49.8 573.5 Yes 210 120 4· 
SHAM - ACO ESTRUS - PM 
SASO . 400 17.2 22.8 39.8 44.3 558.4 104. 6- 18.-7~ 15 202 116 5 
SFll 350 15.3 28.4 27.7 38.8 602.9 116.6 19.34 Yes 240 121 5 
. SF12 352 21.4 14.8 32.4 51.8 755.2 169.4 22.43 9 243 140 5 
SF14 364 17.7 22.2 29.4 40.2 467.3 105.3 22.53 7 242 122 5 
SF22 425 20.0 25.6 31.4 45.8" 509.0 · :1LS 21. 91 7 243 121 5 
Abbreviations same as on page 138 (continued) 
~ 
APPENDIX V: AUTOPSY DATA FROM INDIVIDUAL RATS IN THE 4-MONTH STUDY (continued) 
Animal No. BW AP Thy Adr Ovr uww UDW % DW ULF Ova Age DOP CLA 
LESION - ACO PROESTRUS 
SA19 352 11.6 15.1 23.8 31.4 491.6 151.0 223 125 4 
SA29 316 12.0 19•2 28.6 37 .. o 539.6 Yes 210 120 5 
SA33 336 14.4 17.8 42.6 42.0 648.6 1054.4 214 117 s 
SA38 . 336 13.4 19.4 28.7 49.8 726. 0 129.0 17. 77 374.1 219 119 4 
SA57 38S 7.2 14.4 18.4 34.2 7S9.0 129.2 17.02 Yes 206 123 s 
LESION - ACO ESTRUS - AM 
SA2S 336 16.7 17.2 29.7 40.2 492.8 92.1 18.96 10·, 216 121 4 
SA27 3S6 13.6 21.4 38.9 44.0 4S7.4 92.2 20.16 7 219 122 s 
SA48 373 13.4 2S.O 28.4 42.7 S23.6 104.2 19.90 4 202 112 s 
SAS6 369 !S.8 24.1 40.8 39.2 600.1 113.6 18.93 9 203 116 s 
LESION - ACO ESTRUS - PM 
SAl 363 20.0 10.4 2s.2 35.6 487.2 7 211 122 4 
SA3 440 2S.O 14.0 36.2 62.6 636.6 9 209 118 4 
SAS! 342 16.7 21.9 3S.8 31.6 489.0 98.1 20.06 4- 203 120 4. 
SASS 360 9.9 1+.8 27.S 44.8 S51.0 103.2 18.73 6 232 ·132 4 
SA60 397 19.1 17 .8 2S.2 41. 2 418.0 84.0 20.10 9 202 115 s 
SF5 330 16.3 19.1 31.5 40.0 437.8 91. 5 20.90 6 243 121 4 
SF16 344 14.6 32.2 29.6 34. 6 . 524.1 91.5 17.46 4 240 123 4 
SFl? 41S 16.0 18.6 32.1 . 46. 2 721.8 1S6.6 21.70 9 241 122 4 
SF46 . 292 17.1 16.2 25.6 24.5 S04.5 103.8 20.57 7 243 126 . 4 
-~ SF23 422 23.3 23.2 44.6 48.1 730.0 140.8 19.29 8 247 125 4 
Abbreviations same as on page 138 
pr· 
APPENDIX VI: INDIVIDUAL PLASMA LH VALUES:3-CYCLE STUDY lh9 
Animal No. Assay No. Plasma LH Plasma LH 
11&L2 ml llillml 
CONTROL 
PRO ESTRUS LG42 cs .112 56.0 
LG24 cs .140 70.0 
LG74 C21 .oss 44.0 
LG75 C21 • 039 lS.5 
LG77 C21 • 024 12.0 
LG72 C23 .037 16.5 
LGS9 C23 .035 17. 5 
LG90 C23 • 030 15.0 
SH36 D7 .053 26.5 
SH17 Dl3 .030 15.0 
SB8 & 12 B34 .099 49.5 
SB12 B34 .ooot o.o 
SB3S B34 .051 25.5 
SB32 B34 • 025 12.5 
SF49 C49 .113 56.5 
SFSO C49 .160 80.0 
.... "'t ·-···,·· 
ESTRUS - AM LG80 C23 .000 o:o 
SH27 D7 .000 -o.o 
SH4 D7 .029 19.5 
SH21 D7 .000 o.o 
SH21 & 4 ·D7 .034 17.0 
.SI49 Dl8 .037 18.5 
SH61 D13 .000 o.o :_.-_,. 
SHl Dl3 .029 14.5 
SF34 Dl3 .056 28.0 
ESTRUS - PM · SH26 D7 • 03S 19.0 
SH19 D7 .000 o.o 
SH58 D7 .055 27.5 , .• , . 
SH7 Dl3 • 040 20.0 
SI20 D13 .000 o.o 
SI9 D13 .000 "0.0 
SF43 D49 .000 o.o 
SB2 B34 .ooo o.o 
SB7 B37 .038 19.0 
METESTRUS SH45 D7 .029 14.5 
SH53 D7 .071 35.5 
SH55 D7 .ooo o.o 
SHS D7 .064 32.0 
SE57 C21 .180 90.0 
SE62 C21 .190 95.0 
SF38 C49 .• 035 17.5 
SF41 C49 .186 93.0 
SF40 C49 .038 19.0 
SF44 C49 .ooo o.o 
SF4 C49 .094 47.0. 
SF25 C49 .177 88.5 
SF35 C49 .ooo o.o 
tWhen a plasma sample causes no depletion of ovarian ascor~ic acid 
its LR concentration is assigned a value of .000 µg/2 ml. 
fOmitted by Outlier Critera (.26') 
(continued) 
"!' 
,.. I ... APPENDIX VI: INDIVIDUAL PLASMA.LH VALUES:3-CYCLE STUDY (continued) · J50 
Animal No. Assay No. Pla,rna LH Plasd LH l!~ 2 ml 1 ng ml 
ACO - SHAM 
PROESTRUS SH6 D7 .100 50.0 
SH57 D7 .000 o.o 
SI13 D13 .037 18~5 
SBll B34 .075 37.5 
SB9 & 10 B34 .ooo o.o 
SBlO B34 .. 080 40.0 
SB19 B34 •. 045. 22.5 
ESTRUS - AM SI43 D18 .460 230.0f 
SI17 Dl8 .000 o.o 
SH34 D13 .000 o.o 
SI40 D13 .016 8.0 
SI45 Dl3 .016 8.0 
SI56 D13 .080 40.0 
ESTRUS - PM SH41 D7 .• 042 21.0 
SH50 D7 .100 50:0 
SH35 D7 .ooo o.o 
SH49 Dl3 .049 24.5 
SB16 B34 .072 36.0 
SB34 l~i ·256:j: 28~0 SB3 ~~ .. q 
METE.STJ.WS ~Ht~ & 48 B1 . : 8frg 4~~-: 8:f 
SH22 D7 .076 38.0 
SB15 B34 .112 56.0 
SB28 B34 .029 14.5 
SB40 B34 .280 140.0 
ACO ·- LESION 
PRO ESTRUS SI44 D7 .025 12.5 
SI54 D13 . 480 240. Of . 
SI29 D13 .032 16.0 
SI18 D13 .ooo o.o 
SI32 Dl3 .000 o.o 
SB20 D34 .025 12.5 
SB27 B34 .115 57.5 
SB39 B34 .113 56.5 
SB42 B36 .078 39.0 
ESTRUS - AM .Sltl.2 D7 .ooo o.o 
, S:t6 Dl8 .037 18.5 
SIS D18 .. ooo o.o 
SH18 D13 • 000 o.o 
SH18 Dl3 .• 015 7.5 
Sil D13 .017 8.5 
SI.34 Dl3 .020 10.0 
SI2 D13 .ooo o.o 
ESTRUS - PM SH54 D7 .ooo o.o 
Sl41 D18 .ooo o.o 
SI3 D18 .180 90.0 
SI31 D13 .000 o.o 
Sl33 D13 .165 82.5 
SI28 D13 .018 9.0 
SB24 B34 .121 60.5 
SBL B41 .-ooo :o.o 
Sil54 D7 .ooo o.o 
t .... ,..;:, .. ~ ., ,.. y-'; SB2i B34 .1gs 53:8 • ~ • J. : . > I. J SB4 .B37 .o 0 
.. ; . 
METESTRUS SH37 DJ' 4000 'o .. o 
SH42 D7·· .102 51.0 
SI47 D13 ~038 19:.0 
SI24 D13 .0.18 r9.0 
SI37 D13 ·.016 :a. 0 
$157 D13 :ooo '()·. 0 
SB26 B34 ~ooo o.o 
SB35 B34 .290 145.0 
Legend Same as APPENDIX VI, Page 149 
(continued) 
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APPENDIX VI: INDIVIDUAL PLASMA LH VALUES:2-MONTH STUDY (continued) 151 
Animal No. Assay No. Pla?1~a LH Plasfa LH g ml ng ml 
CONTROL PROESTRUS: 
2:30-3:30 PM SD4 C22 • 220 110. 0 
SD17 C22 '.000 o.o 
SD48 C22 .000 o.o 
SD76 C24 .ooo o.o 
SD57 C24 .210 105.0 
SD88 C27 • 053 26.5 
SE22 C28 • 000 o.o $El5 C28 .225 112.5 
PROESTRUS: AGE 
5:00-6:00 PM SE3 C28 .280 140.0 149 
SE52 C28 .370 185.0 149 
SE42 C28 .480 240.0 151 
SE48 C28 .295 147.5 152 
SE61 C28 .373" 186.5 152 
SE55 · C28 .500 250.0 :'152 
~ESS,52,61 C28 .520 260.0 
ESTRUS - AM SD23 .C22 .098 49.0 . 
SD3 C22 • 087 43.5 
~D74 C25 .ooo o.o 
SD114 C25 .ooo o.o 
SD74 & 114 C25 .039 19.5 
SD82 C27 .000 o.o 
ESTRUS - PM SD71 C22 .110 55.0 
SD34 C22 .ooo 0.0 
SD55 C22 .ooo o.o 
SD34 & 55 C22 .000 o.o 
SD36 C23 .123 61.5 
- SD28 C25 .257 128.5 
SD94 C27 .320 160.0 
SEl C31 .029 14.5 
SE53 C31 .036 18.0 
SE7 C31 .061 30.5 
ACO-- SHAM 
PRO ESTRUS SD19 C22 • 220 110.0 
~D20 C23 .ooo o.o 
SD61 C25 .ooo o.o 
SD116 C27 .252 126.0 
SE46 C31 .0~6 18.0 SD49 C24 .2 0 140.0 
ESTRUS - AM SD58 C22 :1so . 90:0 
SD30 C22 .062 31.0 
SD30 & 26 C22 .365 182.5 
SD90 C24 
.046 24.5 SD67 C25 .oo o.o 
SE40 C31 .ooo o.o 
SES C31 .040 20.0 
SD42 C22 .089 44.5 
SD26 C23 .125 62.5 
ESTRUS - PM SD41 C24 .054 27.0 SD81 C24 .000 0.0 
SD65 C24 .160 80.0 
SD40 C24 • 067 33.5 
SD99 C25 .052 26.0 SDS C25 .087 43.5 
SD109 & 5 C25 .ooo o.o 
SD77 C25 .147 73.5 
SD109 C25 .042 21.0 
SE12 C28 .074 37.0 
SE27 C31 .ooo o.o 
SEll C28 .099 49.5 
Legend Same.-,as 'APPENDIX VI, Page J..49 
(continued) 
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APPENDIX VI: INDIVIDUAL PLASMA LH VALUES:2-MONTH STUDY (continued) 152 
Animal No. Assay No. Plasja LH YB 2 ml Plas7a LH ns ml 
ACO - LESION 
PRO ESTRUS SDlO C22 .160 80.0 SD64 C24 .056 28.0 
SD53 C25 •. 232 116.0 
LG53 C27 • 026 13.0 
SD105 C2T .ooo o.o 
LG53 & SD105 C27 .058 29.0 
SE59 C31 .320 160.0 
SD6 C21 .083 41.5 
SE31 C28 .000 o.o 
SE26 C28 .034 17.0 
SD22 C23 • 084 42.0 
ESTRUS - AM SD32 . Ci2 . 000 o.o 
SD2 C22 • 061 30.5 
SD98 C24 .000. o.o 
SD7 <:24 .• 000 o.o 
SD95 C25 .142 71.0 
SD59 C2:7 .041 20.5 
SE6 C28 .043 21.5 
SE51 C28 .000 o.o 
SE6,21,51 C28 • 038 19.0 
ESTRUS - PM SD9 C22 .000 o.o 
SDll C22 .ooo o.o 
SD80 C24 .143 71.5 
SD50 C24 .104 52.0 
SD113 C27 .034 17.0 
SDl20 C27 .084 42.0 
SElO SElO & 2 Cjl c 1 : 888 g.o .o 
SE13 C31 • 063 31.5 
SE16 · C28 • 000 o.o 
ST - SHAM 
.ESTRUS - AM SD108 C25 .000 o.o 
SD13 C25 .ooo o.o 
SD14 C25 .ooo o.o 
SD44 C25 .066 33.0-
SD84 C25 .ooo o.o 
SD104 C25 .000 o.o 
SE44 D28 .067 33.5 
SE17 D28 .110 55.0 
SE17 & 44 D28 .061 30.5 
ST ..... LESION 
PROESTRUS SD21 C22 .049 24.5 
SD78 C24 • 000 o.o 
SD97 C24 .140 70.0 
SD73 C24 .202 101.0 
SD56 C25 .140 70.0 
ESTRUS - AM SDlOO C24 .054 27.0 
SD33 C24 .153 76.5 
SD96 C25 .055 27.5 
ESTRUS - PM SD46 C24 .099 49.5 
SD66 C24 • 093 46.5 
SD83 C25 .000· o.o 
SD12 C27 .051 25.5 
... 
Legend Same as APPENDIX VI, Page J.49 
(continued) 
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APPENDIX VI: INDIVIDUAL PLASMA LH VALUES;2-MONTH STUDY (continued) 153 
PROESTRUS 
ESTRUS - AM 
PROESTRUS 
Animal No. 
SE4 
SG16 
SG16 
SGS 
SGlO 
SGS & 10 
SG17 
SGS & 17 
SE43 
SE19 
SE19 & 35 
SG13 
SG9 
SG9 & 13 
SGll 
SGll 
SG21 
SG13 & 21 
Assay No. 
AL - SHAM 
C31 
Dl8 
Dl8 
Dl8 
Dl8 
Dl8 
DlS 
Dl8 
C31 
C31 
C31 
Dl8 
Dl8 
Dl8 
Dl8 
Dl8 
D18 
l>l8 
AL - LESION 
Plasma LH 
ug/2 ml -
.• 044 
.• 000 
.• ooo 
.044 
.ooo 
.ooo 
.218 
.044. 
.049 
.ooo 
• 047 
.064 
.ooo 
.000· 
.• 000 
• 042 
• 054 
.000 
Plasma LH 
ng/inl 
22.0 
o.o 
o.o 
22.0 
o.o 
.o.o 
109.ot 
22 •. 0 
24.5 
o.o 
23.5 
32.0 
co:o 
o.o 
o.o 
21.0 
27. 0 
o.o 
SE2S & 36 C31 .059 29.5 
SE49 C31 • 080 40. 0 
SE54 C31 .020 10.0 
SG6 Dl8 .088 44.0 
SG18 Dl8 .000 0.0 
SG6 & 18 Dl8 • 000 O. 0 
ESTRUS - AM SE19 C31 .000 0.0 
-------------------~~!2-~-~~---------f~!-------------~Q~Z-------------~~~~---
PRO ESTRUS 
ESTRUS - PM 
PRO ESTRUS 
ESTRUS - PM 
PRO ESTRUS 
ESTRUS - PM 
SF3 
SF2 
SF2 
SF19 
4-MONTH STUDY: CONTROL 
D28 
SF3 & 19 
SAll 
SA24 
SF7 
SF7 
SFS 
SF17 
SA7 
SA15 
SA14 
SA23. 
SA2S 
SF12 
SF12 & 14 
SF22 
SF22 
SF14 
SFll 
SFll & 14 
SA29 
SA33 SA19 
SF46 
SF5 
SF18 
SF16 
SF16, 
SA3 
SAl 
SF23 
SF23 
SF23 
5, 46 
D28 
D28 
D28 
D28 
B41 
B37 
D28 
D28 
D28 
D28 
B43 
B41 
ACO - SHAM 
B47 
B47 
B47 
D28 
D28 
"Dis 
D2S 
D28 
D2S 
D2S 
ACO - LESION 
B47 
B~I 
D2S 
D2S 
D2S 
D2S 
D2S 
B43 
B35 
D28 
D2S 
D28 
.000 
.ooo 
.ooo 
.000 
.113 
.041 
.312 
.000 
.ooo 
.ooo 
.ooo 
.ooo 
.049 
.255 
.050 
.098 
.ooo 
.ooo 
.000 
.ooo 
.000 
.ooo 
.-ooo 
.490 
:~l~ 
.104 
.540 
.ooo 
.ooo 
.000 
.101 
.035 
.ooo 
.ooo 
.ooo 
Legend Same as APPENDIX. VI, Page J.49 
(continued) 1 
o.o 
o.o 
o.o 
o.o 
56.5 
20.5;i:. 
156.0T 
o.o 
o.o 
o.o 
o.o 
o. o· 
24.5t 
127.5 
25.0 
49.0 
o.o 
o.o 
o.o 
o.o 
o.o 
o.o 
o.o 
245.0 
1~1:8 
52.0+" 
270.0T 
o.o 
o.o 
0.0 
50.5 
17.5 
o.o 
0.0 
o.o 
r. ...... ~, ,41#' 
APPENDIX VI: INDIVIDUAL PLASMA,LH VALUES:4-MONTH STUDY (continued) 154 
······ 
....... . ... ...... ...... ..... 
Animal No. Assay No. Plasma LH Plasma LH 
µg/2 ml ng/ml 
ACO - LESION 
ESTRUS - AM SA27 ';B47 .033 16.5 
'POA - SHAM 
ESTRUS - AM SEB9 C49 .037 18.5 
SE50 C49 • 048 24.0 
POA - LESION 
ESTRUS - AM SE37 C49 .OOQ o.o 
SE45 C49 .142 72.0 
IC - LESION 
ESTRUS - AM SA21 B47 .000 0.0 
HIPP - LESION 
ESTRUS - AM SA17 B4l, .000 o.o 
DMNT - LESION 
ESTRUS 
- AM SA20 B41 .128 64.0 
Legend Same as APPENDIX VI, Page J.49 
·"" 
APPENDIX VII: INDIVIDUAL PITUITARY LH POTENCIES 3-CYCLE STUDY J.55 
RAT NO. ASSAY NO. P* 95% CLt A. 
PROESTRUS 
ESTRUS - AM· 
ESTRUS - PM 
METESTRUS 
PROES.TR,US 
ESTRUS "'."' AM 
ESTRUS - PM 
METESTRUS 
PROESTRUS 
ESTRUS - AM 
ESTRUS - PM 
METESTRUS 
LGl 
SB38 
SB12 
SH61 
LG19} 
LG80. 
SH27-
SI20} 
S19 ' 
SH58j 
SH7 . 
SB7 ' SB21~ 
SH5 
SF4. t 
SF41 ·· 
SF25} 
SF35.: 
SF38 
SE62 
c .... ··. "'! 
SH57 
SBlO 
SB9 
SI60 
SI56 
SH34 
SI40} 
SI45.• 
SB34 
SB16 
SB37 
SH48 
SBlS 
SB40 
SB13 
SI44 
SI29 
SB42 
SB27 
Sll 
SH12 
SB18 
SI28 
SI33 
Sl31 
SB2S 
SHS4 
SB35 
SB26 
SB42 
SI24 
CONTROL 
Cl3 24.27 
C6 22.13 
cs 28.91 
D29 10.0S 
C34 8.70 
Dl2 6.SS 
Dl2 8.40 
D27 11.18 
C2 7.9 
DlO 11.83 
C44 11.80 
C44 11.70 
C48 *16.77 
C20 · *11.41 
ACO ~ SHAM 
D27 15.55 
ClO 15.90 
C12 23.84 
D34 8.93 
D30 8.43 
D20 9.74 
D32 *13.61 
DlS 15.75 
ClO . ll.S6 
Cl 13.57 
D32 14.75 
cs 12.66 
Cl4 10.20 
D29 **11.04 
ACO - LESION 
Dl2 24.Sl 
D20 19.44 
C14 25.80 
ClO *15.06 
D33 . 11.67 
D32 11.22 
D30 13.32 
D34 17.89 
D32 24.SO . 
D30 '15.37 
C2 lS.50 
D29 *16.22 
C2 17.0S 
cs 20.09 
D30 15.36 
*D29 . 10.54 
15.52 - 40.03 
14.07 - 34.21 
17.91 - 50.96 
6.26 - 17.60 
6. 58 - 11.58 
3. 77 - 10. 76. 
5.20 - 13.76 
7.73 - 17.01 
4.35 -· 14.29 
8. 04 - 17. 58 
7.11 - 22.08 
5. 90 -· 25. 86 
9.92 - 32.38 
8.05 - 16.96 
11. 27 - 21. 02 
9.SS - 24.43 
17.60 - 32.80 
6. 63 - 11. 79 
5.11 - 13.08 
7.22 - 12.85 
8.88 - 22.84 
10.45 - 24.67 
7. 77 - 16 .. 94 
9.81 - 18.66 
10.88 - 20.55 
7.94 - 20.16 , 
5.06 - 18.63 
4.26 - 28.30 
13.18 - 45.95 
13.85 - 26.68 
17. 20 - 40. 40 
10.72 - 20.10 
8.30 - 16.22 
7.68 - 16.09 
9.28 - 19.59 
13.12 - 24.44 
14.43 - 48.07 
10.21 - 22.98 
10.91 - 22.22 
4.51 - 59.74 
12.05 - 45.07 
14.40 - 28.84 
12.00 - 19.41 
S.47 - 17.17 
P*Mean·Potency ---.: ., .. , .. -1 '.'~·:: ::·,:.;·'! :,.,.~ -:-·t,:':··.: \..'.. ,.,,'.-~,.-.1 r·:·.-, t.~· 
.202 
.192 
.218 
.216 
.127 
.222 
. 210 
.169 
.250 
.172 
.231 
.• 296 
.239 
.160 
.137 
.196 
.138 
.127 
.200 
.127 
.194 
.184 
.171 
.143 
.138 
.202 
.267 
.358 
.261 
.144 
.185 
.129 
.149 
.161 
.164 
.139 
.243 
.178 
.1S8 
·.433 
.262 
.1S2 
.107 
.223 
,., ........... ... 
*P~tuitary ~otency.Re1~cted Because of Non-Paralle.lismbetween the 
and Pituitary D1lut1ons Standard LH 
**Pituitary Potency Rejected Because A.>. 300. 
~The Index of Precision, Variance t Slope 
t95% Confidence Limits Calculated from the Assay 
(continued) ,... 
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APPENDIX VII: INDIVIDUAL PITUITARY LR POTENCIES 2-MONTH STUDY (continued) 156 
RAT NO. ASSAY NO. p* 95% CL ~. 
CONTROL 
PRO ESTRUS SD48 C43 20. 64 ' 14.74 - 28.62 .148 
SD17 C48 24.78 18.42 - 33.66 .135 
SD4 C40 24.82 15.24 - 43.38 .220 
ESTRUS - AM LG38 D5 10.37 5. 37 ·- 17. 83 .245 
SD74 D3 16. 77 12.01 - 23.84 .152 
SD60 C48 10.95 7.29 - 15.80 .167 
SD23 ·:,c41 *34.90 22.44 - 64.92 .192 
ESTRUS - ·PM SD28 C52 16~88 9.76 - 29.69 .236 
SD94 C45 12.31 7.82 - 18.21 .179 
SD55 C42 18.27 13.67 - 24.33 .129 
SD71 :.~c38 *18.31 12.79 - 29.15 .• 156 SD36 
ACO - SHAM 
PRO ESTRUS SD22 C52 18.93 11.69 - 29.54 .200 
SD80 C43 26.90 20.60 - 35.63 .122 
SD69 Dl 17.32 11. 47 - 25~ 72 .178 
SD20 C44 **20.46 8.48 - 46.14 .330 
ESTRUS - AM SD67 DlO 13.15 8.10 - 21. 50. .211 
SD90 D9 . 10. 31 5. 41 - 17 .15 .231 
SD26 Dl 15.97 10.20 - 24.50 .191 
SD58 D3 *27.25 18.10 - 45.40 .187 
SD30 D5 *7.49 2.12 - 14.84 .308 
ESTRUS - PM SD40 C52 13.95 7.59 - 23.77 .238 
SD65 C50 17.32 11.30 - 26.46 .186 
SD41 C45 17·.86 13.13 - 24.34 .138 
ST - LESION 
PRO ESTRUS SD97 D26 14.30 8.80 - 21.87 .194 
SD21 D24 . 12. 47 7.19 - 19.53 .206 
SD78 D22 19.06 13. 33 - 27. 56 ;161 
ESTRUS - AM SD35 D22 .11.84 8. 00 - 17. 04 .165 
SD33 D24 10.62 6.73 - 16.16 .190 
SDlOO D24 13.02 8. 07 - 21. 07 , .208 
SD96 D26 *5.45 2.80 - 8.69 .206 
ESTRUS - PM. SD46 D24 23.83 13.79 - 49.60 .251 
SD66 D22 12.54 8.30 - 18.25 .171 
SD12 D27 17"~91 13.44 - 24.60 .131 
SD83 D26 10.15 6.35 - 14.85 .173 
ACO - LESION 
PRO ESTRUS SD105 D12 22.03 14.29 - 35.60 .196 
SD64 C45 13.34 8.21 - 20.18 .189 
SD6 C48 17.87 13.87 - 23.19 .115 
SDlO C42 18.55 13.83 - 24.48 .127 
ESTRUS - AM SD95 DlO 16. 82. 9.31 - 32.30 .257 
SD2 Dl 13.97 9.61 - 19.50 .157 
SD98 D3 13. 79 9.39 - 20.14 .164 
SD7 D5 *4. 77 0.53 - 11.34 .390 
SE35 D26 *15.39 10.35 - 23.65 .180 
SE14 D22 *7.94 4.69 - 12.01 .187 
ESTRUS - PM SD120 D5 15.23 7.84 - 27.03 .255 
SD9 C51 22.36 16. 04 - 31. 44 .150 
SD80 Dl 14.96 9.12 - 23.20 .203 
SDll C45 20.45 13. 76 - 31.19 .179 
SD113 D3 *26.67 19.62 - 37.84 .140 
SD50 C52 *13.65 7.59 -
Legend Same as APPENDIX VII, Page 155 21.69 .212 
(continued) 
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APPENDIX VII: INDIVIDUAL PITUITARY LR POTENCIES 4-MONTH STUDY (continued) 
.... .... 
RAT NO. ASSAY NO. p* 95% CL ). 
CONTROL 
PRO ESTRUS SF3 D34 19.14 15.52 - 23.44 .093 
SAll C34 12.81 5.62 - 27.08 .300 
SA59 C37 8.21 4.89 - 12.83 .204 
SF2 D31 *26.08 17.66 - 43.83 .170 
SA24 C33 *11. 76 5.97 - 19.47 .231 
ESTRUS - AM SA16 C39 10.12 7.21 - 13.85 .144 
ESTRUS - PM SF7 D33 16.68 11.46 - 25.29 .171 
SF17 D31 11.02 5.20 - 19.88 .267 
SA22 C33 15.51 10.11 - 24.74 .193 
SA15}. 
SA7 ~ C20 *15.39 8.58 - 36.55 .267 
METESTRUS SA2 C33 14.20 9.10 - 22.66 .197 
ACO :-'SHAM 
PROESTRUS - AM SA6 C39 21.88 16.17 - 29.53 .135 
PROESTRUS - PM SA33 C37 13.92 9. 71 - 19.59 .155 
SA14 C33 17. 54 12.14 - 24.79 .157 
SA28 D15 *29.04 21. 06 - 41. 96 .146 
SA54 D9 *12.77 7.34 - 19.90 .201 
ESTRUS - AM SA34 C39 14.00 8.67 - 22.47 .206 
ESTRUS - PM SF12 D33 15.41 9.88 - 23.85 .192 
SFll D31 16.76 11. 00 - 25. 7 5 .186 
SA50 C37 15.29 10.07 - 23.04 .182 
ACO - LESION 
PROESTRUS - PM SA29 C34 17.10 12.66 - 23.25 .135 
SA38 C39 22.97 15.06 - 37.70 .193 
SA19 C20 *16.34 10.64 - 23.66 , .169 
ESTRUS - AM SA56 D9 *21.15 15. 35 - 31. 20 .143 
SA48 . D9 ~18.67 14.39 - 25.12 .117 
SA27 D15 *19.62 13. 36 - 31. 56 .174 
ESTRUS - PM SF23 D31 19.42 11. 28 - 34. 53 .237 
SF5 D34 15.33 10. 42 - 21. 87 .162 
SA3 C34 17.39 9. 87 - 31. 54 .244 
·SA60 C37 11.15 7.16 - 16.36 .175 
SF46 D33 *24.17 16.49 - 37.91 .175 
SA55 D15 *24.25 17.09 - 36.40 .159 
Legend Same as APPENDIX VII, Page J55 
. ,., 
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APPENDIX VIII: INDIVIDUAL DATA FOR THE OVARIAN COMPENSATORY HYPERTROPHY STUDY 
LEFT OVARY RIGHT OVARY 
WET WEIGHT WET WEIGHT CYCLIC STAGE 
RAT NO. (mg). (mg) ·%OCH AT AUTOPSY EGGS* 
CONTROL - 0 DAYS OCH 
LG62 35.8 36.2 1.12 Proestrus 
LG64 35.5 30.8 -13.24 Proestrus 
LG65 38.0 36.6 -3.68 Proestrus 
LG68 36.0 41.4 15.00 Proestrus 
LG69 31. 7 35.8 12.93 Pro estrus 
I.£74 33.3 34.0 2.10 Proestrus 
I.£75 40.3 48.6 20.60 Pro estrus 
LG77 32.4 36.1 11.42· Proestrus 
I.£78 22.2 28.7 29.28 Proestrus 
LG81 37.4 41.2 10.16 Proestrus 
LG88 46.8 39.6 -15.38 Proestrus 
LGlOl 37.3 37.3 o.oo Proestrus 
LG67 37.6 30.2 +19.68 Proestrus 
LG86 34.4 32.0 -6.98 Proestrus 
I.£87 34.0 42.1 23.82 Proestrus 
LG94 37.2 34.2 -8.06 Proestrus 
LH6 44.8 59.0 31. 70 Proestrus 
SF28 28.4 46.2 62.68 Met estrus 
.. 
... SF29 42.4 38.8 -8.49 Diestrus 
SF30 45.2 39.0 13. 72 Proestrus 
SF31 56.2 51.0 -9.25 Estrus 
SF32 49.4 43.2 -12.55 Di estrus 
SF36 63.2 50.2 -20.56 Diestrus 
SHlO 37.3 28.5 -23.59 Metestrus 
SH14 24.1 25.7 6.63 Estrus ,r~ '. ._.,. 
SH43 24.5 25.7 4.89 Estrus 
SH47 34.8 31.8 -8.62 Proestrus 
CONTROL - 10 DAYS OCH 
SDlll 35.7 54.9 53.78 Diestrus 
SD72 47.0 61.2 30.21 Diestrus 
SD121 33.1 54.7 65.26 Diestrus 
SD47 47.9 57.0 19.00 Metestrus 
SD43 .38.8 53.5 37.89 PSP 
SD16 37.7 47.7 26.53 Met estrus 
SD91 29.2 52.0 78.08 Met estrus 
SD106 47.8 60.1 25.73 Diestrus 
SD93 40.2 59.5 48.01 Diestrus 
SDllO 38.1 56.2 47.51 Di estrus 
SD122 49.1 62.1 26.48 Diestrus 
SD29 53.8 55.2 2.60 Metestrus 
SH9 44.4 57.0 28.37 PSP 
SH24 33.4 42.3 25.51 Estrus 
SH25 38.2 46. 7 . 22.25 Proestrus 
SH39 33.0 51. 7 56.66 Proestrus 
SI26 34.0 49.0 44.11 Met estrus 
SI42 37.2 38.8 4.30 Diestrus 
*If no figure is given, then the animal·was·not inspected for oviductal eggs. 
PSP = Pseudopregnant 
(continued) 
-

(continued) 16o 
APPENDIX VIII: INDIVIDUAL DATA FOR THE OVARIAN COMPENSATORY HYPERTROPHY STUDY 
LEFT OVARY RIGHT OVARY 
WET WEIGHT WET WEIGHT CYCLIC STAGE 
RAT NO. (mg) (mg) % OCH AT AUTOPSY EGGS 
ST LESION - 10 DAYS OCH 
SD54 47.2 40.8 -13.55 PSP 
SD124 38.0 36.9 -2.89 PSP 
SG3 42.1 46.7 +10.90 PSP 
SG20 33.3 39.4 +18.31 Estrus 
SG2 38.9 38.6 -0. 77 PSP 
SGl 35.0 35.8 +2.30 PSP 
ACO LESION - 10 DAYS OCH 
SD119 46.3 . 58.4 +26.13 Estrus 13 
SD89 42.3 45.2 +6.85 Metestrus 
SD75 33.2 35.2 +6. 02 PSP 
SF15 59.3 49.1 -17. 20 PSP 
SF20 50.0 56.8 +13. 60 Metestrus 
SF33 41.9 54.1 +12.94 PSP 
SF45 49.0 53.3 +8.78 Estrus 
SF13 52.1 39.0 -25.14 PSP 
CEREBRAL CORTEX LESION - 10 DAYS OCH 
SI15 29.8 40.0 34.22 Metestrus 
SI19 31.4 32.4 3.18 PSP 
SI27 25.2 43.5 72.62 Met estrus 
SI30 32.8 38.2 16.46 PSP 
SI48 24.6 32.9 33.73 PSP 
SI55 40.6 56.1 38.18 Estrus -8 ,--·.:.:- "-":,. 
ST~LESIONS MISPLACED 
SD92 33.3 45.6 . 36.93 Met estrus 
SI58 33.8 4~.~ ': ' ·, .... 28. 9~ PSP •,:·. 
j ,/''.'· ·-;·· ACO.LESIONS MISPLACED :...: ' ~ - : : .. ..' 
LG2 31.1 41.9 31. 73 PSP 
Legend Same as APPENDIX VIII, Page 158 
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